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Abstract
Instrumental variables (IV) methods have been widely used to determine the causal effect of a treatment,
exposure, policy, or an intervention on an outcome of interest. The IV method relies on having a valid
instrument, a variable that is (A1) associated with the exposure, (A2) has no direct effect on the outcome, and
(A3) is unrelated to the unmeasured confounders associated with the exposure and the outcome. However, in
practice, finding a valid instrument, especially those that satisfy (A2) and (A3), can be challenging. For
example, in Mendelian randomization studies where genetic markers are used as instruments, complete
knowledge about instruments' validity is equivalent to complete knowledge about the involved genes'
functions.
The dissertation explores the theory, methods, and application of IV methods when invalid instruments are
present. First, when we have multiple candidate instruments, we establish a theoretical bound whereby causal
effects are only identified as long as less than 50% of instruments are invalid, without knowing which of the
instruments are invalid. We also propose a fast penalized method, called sisVIVE, to estimate the causal effect.
We find that sisVIVE outperforms traditional IV methods when invalid instruments are present both in
simulation studies as well as in real data analysis.
Second, we propose a robust confidence interval under the multiple invalid IV setting. This work is an
extension of our work on sisVIVE. However, unlike sisVIVE which is robust to violations of (A2) and (A3),
our confidence interval procedure provides honest coverage even if all three assumptions, (A1)-(A3), are
violated.
Third, we study the single IV setting where the one IV we have may actually be invalid. We propose a
nonparametric IV estimation method based on full matching, a technique popular in causal inference for
observational data, that leverages observed covariates to make the instrument more valid. We propose an
estimator along with inferential results that are robust to mis-specifications of the covariate-outcome model.
We also provide a sensitivity analysis should the instrument turn out to be invalid, specifically violate (A3).
Fourth, in application work, we study the causal effect of malaria on stunting among children in Ghana.
Previous studies on the effect of malaria and stunting were observational and contained various unobserved
confounders, most notably nutritional deficiencies. To infer causality, we use the sickle cell genotype, a trait
that confers some protection against malaria and was randomly assigned at birth, as an IV and apply our
nonparametric IV method. We find that the risk of stunting increases by 0.22 (95% CI: 0.044,1) for every
malaria episode and is sensitive to unmeasured confounders.
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ABSTRACT
INSTRUMENTAL VARIABLES AND MENDELIAN RANDOMIZATION WITH
INVALID INSTRUMENTS
Hyunseung Kang
Dylan S. Small
T. Tony Cai
Instrumental variables (IV) methods have been widely used to determine the causal effect
of a treatment, exposure, policy, or an intervention on an outcome of interest. The IV
method relies on having a valid instrument, a variable that is (A1) associated with the ex-
posure, (A2) has no direct effect on the outcome, and (A3) is unrelated to the unmeasured
confounders associated with the exposure and the outcome. However, in practice, finding a
valid instrument, especially those that satisfy (A2) and (A3), can be challenging. For ex-
ample, in Mendelian randomization studies where genetic markers are used as instruments,
complete knowledge about instruments’ validity is equivalent to complete knowledge about
the involved genes’ functions.
The dissertation explores the theory, methods, and application of IV methods when invalid
instruments are present. First, when we have multiple candidate instruments, we establish
a theoretical bound whereby causal effects are only identified as long as less than 50% of
instruments are invalid, without knowing which of the instruments are invalid. We also
propose a fast penalized `1 method, called sisVIVE, to estimate the causal effect. We find
that sisVIVE outperforms traditional IV methods when invalid instruments are present
both in simulation studies as well as in real data analysis.
Second, we propose a robust confidence interval under the multiple invalid IV setting. This
work is an extension of our work on sisVIVE. However, unlike sisVIVE which is robust
vi
to violations of (A2) and (A3), our confidence interval procedure provides honest coverage
even if all three assumptions, (A1)-(A3), are violated.
Third, we study the single IV setting where the one IV we have may actually be invalid.
We propose a nonparametric IV estimation method based on full matching, a technique
popular in causal inference for observational data, that leverages observed covariates to
make the instrument more valid. We propose an estimator along with inferential results
that are robust to mis-specifications of the covariate-outcome model. We also provide a
sensitivity analysis should the instrument turn out to be invalid, specifically violate (A3).
Fourth, in application work, we study the causal effect of malaria on stunting among children
in Ghana. Previous studies on the effect of malaria and stunting were observational and
contained various unobserved confounders, most notably nutritional deficiencies. To infer
causality, we use the sickle cell genotype, a trait that confers some protection against malaria
and was randomly assigned at birth, as an IV and apply our nonparametric IV method. We
find that the risk of stunting increases by 0.22 (95% CI: 0.044, 1) for every malaria episode
and is sensitive to unmeasured confounders.
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CHAPTER 1 : Introduction
1.1. Association Versus Causation in Observational Studies and the Problem of Un-
measured Confounding
“Association does not imply causation.” It is an old mantra taught in introductory statis-
tical courses, usually accompanied with comical examples from contemporary news articles
such as the “causal” relationship between global average temperatures and the number of
pirates (Anderson, 2012) or more serious issues such as the “causal” relationship between
childhood vaccinations and autism in children based on a methodologically flawed asso-
ciation analysis (Institute of Medicine of the National Academies: Immunization Safety
Review Committee, 2004). With the latter, the deadly mistake of equating association with
causation and the fear the study generated have led to a resurgence in preventable childhood
diseases in the United States during the 21st century (Omer et al., 2009) along with count-
less and wasteful public resources dedicated to debunking this myth (Institute of Medicine
of the National Academies: Immunization Safety Review Committee, 2004). In fact, often
the goal in a scientific inquiry is causal. But, scientists, for costs or other reasons, are left
with associational (observational) data to draw causal conclusions. Since association does
not imply causation, is all hope of drawing causal conclusions from associational data lost?
Are we bound to make the same faulty causal conclusions like the ones discussed above?
The statistical theory of observational studies seeks to provide principles and methods for
designing and analyzing associational studies with the aim of connecting association and
causation (see Rosenbaum (2002) and Rubin (2005) for an overview). Using the tools
developed in observational studies, associational data has often contributed to important
findings such as the finding of the 1964 Surgeon’s General report that “cigarette smoking
is causally related to lung cancer in men,” which was based on observational studies with
associational data and had a huge impact on public health (United States Surgeon Gen-
eral, 1988). A central problem in observational studies is how to deal with unmeasured
1
confounding. To illustrate, consider a study where we were given observational data about
children in sub-Saharan Africa, specifically their malarial infections and height. The goal
of the study was to determine whether malarial infections caused a child to have stunted
height, i.e. abnormally short height. The problem was that there were other potential
explanations for stunted height besides malaria that were unmeasured for in the data, such
as the child’s daily diet, which can impact his/her growth as well as his/her immune sys-
tem, making him/her more susceptible to malarial infections. In short, the child’s diet was
an unmeasured confounder that confounded the causal relationship between malaria and
stunted height. Successfully dealing with unmeasured confounding is a central goal in the
theory of observational studies.
1.2. A Potential Solution for Unmeasured Confounding: Instrumental Variables and
Mendelian Randomization
One method, instrumental variables (IV), has remained a popular tool in statistics for
overcoming the problem of unmeasured confounding. IV methods have been widely used in
many fields outside of statistics, including economics (Angrist and Krueger, 2001), genomics
and epidemiology (Davey Smith and Ebrahim, 2003), sociology (Bollen, 2012), psychology
(Gennetian et al., 2008), political science (Sovey and Green, 2011), and countless others.
For example, the malaria study mentioned above used one of our proposed IV matching
methods in Chapter 4 to conclude, from observational data, that there is a causal effect
between repeated malarial episodes and stunting where the risk of stunting increases by 0.22
for every malaria episode (p-value: 0.011, 95% confidence interval: 0.04, 1, see Chapter 5
for more details on this study).
The popularity of IV methods can be attributed to the fact that they alleviate the re-
quirement to conduct a randomized experiment to determine a causal effect. Randomized
experiments are the gold standard in determining causal effects. But, they are often expen-
sive and sometimes unethical. For example, with our malarial study, a randomized clinical
trial would involve randomly assigning children to receive the malarial parasite at the whim
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of a coin flip, a highly unethical task. IV methods avoid the need for a traditional ran-
domized experiment by finding an instrument where the instrument is (A1) related to the
exposure, (A2) has no direct pathway to the outcome, and (A3) is not related to unmeasured
confounders that affect the exposure and the outcome. Recently, IV methods have been
applied to genetic data where instruments are genes and the field is known as Mendelian
randomization (MR)(Davey Smith and Ebrahim, 2003, 2004). For example, in our malaria
study to be discussed in Chapter 5, we used the sickle cell trait, one of the genotypes that
determines the shape of a red blood cell, as an instrument (see Figure 1). The sickle cell
genotype has been shown to provide protection against malaria, satisfying (A1) (Friedman,
1978; Hill et al., 1991). For satisfying (A2) and (A3), prior studies (Ashcroft et al., 1978;
Rehan, 1981) from non-malaria endemic areas, but where the sickle cell trait was present,
provided support for the two assumptions (see Chapter 5 for more details).
Sickle 
Cell Trait
Repeated 
Malaria 
Episodes
Stunted 
Height
Unmeasured
Confounders(A3)
(A2)
(A1)
Figure 1: Diagram of instrumental variables assumptions in the malaria study. Arrows rep-
resent associations between variables. Absence of arrows indicates no relationship. Numbers
(A1), (A2), and (A3) indicate different instrumental variables assumptions.
1.3. A Major Challenge in Instrumental Variables: Finding Valid Instruments
One of the biggest challenges in IV methods is finding an instrument that satisfies the
conditions (A1)-(A3). Specifically, satisfying assumption (A2), also known as the no direct
effect assumption, has been problematic in many IV studies. For example, if the instruments
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are genes, as is the case in Mendelian randomization, satisfying (A2) would imply that the
gene/instrument’s only biological function is to affect the exposure only, i.e. the gene is not
pleiotropic. However, this assumption is unreasonable for many genetic markers as they
often have multiple functions (Solovieff et al., 2013); in fact, our malaria study explained
in Section 1.2 is no exception to this problem.
Many epidemiologists who use genetic instruments are aware of this problem (Davey Smith
and Ebrahim, 2003; Lawlor et al., 2008); Lawlor et al. (2008) also describes other types of
biological phenomena such as linkage disequilibrium and population stratification, which
are unique to IV studies where instruments are genetic, and may violate (A2) and (A3).
Unfortunately, without complete biological knowledge of the gene and its plethora of func-
tions or effects by linkage disequilibrium, all IV methods in Mendelian randomization are
plagued by possible violations of (A2) and (A3). Also, economists who use IV methods
face similar problems, specifically concerning whether their candidate instruments violate
(A2) and (A3) (Murray, 2006). Previous IV methods have assumed that there is at least
one known valid instrument satisfying (A1)-(A3). However, in many applications, one may
have many candidate instruments, but is not sure about the validity of any of them.
Also, in some cases, we may not have many candidate instruments and we may end up with
only one candidate instrument. With the one instrument, we have to do our best to make
sure that this instrument is valid and to assess the impact on our statistical analysis should
this instrument turn out to be invalid despite our best efforts. For example, in our malaria
example, the data only provided one instrument, the sickle cell genotype, for us to infer the
causal effect of malaria and stunting.
In short, all IV analysis, to varying degree, suffer from the “invalid instrument problem.”
For example, if we are given multiple candidate instruments, we are never certain whether
all of them are valid, that is satisfy (A2) and (A3); it is probably the case that some of them
are invalid. As another example, if we are left with only a single candidate instrument, we
have to find ways to make the instrument “more valid” and, more importantly, to assess
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the sensitivity of the statistical analysis should the instrument fail to be valid, despite our
best efforts.
1.4. Our Contributions and Outline of Dissertation
Broadly speaking, the thesis tackles the invalid instrument problem into two cases, the case
with multiple instruments and the case with one instrument. In Chapter 2, we consider the
multiple instrument case where we aren’t sure whether these instruments satisfy conditions
(A2) and (A3). We show that key parameters in the data generating model can still be
identified even without knowing which candidate instruments are valid or invalid by pro-
viding both a necessary and sufficient condition for identification. In particular, the causal
effect of the treatment on the outcome can always be identified if the number of invalid
instruments (denoted by s) is strictly less than 50% of the total candidate instruments L
(i.e. s < L/2), even if one does not know which of the L instruments are valid and invalid,
a priori. If more than 50% of the total candidate instruments may be invalid, then the
scientist can check the necessary and sufficient conditions to see whether the parameters in
the model are identified.
In line with the identification result, Chapter 2 also proposes a method to estimate the causal
effect of the treatment on the outcome if some instruments are invalid, without knowing
which instruments are invalid. Our proposed estimator, sisVIVE, is a penalized `1 estimator,
which has theoretical guarantees on performance under certain regularity conditions. Also,
in simulation studies and a real data analysis, we show that sisVIVE dominates the most
popular IV method, the two stage least squares, whenever invalid instruments are present.
Chapter 3 extends the work in Chapter 2 by providing a robust confidence interval under the
settings described in Chapter 2. In particular, we propose a simple and general method to
construct confidence intervals that are theoretically guaranteed to provide honest coverage
in the presence of invalid instruments.
In Chapter 4, we consider the case where we are only given one candidate instrument.
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In this work, we attempt to make the IV assumptions more plausible, specifically (A3), by
controlling for measured covariates. Conditional on these covariates, the instrument behaves
as if it was a result of random assignment and hence, is unassociated with the unmeasured
confounders. We incorporate this idea of conditioning by full matching, which has been
shown to have some advantages compared to other methods that condition on covariates
(Stuart, 2010). A matching algorithm generates matched sets by grouping individuals in
the data who are similar to each other, except for the value of the instrument. For example,
if the instrument is binary and is denoted by Z, the matching algorithm may generate I
matched sets with each set containing nk individuals of which mk have Zs equal to 1 and
nk −mk have Zs equal to 0.
Once we obtain matched sets, we propose a nonparametric estimator of the causal effect
of the exposure on the outcome where we do not assume a parametric model between the
outcome Yi and the covariates Xi. We prove some desirable theoretical properties concerning
our nonparametric estimator. We also derive a general formula for computing efficiency of
any IV matching-based estimators. Finally, we propose sensitivity analysis if the instrument
does violate (A3) even after controlling for the covariates using our nonparametric matching
method.
In Chapter 5, we apply the nonparametric full matching technique developed in Chapter
4 by analyzing the malaria example mentioned in Section 1.2. Specifically, the goal in the
data analysis is to provide an estimate of the causal effect of malaria episodes on stunted
growth in children from Ghana. The novel idea in this work is the use of the sickle cell
trait as an instrument. The trait has been known to confer some level of protection against
malaria, thereby satisfying (A1). But, it’s possible that (A2) and (A3) may be violated. We
use the method in Chapter 4 to alleviate some of these concerns and provide an estimate
of the causal effect.
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CHAPTER 2 : Instrumental Variables With Possibly Invalid Instruments: Theory
and Point Estimation
This is joint work with Anru Zhang, Tony Cai, and Dylan Small.
2.1. Motivating Examples of Invalid Instruments in Mendelian Randomization
As mentioned before, the goal in Mendelian randomization (MR) is to estimate the causal
effect of an exposure on an outcome by using genetic markers, specifically single nucleotide
polymorphisms (SNPs), as instruments (Davey Smith and Ebrahim, 2003, 2004; Lawlor
et al., 2008; Wehby et al., 2008). However, there is always concern as to whether these
SNPs satisfy the IV assumptions. For example, Timpson et al. (2005) studied the causal
effect of C-reactive protein (CRP), the exposure, on various metabolic outcomes, such as
body mass index (BMI) and cholesterol biomarkers (e.g. tryglycerides), using four hap-
lotypes constructed from three SNPs (rs1800947, rs1130864, rs1205) as instruments. The
instruments have been previously associated with plasma CRP levels, thereby agreeing
with (A1). However, agreement with (A2) and (A3) is less certain. As the authors of the
study noted, it is plausible that one or more of the genes that contain the SNPs, rs1800947,
rs1130864, and rs1205, may have multiple functions, known as pleiotropy, where, in addition
to changing CRP levels (the exposure), the gene containing one of these SNPs would change
triglyceride levels or BMI (the outcome) and (A2) would not hold. Indeed, recent work by
Mart´ınez-Calleja et al. (2012) suggested that one of the instruments used, rs1130864, is
directly linked to BMI, one of the outcomes, raising doubts about causal estimates when
this SNP is assumed to be a valid instrument.
As another example, Katan (1986), in one of the first discussions of MR, proposed to
estimate the causal effect of serum cholesterol level on cancer by using the apolipoprotein
E polymorphism (APOE)’s effect on serum cholesterol levels. However, as Davey Smith
and Ebrahim (2004) argued, the current knowledge about the APOE gene and its multiple
pleiotropic effects on longevity, cholesterol biomarkers, and several other variables, would
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invalidate the APOE gene as a valid instrument, specifically due to its violation of (A2),
and make an IV analysis based on it biased.
Both examples highlight a fundamental limitation with MR studies. For one, pleiotropy and
its impact on (A2) is a concern in most MR studies (Little and Khoury, 2003; Davey Smith
and Ebrahim, 2003, 2004; Thomas and Conti, 2004; Brennan, 2004; Lawlor et al., 2008).
Lawlor et al. (2008) also list other biological phenomena associated with genetic instru-
ments such as linkage disequilibrium and population stratification that may violate (A2)
and (A3). Unfortunately, verifying genetic instruments as valid IVs requires having com-
plete knowledge of the instruments’ biological function and pleoitropic effects. As both
examples highlight, the biological understanding of many genetic markers and their poten-
tial pleiotropic effects are typically incomplete at the time of the study (Solovieff et al.,
2013). In the face of incomplete biological knowledge and possible instrument invalidity,
can valid causal estimates be derived?
Previous work in IV estimation in the presence of possibly invalid instruments is limited.
Traditional instrumental variables literature has stated that to estimate the causal effect of
an exposure on an outcome when there are unmeasured confounders, one needs to have at
least one instrument that one knows is valid (Wooldridge, 2010). Andrews (1999) considered
the invalid instrument case in the general context of generalized method of moments (GMM)
estimation common in econometrics and arrived at an identification result that is similar to
our identification result in Theorem 2.1. The author also proposed an estimation strategy,
called the moment selection criteria (MSC), to correctly select the valid instruments, which
is similar to equation (2.10) in Section 2.3.3. Unfortunately, as we discuss in Section 2.3.3,
MSC is computationally infeasible when the number of instruments is large. Kolesa´r et al.
(2013) considered the possibility of identifying causal effects when all the instruments are
invalid because of direct effects on the outcome. The authors showed that if the direct
effects are orthogonal to the instruments’ effects on the treatment, then the causal effect
can be identified. Kolesa´r et al. (2013) describes conditions under which this orthogonality
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is plausible. But, for MR, this stringent structure on the instruments would not hold in
most cases as it would mean that the pleiotropic effects of the IVs are orthogonal to the
effects of the IVs on the treatment. Gautier and Tsybakov (2011) analyzed instrumental
variables regression in the presence of possibly invalid instruments. However, for their
procedure to work, one must have a pre-defined set of known valid instruments. Finally,
Mealli and Pacini (2013) explored how using an auxiliary outcome can tighten bounds or
provide identification of the effect of a treatment on a primary outcome when there is only
one binary instrument that may violate (A2) by using an using auxiliary outcome. However,
their work is different to our problem where we consider multiple candidate instruments.
We add to the prior literature as follows. First, we show that it is indeed possible to identify
and estimate the causal effect without a known pre-defined set of valid instruments. In
particular, under a weaker condition where the proportion of invalid instruments is strictly
less than 50% of the total instruments, we show that identification and estimation are
possible. For example, given four possible haplotypes/instruments in the previous example
by Timpson et al. (2005), estimation of the causal effect of CRP on metabolic phenotypes
is still possible if no more than one instrument is invalid, without knowing exactly which of
the four is invalid. We also show conditions for identification when the 50% threshold may
not hold.
Second, we develop a fast `1 estimation procedure to estimate the causal effect of the
exposure on the outcome in the presence of possibly invalid instruments. The procedure
has provable theoretical guarantees on estimation performance and is computationally as
fast as ordinary least squares. The procedure is implemented and available on CRAN as an
R package sisVIVE, which stands for Some Invalid Some Valid IV Estimator.
Third, we conduct a simulation study that compares our method to two stage least squares
(TSLS), the most popular IV estimation procedure. We show that our procedure dominates
TSLS when the instruments may be invalid. We also conduct a real MR study concerning
the effect of BMI on a health-related quality of life (HRQL) measure using our new method.
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2.2. Causal Model for Instrumental Variables With Invalid Instruments
2.2.1. Notation
To define valid instruments, the potential outcomes approach (Neyman, 1923; Rubin, 1974)
for instruments laid out in Holland (1988) is used. For each individual i ∈ {1, . . . , n},
let Y
(d,z)
i ∈ R be the potential outcome if the individual were to have exposure d ∈ R
and instruments z ∈ RL. Let D(z)i ∈ R be the potential exposure if the individual had
instruments z ∈ RL. For each individual, only one possible realization of Y (d,z)i and D(z)i
is observed, denoted as Yi and Di, respectively, based on his observed instrument values
Zi. ∈ RL and exposure Di. In total, n sets of outcome, exposure, and instruments, denoted
as (Yi, Di,Zi.), are observed in an i.i.d. fashion.
We denote Y = (Y1, . . . , Yn) to be an n-dimensional vector of observed outcomes, D =
(D1, . . . , Dn) to be an n-dimensional vector of observed exposures, and Z to be a n by L
matrix of instruments where row i consists of Zi..
For any vector α ∈ RL, let αj denote the jth element of α. Let ‖α‖1, ‖α‖2, and ‖α‖∞
be the usual 1, 2 and ∞-norms, respectively. Let ‖α‖0 denote the 0-norm, i.e. the number
of non-zero elements in α. The support of α, denoted as supp(α) ⊆ {1, . . . , L}, is defined
as the set containing the non-zero elements of the vector α, i.e. j ∈ supp(α) if and only if
αj 6= 0. A vector α is called s-sparse if it has no more than s non-zero entries. Also, for a
vector α ∈ RL and a set A ⊆ {1, . . . , L}, we denote αA ∈ RL to be the vector where all the
elements except whose indices are in A are zero.
For any n by L matrix M ∈ Rn×L, we denote the (i, j) element of matrix M as Mij ,
the ith row as Mi., and the jth column as M.j . Let M
T be the transpose of M. Let
PM be the n by n orthogonal projection matrix onto the column space of M, specifically
PM = M(M
TM)−1MT ; it is assumed that MTM has a proper inverse, unless otherwise
noted. Let PM⊥ be the residual projection matrix, specifically PM⊥ = I−PM where I is
an n by n identity matrix.
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For any set A ⊆ {1, . . . , L}, we denote AC to be the complement of set A. Also, we denote
|A| to be the cardinality of set A.
2.2.2. Model
We consider the Additive LInear, Constant Effects (ALICE) model of Holland (1988) and
extend it to allow for multiple valid and possibly invalid instruments as in Small (2007).
Let d′, d ∈ R be possible values of the exposure and z′, z ∈ RL be possible values of
the instruments. Let i = Y
(0,0)
i − E[Y (0,0)i |Zi.] and the collection of i be denoted as
 = (1, . . . , n). Suppose we have the following potential outcomes model for the outcome
Y
(d′,z′)
i − Y (d,z)i = (z′ − z)Tφ∗ + (d′ − d)β∗ (2.1)
E(Y
(0,0)
i |Zi.) = ZTi.ψ∗ (2.2)
where φ∗,ψ∗ ∈ RL, and β∗ ∈ R are unknown parameters. In equation (2.1), the parameter
β∗ represents the causal parameter of interest, the causal effect of changing the exposure
by one unit on the outcome. Also in equation (2.1), the parameter φ∗ represents the direct
effect of the instruments on the outcome; changing instruments from z′ to z results in a
direct effect on the outcome of (z′− z)Tφ∗. In equation (2.2), the parameter ψ∗ represents
the confounders that affect the instrument and the outcome. In particular, without any
confounders, there should not be any relationship between the instruments Zi. and the
potential outcome Y
(0,0)
i . Instead, in equation (2.2), they are related via ψ
∗.
Let α∗ = φ∗ + ψ∗. When we combine equations (2.1) and (2.2) along with the definition
of i, we have the observed data model
Yi = Z
T
i.α
∗ +Diβ∗ + i, E(i|Zi.) = 0 (2.3)
We make the following remarks regarding the model (2.3). First, the model can include
exogenous measured covariates, say Xi. ∈ Rp which may include the intercept term, and
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we can replace the variables Yi, Di, and Zi. with the residuals after regressing them on X,
where X is the n by p matrix of covariates, e.g. replace Y by (I−PX)Y (Wang and Zivot,
1998). The results in this paper will hold generally when working with such data that is
transformed by regressing out the effect of X. In the same spirit, the model can be extended
to non-linear models by including appropriate basis transformations of Zi.. However, for
simplicity of exposition, we will focus on a model without any measured covariates or non-
linear terms. We will also assume that Y, D, and the columns of Z are centered, which can
also result from a residual transformation with X containing only the intercept term.
Second, following Heckman and Robb Jr. (1985), Bjo¨rklund and Moffitt (1987), and Small
(2007), we can incorporate heterogeneous effects as follows. Suppose, instead of equation
(2.1), the potential outcomes model for the outcome is
Y
(d′,z′)
i − Y (d,z)i = (z′ − z)Tφ∗ + (d′ − d)β∗i (2.4)
where β∗ = E(β∗i ) is the average effect of the exposure for everyone in the population.
Then, the observed data model can be derived from (2.4) as follows.
Yi = Z
T
i.α
∗ +Diβ∗ + (β∗i − β∗)Di + i, E(i|Zi.) = 0 (2.5)
If (β∗i − β∗) is independent of Di given Zi., the heterogeneous model in (2.5) is identical to
model (2.3) and our result for Theorem 2.1 in Section 2.3.1 hold. Also, as Small (2007) notes
in page 1055, the assumption that (β∗i − β∗) is independent of Di given Zi. is equivalent
to that “units do not select their treatment levels Di given Zi. based on the gains they
would experience from treatment Di given Zi..” If this assumption is violated, different
groups of people will have different treatment effects, which in turn would lead to possibly
non-zero α∗ (see Angrist and Imbens (1995) and Small (2007) for details). For simplicity
of exposition, we will focus on a model with a constant linear effect β∗.
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2.2.3. Definition of Valid Instruments
Based on the observed model in (2.3), the parameter α∗ combines both the direct effect,
represented by φ∗, and the effect of confounders on the Zi. and Y
(0,0)
i relationship, repre-
sented by ψ∗. If there is no direct effect and no effect of the confounders, then α∗ = 0.
Hence, the value of α∗ captures the notion of valid and invalid instruments. The definition
below formalizes this idea:
Definition 2.1. Suppose we have the models in (2.1) -(2.3) with L instruments. We say
instrument j ∈ {1, . . . , L} is valid if α∗j = 0 and invalid if α∗j 6= 0.
Definition 2.1 distinguishes valid and invalid instruments based on supp(α∗), the support
of α∗. If instrument j = 1, . . . , L is not in the support, it is valid. If the instrument is in
the support of α∗, it is invalid. Consequently, not knowing which instruments are valid and
invalid directly translates to not knowing the support of α∗ in model (2.3).
In the case of only one instrument (i.e. L = 1), Definition 2.1 of a valid instrument matches
with the informal definition (A2) and (A3) in Section 1.2 and the formal definition in Holland
(1988). Specifically, the notion of exclusion restriction (A2), Y
(d,z)
i = Y
(d,z′)
i for all z, z
′ ∈ R
is equivalent to the parameter φ∗ in equation (2.1) being zero. Also, the assumption of
no unmeasured confounding of the IV-outcome relationship (A3) where Y
(d,z)
i and D
(z)
i are
independent of Zi for all d, z ∈ R, is encoded by ψ∗ in (2.2) being zero. Hence, φ∗ = ψ∗ = 0,
which implies α∗ = 0 and a valid IV in Holland (1988) is also a valid IV in our definition.
Also, for one instrument, our model and definition is a special case of the definition of a
valid instrument discussed in Angrist et al. (1996) where our model assumes an additive,
linear, and constant treatment effect β∗.
For more than one instruments (i.e. L > 1), our model (2.1)-(2.3) and definition of valid
IVs can be viewed as a generalization of Holland (1988). It is important to note that in this
generalization, Definition 2.1 defines the validity of an instrument j in the context of the
set of instruments {1, . . . , L} being considered. Specifically, an instrument j could be valid
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in the context of the set {1, . . . , L} (i.e. α∗j = 0), but invalid if considered alone because Z.j
may be associated with or causally affect another IV Z.j′ , j 6= j′ where α∗j′ 6= 0.
2.3. Estimation of Causal Effect With Invalid Instruments
2.3.1. Identifiability of Model
We first address whether the model in equation (2.3) is identifiable, that is whether we can
estimate the unknown parameters if we were given infinite data, even without any knowledge
about which instruments are valid and invalid. We begin by making the assumptions.
(a) E(ZTZ) is full rank;
(b) For E(ZTD) = E(ZTZ)γ∗, the components of γ∗ are all not equal to zero, i.e. γ∗j 6= 0
for j = 1, . . . , L.
Assumption (a) states that the matrix of instruments Z is full rank, a common assump-
tion in the instrumental variables literature (Wooldridge, 2010). Assumption (b) states
that the instruments are associated with the exposure, akin to assumption (A1), that the
instruments are relevant to the exposure; note that there does not need to be a causal re-
lationship between the instrument Z and the exposure D, just an association (Herna´n and
Robins, 2006; Didelez and Sheehan, 2007; Glymour et al., 2012). As one reviewer remarked,
assumption (b) requires that all L instruments are related to the exposure, γ∗j 6= 0 for all j.
If we have instruments that are not relevant to the exposure, γ∗j = 0, we can exclude them
from further analysis and concentrate only on those instruments that affect the exposure.
Now, the model in (2.3) implies the following moment condition.
E(ZT (Y − Zα∗ −Dβ∗)) = 0 (2.6)
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Suppose assumptions (a) and (b) hold. Then, the moment equation in equation (2.6)
simplifies to
Γ∗ = α∗ + γ∗β∗ (2.7)
where Γ∗ = E(ZTZ)−1E(ZTY). Since both Γ∗ and γ∗ can be identified by their moments
based on observed data E(ZTZ)−1E(ZTY) and E(ZTZ)−1E(ZTD), respectively, α∗ and
β∗ are identified if we can find a bijective mapping between α∗, β∗ and Γ∗,γ∗, i.e. a unique
solution of α∗, β∗ given Γ∗,γ∗.
If we know exactly which instruments are invalid A∗ = supp(α∗) = {j : α∗j 6= 0} and hence,
know the set of valid instruments (A∗)C = {j : α∗j = 0}, equation (2.7) becomes
α(A∗)C + γ
∗
(A∗)Cβ
∗ = γ∗(A∗)Cβ
∗ = Γ∗(A∗)C
There is a unique β∗ so long as |(A∗)C | > 0, or there is at least one known valid instrument.
This is a special case of the classic identification result for linear simultaneous equation
models (Koopmans et al., 1950) and is commonly used in the traditional IV literature.
If we know that there is a valid instrument, but are not sure of the identity of the valid
instrument(s), then a unique solution to (2.7) and hence, identification, is not guaranteed.
For example, let there be four instruments, L = 4 with γ∗ = (1, 2, 3, 4) and Γ∗ = (1, 2, 3, 8).
Then, depending on the set of valid instruments (A∗)C , which is unknown, we have two
different β∗ that satisfy equation (2.7). If the set of valid instruments (A∗)C is (A∗)C =
{1, 2, 3}, we have γ∗
(A∗)Cβ
∗ = Γ∗
(A∗)C and β
∗ = 1. However, if the set of valid instruments
is (A∗)C = {4}, β∗ = 2. Without knowing exactly which (A∗)C is the true set of valid
instruments, we cannot choose between the two β∗s and hence, there is not a unique solution
to (2.7).
But, suppose we impose constraints on A∗. Specifically, suppose the number of invalid
instruments, s = |A∗|, has to be less than some number U , s < U , without knowing which
instruments are invalid or knowing exactly the number of invalid instruments. For example,
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geneticists may have a rough idea on the maximum number of invalid instruments, U , but
not know exactly the number of invalid instruments nor do know exactly which instruments
are invalid. Note that this condition of knowing the maximum number of invalid instruments
is a much weaker requirement than what is traditionally required in IV and MR literature
where one must know exactly which instruments are invalid, i.e. know exactly the set A∗;
here, we only need an upper bound on the cardinality of A∗. Under the weaker condition
s < U , a unique solution to (2.7) can exist and this is stated in Theorem 2.1.
Theorem 2.1 (Uniqueness of Solution). Suppose we assume assumptions (a) and (b) and
the modeling assumption (2.3). Let s ∈ {0, 1, . . . , L} with s < U where U = 1, . . . , L.
Consider all sets Cm ⊆ {1, . . . , L},m = 1, . . . ,M of size |Cm| = L−U + 1 with the property
γ∗j qm = Γ
∗
j j ∈ Cm
where qm is a constant. There is a unique solution α
∗ and β∗ to (2.7) if and only if qm = qm′
for all m,m′ ∈ {1, . . . ,M}.
To understand Theorem 2.1, note that if the valid instruments are those in the set Cm, then
the causal effect β∗ = qm. More specifically, Theorem 2.1 says that β∗ is identified as long
as there are not two subsets of the instruments of cardinality L−U + 1 that give internally
consistent estimates of β∗ (i.e. all instruments in each subset give the same estimate of β∗),
but are externally inconsistent (i.e. the estimates of β∗ from the two subsets are different).
We call the property in Theorem 2.1 that there is a unique solution to α∗ and β∗ to (2.7) if
and only if qm = qm′ for all m,m
′ ∈ {1, . . . ,M} the consistency criterion. We thank Jack
Bowden for his insight and suggestions on terminology for interpreting Theorem 2.1.
Checking the consistency criterion can be computationally difficult, especially if U is large;
it requires looking at
(
L
L−U+1
)
possible subsets of {1, . . . , L} and the constants qm associated
with Γ∗ and γ∗. Corollary 2.1 says that the consistency criterion is automatically satisfied
if U ≤ L/2 (i.e. if 50% of the total candidate of L instruments are invalid) regardless of the
values of γ∗ and Γ∗.
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Corollary 2.1. If U ≤ L/2, there is always a unique solution to (2.7)
In addition to the computational benefits, compared to Theorem 2.1, Corollary 2.1 is simpler
to interpret. For example, for a geneticist, without knowing the entire biology of genetic
instruments, specifically knowing which instruments are valid and invalid, as long as the
number of invalid instruments is less than 50% of the total instruments, then the geneticist
can rest assured that the parameters can always be identified. If this is not the case, the
geneticist can always check the consistency criterion stated in Theorem 2.1.
We would like to mention two final points about Theorem 2.1. First, Theorem 2.1 is a
statement about uniqueness of solutions for the parameters α∗, and β∗ in equation (2.7).
A natural question to ask is whether the uniqueness is guaranteed for just β∗, the causal
effect of interest, at the expense of non-uniqueness of α∗. In the proof of Theorem 2.1 in the
Appendix, we show that this cannot be the case. Specifically, regardless of the condition
on s, the parameter β∗ is a unique solution to (2.7) if and only if the parameter α∗ is a
unique solution to (2.7). Second, Theorem 2.1 supposes the existences of the sets Cm and
proceeds to compare their corresponding qm. However, one may ask whether these sets Cm
even exist in the first place. In the proof of Theorem 2.1 in the Appendix, we provide a
rigorous argument that, indeed, under model (2.3) and s < U , at least one set Cm has to
exist.
2.3.2. Some Examples of Identified Models Using Theorem 2.1
To illustrate the nature of identified models with invalid instruments, specifically in relation
to Theorem 2.1, we consider a couple of examples. First, let us revisit the earlier numerical
example in Section 2.3.1 with γ∗ = (1, 2, 3, 4) and Γ∗ = (1, 2, 3, 8). Suppose our prior
knowledge on the upper bound on s is 3, i.e. U = 3. Then, by Theorem 2.1 we have
3 sets C1 = {1, 2}, C2 = {1, 3}, C3 = {2, 3} with q1 = q2 = q3 = 1. Hence, γ∗ and Γ∗
satisfy the consistency criterion of Theorem 2.1 and we have a unique solution α∗ and
β∗ to (2.7). In contrast, if γ∗ = (1, 2, 3, 4) and Γ∗ = (1, 2, 6, 8), we would have two sets
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C1 = {1, 2}, C2 = {3, 4} with q1 = 1 and q2 = 2, respectively. These γ∗ and Γ∗ do not
satisfy the consistency criterion of Theorem 2.1 because q1 6= q2 and there are no unique
solutions α∗ and β∗ to (2.7).
One of the reviewers, however, mentioned an extension of this numerical example where
the setup is identical except Γ∗ is perturbed by  > 0 such that Γ˜∗ = (1, 2, 6, 8 + ). With
Γ˜∗, there is only one set C1 = {1, 2} where q1 = 1 and we have identification for any .
However, we can shrink  to be arbitrary small such that Γ∗ and Γ˜∗ = (1, 2, 6, 8 + ), are
arbitrarily close to each other.
However, consider the identical setup as before, except Γ∗ = (1, 2, 7, 9). Then, there is only
one subset C1 = {1, 2} where q1 = 1 and identification is achieved. Furthermore, any small
perturbation of Γ∗ by δ > 0 and  > 0, i.e. Γ˜∗ = (1, 2, 7 + δ, 9 + ), will still produce only
subset C1 = {1, 2} and identification is maintained.
The two numerical examples with Γ∗ = (1, 2, 6, 8) and Γ∗ = (1, 2, 7, 9) illustrate what we
call the identification boundary. The vector Γ∗ = (1, 2, 6, 8) lies just at the identification
boundary where any small perturbation can render the model unidentified or identified. In
contrast, for Γ∗ = (1, 2, 7, 9), the vector Γ∗ lies far from the identification boundary and any
small perturbation can still make the model identifiable. Exploration of the identification
boundary for different values of Γ∗ and γ∗ is a topic for future research.
As a second example of identification using Theorem 2.1, we consider the classical linear
simultaneous/structural equations model in econometrics (Koopmans et al., 1950). To do
so, we impose two additional modeling assumptions which are not needed for identification,
but are part of the classical ecnoometrics model, and discuss the identification result in
2.3.1 under this context. The first additional modeling assumption is that the relationship
between Di and Zi. is linear
Di = Z
T
i.γ
∗ + ξi, E(ξi|Zi.) = 0 (2.8)
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where γ∗ relates the instruments to the exposure. The second additional assumption is that
the error terms are bivariate Normal
(i, ξi)
iid∼ N(0,Σ) (2.9)
Under these assumptions in (2.8) and (2.9), the distributions of Yi and Di conditional on
Zi. are fully characterized by finite-dimensional parameters α
∗, β∗,γ∗, and Σ known as
“structural” parameters in econometrics (Wooldridge, 2010). Let ′i = β
∗ξi + i. Then, we
have the “reduced forms” (Wooldridge, 2010)
Yi = Z
T
i.Γ
∗ + ′i
Di = Z
T
i.γ
∗ + ξi
where Γ∗ = α∗ + β∗γ∗ and the covariance matrix of (′i, ξi) is Σ
′ = MΣMT with
M =
1 β∗
0 1

We see that the distributions of Yi and Di are also fully characterized by the reduced form
parameters Γ∗,γ∗ and Σ′. By Rothenberg (1971), the reduced form parameters, Γ∗,γ∗, and
Σ′, are globally identified. Also, by Rothenberg (1971), the structural parameters, α∗, β∗,
γ∗, and Σ, are identified if and only if the mapping between the reduced form parameters,
Γ∗,γ∗,Σ′, and the structural parameters, α∗, β∗, γ∗,Σ, represented by equations Σ′ =
MΣMT , γ∗ = γ∗, and Γ∗ = α∗+ β∗γ∗, is bijective. We see that M is an invertible matrix
for any β∗ and hence there is a bijective map between Σ and Σ′. For γ∗, it maps onto
itself between the structural and reduced form parameters. Consequently, whether there is
a bijection between the structural parameters and reduced form parameters is determined
only by whether there is a unique solution α∗ and β∗ to equation 2.7 given γ∗ and Γ∗.
Theorem 2.1 states that a unique solution α∗ and β∗ of (2.7) exists if and only if the
consistency criterion holds, that qm = qm′ for all m,m
′ ∈ {1, . . . ,M}. Hence, with the
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modeling assumptions (2.8) and (2.9), we have identification of the structural parameters
if and only if the consistency criterion in Theorem 2.1 holds.
2.3.3. Estimation of the Causal Effect of Exposure on Outcome
Given the model (2.3) and s < U , Theorem 2.1 lays out the sufficient and necessary condition
for finding a unique solution to the moment equation (2.6). Specifically, if the model is
identified, the moment equation (2.6) is zero at exactly one value, the true value of α∗ and
β∗. Naturally then, a method to estimate the one true value is to find the values of α∗ and
β∗ that minimize (2.6) subject to the parameter constraint that s < U . Formally, we can
write this estimation strategy as
argmin
α,β
1
2
‖PZ(Y − Zα−Dβ)‖22, s.t. ||α||0 < U (2.10)
where ||α||0 is the number of non-zero entries of α and by Definition 2.1, s = ||α||0. Equa-
tion (2.10) is similar to the moment selection criterion (MSC) in Andrews (1999). However,
both the moment selection criterion in Andrews (1999) and (2.10) are computationally in-
feasible in the sense that both require going through all subsets of size less than U and
this type of problem has been shown to be NP-hard (Natarajan, 1995). Instead, a com-
putationally tractable version of estimation strategies like (2.10) has been proposed in the
literature using a convex surrogate of the `0 norm (Candes and Tao, 2005; Tropp, 2006;
Donoho, 2006). Specifically, the computationally feasible version of the estimation strategy
in (2.10) can be written as
argmin
α,β
1
2
‖PZ(Y − Zα−Dβ)‖22, s.t. ||α||1 ≤ t (2.11)
where the `0 norm is replaced by the convex norm `1 and U is replaced by a user-specified
tuning parameter t > 0. In this paper, we propose the equivalent Lagrangian form as our
estimator of the causal effect, called some invalid some valid IV estimator, or sisVIVE, as
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follows
(αˆλ, βˆλ) ∈ argmin
α,β
1
2
‖PZ(Y − Zα−Dβ)‖22 + λ‖α‖1 (2.12)
for some tuning parameter λ > 0 and λ corresponds to t in (2.11). If λ = 0 in (2.12),
then (2.12) is the popular two stage least squares (TSLS) estimator, which is equivalent to
the generalized method of moments (GMM) estimator when  in Section 2.2.2 are assumed
to be homoscedastic (Hansen, 1982). Hence, sisVIVE can be viewed as a generalization of
TSLS or GMM.
sisVIVE also bears some resemblance to the traditional `1 penalization procedure, in par-
ticular the Lasso (Tibshirani, 1996) or the recent `1 penalty procedures in IV estimation by
Gautier and Tsybakov (2011) and Belloni et al. (2012). However, there are a few important
differences. First, with regards to the traditional Lasso and the procedure proposed by
Gautier and Tsybakov (2011), our procedure in (2.12) only penalizes α∗. The estimator
(2.12) does not penalize β∗, the causal effect of the exposure on the outcome, because the
causal effect may be far from zero. In contrast, the prior works we mentioned penalize all
the parameters in the model. Second, the traditional Lasso only considers regression with
all exogenous regressors, which are regressors that are assumed to be independent of the
error term or assumed to be fixed. The regressors in our model (2.3) are not all exogenous;
specifically, model (2.3) contains one random endogenous variable, Di, which is dependent
on the error term. Third, Gautier and Tsybakov (2011) and Belloni et al. (2012) assume
that either all the L instruments are valid or we know exactly which subset of them are
valid. In contrast, our procedure does not assume this.
Finally, a careful reader may have recognized that there may be multiple minimizers to
equation (2.12), specifically βˆλ, because ||α||1 is not strictly convex and hence, we use the
set notation instead of the equality sign in (2.12). This might seem to be a concern as
there are multiple estimates of β∗. However, as we will show in Section 2.3.5, all minimizers
of (2.12) are close to the true values β∗. Also, if the entries of the matrix PDˆ⊥Z where
Dˆ = PZD (i.e. the predicted value of the exposure given the instruments) are drawn from
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a continuous distribution, then the solution to (2.12) is unique (Tibshirani, 2013).
Without loss of generality, we assume that the columns of Z are scaled to unit length. This
allows all L instruments to have identical units so no columns of Z gets unfairly penalized
by the penalty term in (2.12) simply due to their original units.
2.3.4. Choice of λ
Like many penalization procedures, the choice of the tuning parameter λ affects the perfor-
mance of the estimation procedure and this is certainly the case with sisVIVE. High values
of λ force heavy penalization on α, which will put most elements of αˆλ to zero and most
instruments will be estimated as valid instruments. In contrast, low values of λ will put
few elements of αˆλ to zero and most instruments will be estimated as invalid instruments.
In short, the optimal choice of λ depends on knowing the exact number of invalid and valid
instruments, something not implied by the condition s < U .
In practice, cross validation is a popular data-driven method to choose λ. In the same spirit,
we use a K-fold cross validation where we minimize the estimating equation ||PZ(Y−Zα−
Dβ)||2 instead of the predictive error ||(Y − Zα − Dβ)||2. We minimize the estimating
equation instead of the predictive error since the parameter of interest is the causal effect
β∗ that sets the expected value of the estimating equation to zero (see equation (2.6),
Sections 2.3.1 and 2.3.3). We use the “one standard error” rule used in most cross-validation
procedures (Hastie et al., 2009) and choose the smallest λ that is no more than one standard
error above the minimum of the estimating equation. In Section 2.4.1, we discuss the
performance of βˆλcv , where λcv is the cross-validated λ based on the estimating equation
through various simulation studies. Also, in Kang et al. (2015), we discuss another method
of choosing λ, in particular, choosing λ based on the theoretical guidance from Theorem
2.2 and Corollary 2.2. In short, we show that for better estimation performance of βˆλ, it is
important not to incorrectly set invalid IVs to be valid (i.e. let αˆj be zero when the true
α∗j is not zero), while the reverse is not as important. This observation argues for choosing
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λ that tends to set relatively few elements of αˆλ to be zero and we demonstrate that cross
validation achieves this goal in a wide variety of settings.
2.3.5. Estimation Performance
How well does sisVIVE estimate the causal effect β∗? In order to analyze the performance
of sisVIVE, we first introduce some basic notations and definitions.
Definition 2.2. For any matrix M, the upper and lower restricted isometry property (RIP)
constants of order k, denoted as δ+k (M) and δ
−
k (M) respectively, are the smallest δ
+
k (M)
and largest δ−k (M) such that
δ−k (M)‖α‖22 ≤ ‖Mα‖22 ≤ δ+k (M)‖α‖22 (2.13)
holds for all k-sparse vectors α.
RIP conditions have been widely used in the literature on compressed sensing and high-
dimensional linear regression. See Cai and Zhang (2013a) and the references therein. The
following theorem characterizes the performance of sisVIVE in finite samples using the RIP
conditions. Note that this characterizes all the minimizers βˆλ from sisVIVE in (2.12).
Theorem 2.2 (Estimation performance of sisVIVE under RIP). Suppose we have the
model given in (2.3). Let Dˆ = PZD. Let the restricted isometry constants δ
+
2s(Z), δ
−
2s(Z),
δ+2s(PDˆZ) be defined as in (2.13), where s is the number of invalid instruments. Suppose
2δ−2s(Z) > δ
+
2s(Z) + 2δ
+
2s(PDˆZ) (2.14)
holds. Then, the estimate βˆλ given by (2.12) with tuning parameter λ ≥ 3‖ZTPDˆ⊥‖∞ has
the following performance guarantee
|βˆλ − β∗| ≤ |Dˆ
T |
‖Dˆ‖22
+
1
‖Dˆ‖2
 (4/3√5)λ
√
sδ+2s(PDˆZ)
2δ−2s(Z)− δ+2s(Z)− 2δ+2s(PDˆZ)
 . (2.15)
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Condition (2.14) includes the RIP constants, δ−2s(Z), δ
+
2s(Z), and δ
+
2s(PDˆZ). Unfortunately,
these RIP constants in (2.14) are difficult to evaluate. Hence, in some applications, it is
more convenient to use a slightly stronger but much simpler and interpretable condition
called the “mutual incoherence property” (MIP). Specifically, let Dˆ = PZD and ‖Z.j‖2 = 1
for all j = 1, . . . , L. Define the constants µ and ρ as
µ = max
i 6=j
|ZT.iZ.j | and ρ = max
j
|DˆTZ.j |/‖Dˆ‖2. (2.16)
First, the constant µ measures the maximum correlation between any two columns of the
matrix of instruments Z. This is related to Assumption (a) in Section 2.3.1 where a full rank
Z means the columns of Z are linearly independent. In fact, if µ < 1/(L−1), Z is full rank.
Second, the constant ρ measures the maximum strength of individual instruments. A high
ρ doesn’t necessarily imply that all L instruments are individually strong; it just implies
that one of the L instruments is strong (i.e. has a high correlation to D); it’s possible
that the rest of the L − 1 instruments are weak. This notion of strength by ρ is slightly
different than the concentration parameter, which measures the overall strength of all the L
instruments (see Section 2.4.1 for more discussion). Also, ρ stands in contrast to Condition
(b) in Theorem 2.1 which looks at the individual values of γj , j = 1, . . . , L, instead of the
maximum of γjs.
Given the two MIP constants µ and ρ, we have the following result on estimation perfor-
mance. Like Theorem 2.2, Corollary 2.2 characterizes all the minimizers βˆλ from sisVIVE
in (2.12).
Corollary 2.2 (Estimation performance of sisVIVE under MIP). Let the MIP constants µ
and ρ be given in (2.16). If the number of invalid instruments, s, satisfies
s < min(
1
12µ
,
1
10ρ2
) (2.17)
the estimate βˆλ given by (2.12) with tuning parameter λ ≥ 3‖ZTPDˆ⊥‖∞ has the following
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performance guarantee
|βˆλ − β∗| ≤ |Dˆ
T |
‖Dˆ‖22
+
1
‖Dˆ‖2
(
4
√
105/9λsρ
1− s(5ρ2 + 6µ)
)
. (2.18)
We make the following remarks. First, in the Appendix, we show the condition in equation
(2.17) directly implies the condition in equation (2.13). Note that the converse is not true.
For example, suppose the matrix of instruments Z is an n by L matrix where each entry
Zij are from i.i.d. standard Normal. Based on Theorem 5.2 in Baraniuk et al. (2008), when
n ≥ Cs log(L/s) for some C not dependent on L and s, we are able to ensure the RIP
condition 2δ−2s(Z) > 3δ
+
3s(Z) with high probability. Here, 2δ
−
2s(Z) > 3δ
+
3s(Z) is a stronger
condition than 2δ−2s(Z) > δ
+
3s(Z) + 2δ
+
2s(PDˆZ), the RIP condition we need for Theorem 2.2.
However, based on Theorem 8 in Cai et al. (2013), to guarantee our MIP condition µ < 112s ,
we need n ≥ Cs2 logL for some C not dependent on L and s. In short, when the order of
n is between s log(L/s) and s2 logL, Z meet the RIP condition but not the MIP condition,
with high probability.
Second, the constraint on the number of invalid instruments, s, in Corollary 2.2 is strict, but
is required to precisely characterize the bound on estimation performance. As two reviewers
pointed out, if the instruments are even slightly correlated at µ = 0.1, s < 10/12, no invalid
instruments are allowed, and Corollary 2.2 is not useful in characterizing the performance of
sisVIVE. In Section 2.4.2, we study the behavior of sisVIVE when this constraint in (2.17)
may not hold.
Third, in the case where all the instruments are uncorrelated with each other so that
µ = 0, a small ρ provides a less restrictive upper bound on s. At first glance, this may be
counterintuitive since a small ρ implies that all the instruments’ individual correlation to
the exposure is weak and, therefore, having weak instruments allow one to have more invalid
instruments. However, we note that the denominator of the bound (2.18), specifically ‖Dˆ‖22
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is a function of the correlation of the instruments, and having a small ρ would translate
to having a small ‖Dˆ‖22. Hence, even though the condition (2.17) allows for more invalid
instruments, the upper bound (2.18) becomes worse and our estimator βˆλ will be far from
β∗.
Finally, we emphasize that the conditions in both Theorem 2.2 and Corollary 2.2 are suf-
ficient, but not necessary conditions for the performance bounds to hold. In particular, a
violation of these conditions does not imply that sisVIVE will perform badly (see Section
2.4.2).
2.3.6. Fast Numerical Algorithm
In addition to the theoretical guarantees on estimation performance, in practice, a fast,
scalable numerical algorithm for estimation is desirable, especially for MR where genetic
data can be large. Theorem 2.3 outlines a two-step numerical method whose solution is
identical to sisVIVE in (2.12), but is as fast as ordinary least squares.
Theorem 2.3 (Fast two-step numerical algorithm). Let PDˆ be the projection matrix onto
the vector Dˆ and PDˆ⊥ = I−PDˆ. We propose the two-step algorithm as follows.
Step 1: For a given λ > 0, solve:
αˆλ ∈ argmin
α
1
2
||PDˆ⊥PZY −PDˆ⊥Zα||22 + λ||α||1
Step 2: Use αˆλ from Step 1 to estimate βˆλ by
βˆλ =
DˆT (Y − Zαˆλ)
||Dˆ||22
The solution to the two-step algorithm is identical to the solution to sisVIVE in (2.12)
In the two-step algorithm, step 1 is the standard Lasso problem with outcome PDˆ⊥PZY
and design matrix PDˆ⊥Z; remember, sisVIVE in (2.12) is not the standard Lasso problem
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as discussed in Section 2.3.3. Fast algorithms for the Lasso exist, most notably LARS
(Efron et al., 2004). In fact, LARS is able to solve αˆλ for all values of λ > 0 at the
same computational efficiency as ordinary least squares. Step 2 is also numerically efficient,
requiring a simple dot product operation between Dˆ and Y − Zαˆλ. Thus, the proposed
two-step algorithm is, practically speaking, as fast as ordinary least squares. Best of all,
the estimate from this two-step algorithm is identical to sisVIVE.
2.4. Simulation
2.4.1. General Setup
We conduct various simulation studies to study the estimation performance between sis-
VIVE,two stage least squares (TSLS), the most popular estimator in IV and MR, and ordi-
nary least squares (OLS) under various settings that vary the instruments’ absolute/overall
and relative strength, their validity and correlation among each other, and endogeneity.
Let there be n = 2000 individuals and L potential candidate instruments. The observations
(Yi, Di,Zi.), i = 1, . . . , n are generated by
Yi = pi
∗ + ZTi.α
∗ +Diβ∗ + i
Di = γ
∗
0 + Z
T
i.γ
∗ + ξi
,
i
ξi
 iid∼ N

0
0
 ,
 1 σ∗ξ
σ∗ξ 1


where Zi. is drawn from a multivariate normal with mean 0 and covariance matrix where
the diagonals are all one. Throughout the simulation, the parameters pi∗, β∗, and γ∗0 are
fixed. However, we vary the following parameters
(i) the number of invalid instruments (L)
(ii) the endogeneity parameter (σ∗ξ)
(iii) the direct effect parameter α∗ = (1, 1, . . . , 0, 0) (s in ‖α∗‖0 = s )
(iv) the pairwise correlation between instruments (µ in equation (2.16))
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(v) the correlation structure between instruments (covariance matrix of Zi.)
(vi) the absolute/overall strength of instruments (concentration parameter)
(vii) the relative strength of all instruments (individual elements of γ∗)
(viii) the relative strength between invalid and valid instruments (γ∗A∗ and γ
∗
(A∗)C where
A∗ =supp(α∗))
In particular, for (i), we let L = 10 and L = 100. For (ii), we vary σ∗ξ from 0 to 0.9. For
(iii), we vary s from 0 to 9. For (iv), we set µ at four different values, 0, 0.25, 0.5, and
0.75. For (v), we consider three types of correlation structures between instruments. The
first case is where all the pairwise correlation between instruments is set to µ, i.e. the off-
diagonal elements of the covariance matrix for Zi. is set to µ. The second case is where only
the pairwise correlation between valid instruments is set to µ and the pairwise correlation
between invalid instruments is set to µ. However, there is no correlation between any pair
consisting of one valid and one invalid instrument. The third case is where the pairwise
correlation between a valid instrument and an invalid instrument is set to µ. However,
there is no pairwise correlation between any pair of valid instruments or any pair of invalid
instruments.
For (vi), we vary the absolute/overall instrument strength by the concentration parameter.
The concentration parameter is a popular measure for instrument strength; high values of
the concentration parameter indicate the overall strength of all L instruments is strong and
vice versa. The concentration parameter is also the population value of the first stage F
statistic for the instruments when the exposure is regressed on them; this first stage F statis-
tic is often used to check instrument strength (Stock et al., 2002). Based on Table 1 in Stock
et al. (2002), a set of instruments with a concentration parameter (scaled by the number of
valid instruments) of around 10 is considered weak in the absolute/overall sense and a set of
instruments with a concentration parameter (scaled by the number of valid instruments) of
around 100 is considered strong in the absolute/overall sense. We use these concentration
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parameters, 10 and 1000, to var the absolute, overall strength of the instruments. For (vii),
we vary the relative instrument strength by changing the individual entries of the vector γ∗
while keeping the concentration parameter fixed. Specifically, for a particular concentration
parameter, say 10, we consider instruments to have equal relative strength if γ∗j = γ
∗
k for
all j 6= k and variable relative strength if γ∗j = 2 ∗ γ∗k for various values of j 6= k. For
(viii), we look at two cases, the case where the invalid instruments are “stronger” than the
valid instruments and the case where the valid instruments are “stronger” than the invalid
instruments. To simulate these two new cases, we first fix the concentration parameter
from the setup in (vi). Then, for the case when the invalid instruments are “stronger” than
the valid instruments, we find γ∗ where γ∗j = 2 ∗ γ∗k for j ∈supp(α∗) (i.e. set of invalid
instruments) and k ∈supp(α∗)C (i.e. set of invalid instruments). In other words, the γ∗j s
associated with invalid instruments have twice the magnitude of the γ∗j s associated with the
valid instruments. For the case when the valid instruments are “stronger” than the invalid
instruments, we flip the roles of j and k where j now belongs to supp(α∗)C and k belongs
to supp(α∗).
For each simulation setting, we repeat the simulation either 500 or 1000 times. For each
repetition, we compute sisVIVE’s estimate of the causal effect, βˆλ, where λ is chosen by
10-fold cross validation outlined in Section 2.3.4. We also compute estimates from TSLS
and OLS. For TSLS, we run two types of TSLS. First, we run the “naive” TSLS as if all
the instruments are valid. This is quite common in MR studies where all the instruments
are assumed to be valid and the causal estimate is computed using TSLS. When some
of the instruments are in fact invalid, naive TSLS should give biased estimates. Second,
we run TSLS as if we knew exactly which instruments are valid, i.e. the “oracle” TSLS.
Specifically, we use the knowledge of the support of α∗ and run TSLS controlling for the
invalid instruments that are in the support of α∗ as covariates. Finally, we run OLS with
Z and D as our regressors and Y as our outcome. We expect OLS to perform poorly when
there is substantial endogeneity by D since OLS cannot control for endogenous variables.
But, OLS should be more efficient than IV methods if there is no endogeneity (Richardson
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and Wu, 1971).
2.4.2. Simulation Setup 1: L = 10, Pairwise Correlation Between All IVs and Uniform IV
Strength Between Valid and Invalid IVs
This setup has 10 candidate instruments (i.e. L = 10 in (i)), there is pairwise correlation
between all instruments (i.e. the first case in (v)), and there is no distinction between
invalid and valid IVs with regards to strength (i.e. we ignore (viii)). All other parameters
described in the previous section are varied.
Figure 2 shows the estimation error for β∗ when endogeneity is varied (i.e. vary (ii)). The
number of invalid instruments is fixed at s = 3 and we consider 16 different sets of instru-
ments based on their absolute and relative strength as well as their pairwise correlations.
For example, the top lefthand plot of Figure 2 corresponds to instruments whose over-
all strength is strong (i.e. scaled concentration parameter is around 100) , their relative
strength is equal (i.e. γ∗j are identical for all j = 1, . . . , L), and their pairwise correlations
are 0. In contrast, the bottom right plot of Figure 2 corresponds to instruments whose
their overall strength is weak (i.e. scaled concentration parameter is around 10), their rel-
ative strength is variable (i.e. γ∗j = 2 ∗ γ∗k for various values of j 6= k) and their pairwise
correlations are equal to 0.75.
As expected, OLS dominates naive TSLS, oracle TSLS, and sisVIVE when the endogeneity
is small and close to zero, with the dominance being greater for weak instruments. Once
there is a sufficient amount of endogeneity, oracle TSLS, which knows exactly which instru-
ments are valid and invalid, does best. However, sisVIVE, which is a feasible rather than
an infeasible oracle estimator, is close to the oracle TSLS; the gap between oracle TSLS
and sisVIVE gets larger as the instruments’ absolute strength gets weaker. Regardless of
instrument strength, naive TSLS, which assumes all the L instruments are valid, has a high
error since it cannot take into account the bias introduced by invalid instruments.
Figure 3 shows the estimation error for β∗ when the number of invalid instruments is
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Figure 2: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Corre-
lation Exists Between All IVs (Setup 1). There are ten (L = 10) instruments. Each line
represents median absolute estimation error (|β∗ − βˆ|) after 1000 simulations. We fix the
number of invalid instruments to s = 3. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are two
types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding
the absolute strength (i.e. concentration parameter) fixed. Each row corresponds to the
maximum correlation between instruments.
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Instrument
Corr. (µ)
Strong Instru-
ment, Equal
Strength
Strong Instru-
ment, Variable
Strength
Weak Instru-
ment, Equal
Strength
Weak Instru-
ment, Variable
Strength
0 0.31 0.39 0.20 0.22
0.25 0.54 0.58 0.36 0.37
0.5 0.72 0.73 0.53 0.53
0.75 0.87 0.87 0.73 0.73
Table 1: Values of ρ in Corollary 2.2 for sisVIVE Simulation Study (Setup 1)
varied. The endogeneity, σ∗ξ, is fixed at 0.8. Like Figure 2, we consider the same 16 sets
of instruments. We first see that at s = 0, i.e. when there are no invalid instruments,
sisVIVE’s performance is nearly identical to naive and oracle TSLS. However, sisVIVE
does not use the knowledge that one knows exactly which instruments are valid while the
two TSLS estimators do. Also, sisVIVE’s performance degrades slightly for instruments
with weak absolute strength when the correlation between instruments increases.
When s < L/2 = 5, sisVIVE’s performance is comparable to oracle TSLS and better than
naive TSLS. However, for instruments with weak absolute strength, sisVIVE does slightly
worse compared to the oracle TSLS than for instruments with strong absolute strength.
Once we reach the identification boundary in Corollary 2.1, s < L/2 = 5, sisVIVE’s per-
formance becomes similar to naive TSLS. This is the case regardless of the instruments’
absolute and relative strength. Finally, for any s, oracle TSLS performs much better than
all the other estimators.
Also, in all 16 sets of instruments, we compute ρ and µ found in the condition for Corollary
2.2 from the simulated data. Specifically, we computed ρ from each simulated data set and
take the median value of it after 1000 simulations. For µ, we use the true values of the
correlation of Zi., specifically µ = 0, 0.25, 0.5, and 0.75. Table 1 shows the results.
Using Table 1, we see that the top lefthand plot of Figure 2 in our simulation study has ρ
of approximately 0.31 and µ = 0. Based on this, the upper bound on s in Corollary 2.2 is
1.04. However, since s = 3 for the simulations in Figure 2, the condition (2.17) in Corollary
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Figure 3: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and Where
Correlation Exists Between All IVs (Setup 1). There are ten (L = 10) instruments. Each
line represents median absolute estimation error (|β∗ − βˆ|) after 1000 simulations. We
fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while
holding the absolute strength fixed. Each row corresponds to maximum correlation between
instruments.
33
2.2 is violated and cannot be used to characterize the behavior of sisVIVE.
Table 2 shows the condition required by Corollary 2.2, specifically the upper bound on s in
(2.17), for all values of ρ and µ in Table 1. Based on Table 2, the condition for Corollary 2.2
is only satisfied when s = 0, i.e. when there are no invalid instruments, for vast majority
of cases. For example, when instrument are correlated and µ > 0, Corollary 2.2 cannot be
used to characterize the performance of sisVIVE if invalid instruments are present. Table
2 also re-illustrates the point in Section 2.3.5 that the condition for Corollary 2.2, even
though it’s interpretable, are strict and that Theorem 2.2 is a generalization of Corollary
2.2 at the expense of interpretability.
Instrument
Corr. (µ)
Strong Instru-
ment, Equal
Strength
Strong Instru-
ment, Variable
Strength
Weak Instru-
ment, Equal
Strength
Weak Instru-
ment, Variable
Strength
0 1.04 0.66 2.50 2.07
0.25 0.33 0.33 0.33 0.33
0.5 0.17 0.17 0.17 0.17
0.75 0.11 0.11 0.11 0.11
Table 2: Condition on s in Corollary 2.2 for sisVIVE Simulation Study (Setup 1)
Overall, in this setting, we find that in terms of absolute estimation error, |β∗ − βˆλ|, sis-
VIVE dominates TSLS whenever there are invalid IVs and its performance is similar to the
oracle. Also, we find that Corollary 2.2, while interpretable, provides a poor theoretical
characterization of sisVIVE’s performance.
2.4.3. Simulation Setup 2: L = 10, Pairwise Correlation Between Subsets of IVs and
Uniform IV strength Between Valid and Invalid IVs
This simulation setup is identical to Section 2.4.2, except we have two different types of
pairwise correlation between subsets of instruments instead of having pairwise correlation
between all instruments. Specifically, Figures 4 and 5 represent the setting where the
pairwise correlation between valid instruments is set to µ and the pairwise correlation
between invalid instruments is also set to µ. However, there is no correlation between any
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pair consisting of one valid and one invalid instrument. Figures 6 and 7 represent the setting
where the pairwise correlation between a valid instrument and an invalid instrument is set
to µ. However, there is no pairwise correlation between any pair of valid instruments or
any pair of invalid instruments.
Figures 4 and 6 vary endogeneity, but the number of invalid instruments is fixed at s = 3.
The behavior of all the estimators are similar to each other and to those in Section 2.4.2,
specifically Figure 2. OLS dominates naive TSLS, oracle TSLS, and sisVIVE when endo-
geneity is small and close to zero, with the dominance being greater for weaker instruments.
Once there is a sufficient amount of endogeneity, oracle TSLS, which knows exactly which
instruments are valid and invalid, does best. sisVIVE also resembles the oracle in terms of
performance. Naive TSLS, which assumes all the L instruments are valid, does worst since
it assumes that all the L instruments are valid.
Similarly, Figures 5 and 7 vary the number of invalid instruments, s, but fix the endogeneity
to 0.8. The estimators behave similarly across the two figures and to those in Section 2.4.2,
specifically Figure 3. We first see that at s = 0, i.e. when there are no invalid instruments,
sisVIVE’s performance is nearly identical to naive and oracle TSLS, although it degrades
slightly for instruments with weak absolute strength. Also, when s < L/2 = 5, sisVIVE’s
performance is comparable to oracle TSLS and better than naive TSLS. Once we reach
the identification boundary, s < L/2 = 5, sisVIVE’s performance becomes similar to naive
TSLS. This is the case regardless of the instruments’ absolute and relative strength.
Overall, in this setting, we find that the three correlation structures produce similar simu-
lation results with regards to the estimation error |β∗ − βˆλ|.
2.4.4. Simulation Setup 3: L = 10, Pairwise Correlation Between All IVs and Non-Uniform
IV Strength Between Valid and Invalid IVs
This simulation setup is identical to Section 2.4.2, except we consider two other types of
instrument strength, specifically the case where the invalid instruments are “stronger” than
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Figure 4: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Cor-
relation Only Exists Within Valid and Invalid IVs (Setup 2). There are ten (L = 10)
instruments. Each line represents the median absolute estimation error (|β∗ − βˆ|) after
500 simulations. We fix the number of invalid instruments to s = 3. Each column in the
plot corresponds to different variation of instruments’ absolute and relative strength. There
are two types of absolute strengths, “Strong” and “Weak”, measured by the concentration
parameter. There are two types of relative strengths, “Equal” and “Variable”, measured by
varying γ∗ while holding the absolute strength (i.e. concentration parameter) fixed. Each
row corresponds to the maximum correlation between instruments, but correlation only
exists within valid and invalid instruments.
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Figure 5: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and Where
Correlation Only Exists Within Valid and and Invalid IVs (Setup 2). There are ten (L = 10)
instruments. Each line represents the median absolute estimation error (|β∗− βˆ|) after 500
simulations. We fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds
to a different variation of instruments’ absolute and relative strength. There are two types of
absolute strengths, “Strong” and “Weak”, measured by the concentration parameter. There
are two types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while
holding the absolute strength fixed. Each row corresponds to the maximum correlation
between instruments, but correlation only exists within valid and invalid instruments.
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Figure 6: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Cor-
relation Only Exists Between Valid and Invalid IVs (Setup 2). Each line represents the
median absolute estimation error (|β∗ − βˆ|) after 500 simulations. We fix the number of
invalid instruments to s = 3. Each column in the plot corresponds to a different variation
of instruments’ absolute and relative strength. There are two types of absolute strengths,
“Strong” and “Weak”, measured by the concentration parameter. There are two types
of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding the
absolute strength (i.e. concentration parameter) fixed. Each row corresponds to the maxi-
mum correlation between instruments, but correlation only exists between valid and invalid
instruments.
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Figure 7: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and Where
Correlation Only Exists Between Valid and and Invalid IVs (Setup 2). There are ten
(L = 10) instruments. Each line represents the median absolute estimation error (|β∗− βˆ|)
after 500 simulations. We fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot
corresponds to a different variation of instruments’ absolute and relative strength. There
are two types of absolute strengths, “Strong” and “Weak”, measured by the concentration
parameter. There are two types of relative strengths, “Equal” and “Variable”, measured
by varying γ∗ while holding the absolute strength fixed. Each row corresponds to the
maximum correlation between instruments, but correlation only exists between valid and
invalid instruments.
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the valid instruments and the case where the valid instruments are “stronger” than the
invalid instruments, i.e. where the strength of IVs are non-uniform between valid and
invalid IVs.
Figure 8 varies endogeneity, but fixes s = 3. In this case, sisVIVE performs as well as the
oracle for strong instruments. For weak instruments, sisVIVE does better when the valid
instruments are stronger than the invalid instruments (i.e. “Stronger Valid”) than when
the invalid instruments are stronger than the valid instruments (i.e. “Stronger Invalid”).
Under any strength, sisVIVE does much better than the next best alternative, naive two
stage least squares.
Figure 9 varies s, but fixes endogeneity to 0.8. In this case, sisVIVE deviates from the oracle
at s = 4 for the case when the invalid instruments are stronger than the valid instruments
(i.e. “Stronger Invalid”) and at s = 7 for the case when the valid instruments are stronger
than the invalid instruments (i.e. “Stronger Valid”). When sisVIVE deviates from oracle
TSLS, sisVIVE’s performance is no worse than naive TSLS.
In addition, for each of the simulation setups in this section (16 in total, each corresponding
to 16 subfigures in Figures 8 and 9), we compute ρ and µ that appear in Corollary 2.2,
similar to what we did in Section 2.4.2. Table 3 and 4 show the results. The column and
row labels in the two tables are identical to those found in Section 2.4.2, except the new
headings “Stronger Invalid” and “Stronger Valid.”
Instrument
Corr. (µ)
Strong Instru-
ment, Stronger
Invalid
Strong Instru-
ment, Stronger
Valid
Weak Instru-
ment, Stronger
Invalid
Weak Instru-
ment, Stronger
Valid
0 0.41 0.33 0.28 0.18
0.25 0.60 0.54 0.47 0.33
0.5 0.75 0.71 0.64 0.49
0.75 0.88 0.86 0.81 0.70
Table 3: Values of ρ in Corollary 2.2 for sisVIVE Simulation Study (Setup 3)
The simulation study in this section showed that in vast majority of cases, sisVIVE estimates
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Figure 8: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Corre-
lation Exists Between All IVs (Setup 3). We also vary the instrument strength of valid
and invalid instruments. There are ten (L = 10) instruments. Each line represents the
median absolute estimation error (|β∗ − βˆ|) after 500 simulations. We fix the number of
invalid instruments to s = 3. Each column in the plot corresponds to a different variation
of instruments’ absolute and relative strength. There are two types of absolute strengths,
“Strong” and “Weak”, measured by the concentration parameter. There are two types of
strengths for valid and invalid instruments, “Stronger Invalid” and “Stronger Valid”, deter-
mined by varying γ∗ while holding the absolute strength fixed. Each row corresponds to
the maximum correlation between instruments.
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Figure 9: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and Where
Correlation Exists Between All IVs (Setup 3). We also vary the instrument strength of valid
and invalid instruments. There are ten (L = 10) instruments. Each line represents the
median absolute estimation error (|β∗ − βˆ|) after 500 simulations. We fix the endogeneity
σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different variation of instruments’
absolute and relative strength. There are two types of absolute strengths, “Strong” and
“Weak”, measured by the concentration parameter. There are two types of strengths for
valid and invalid instruments, “Stronger Invalid” and “Stronger Valid”, determined by
varying γ∗ while holding the absolute strength fixed. Each row corresponds to the maximum
correlation between instruments.
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Instrument
Corr. (µ)
Strong Instru-
ment, Stronger
Invalid
Strong Instru-
ment, Stronger
Valid
Weak Instru-
ment, Stronger
Invalid
Weak Instru-
ment, Stronger
Valid
0 0.60 0.90 1.27 3.02
0.25 0.28 0.33 0.33 0.33
0.5 0.17 0.17 0.17 0.17
0.75 0.11 0.11 0.11 0.11
Table 4: Condition on s in Corollary 2.2 for sisVIVE Simulation Study (Setup 3)
the causal effect of interest better than the next best alternative, naive TSLS, and in many
cases, sisSIVE’s performance is similar to the oracle. However, when the invalid instruments
are stronger than the valid instruments (i.e. “Stronger Invalid”), sisVIVE’s performance
does not do as well as the oracle, even though by the identification result in Corollary 2.1,
at s = 4, identification is guaranteed. The degradation in performance of sisVIVE may be
due to a number of reasons. It may follow from the fact that the condition in Corollary 2.2
are not met since Table 4 shows that in the “Stronger Invalid” case, s has to be less than 1
or 2. It may be that we chose a bad tuning parameter λ (see Sections 2.4.7 and 2.4.8). A
closer analysis of this particular case is a topic for future research. Regardless, even when
sisVIVE’s performance degrades compared to the oracle, sisVIVE does no worse than the
next best alternative, naive TSLS.
2.4.5. Simulation Setup 4: L = 10, Pairwise Correlation Between Subsets of IVs and Non-
Uniform IV Strength Between Valid and Invalid IVs
The simulation setup is identical to Section 2.4.3, except we consider the two types of
strengths considered in Section 2.4.4.
Figures 10 and 11 vary endogeneity, but fix s = 3. Figure 10 is the case where there is no
correlation between an invalid instrument and valid instrument and Figure 11 is the case
where there is no correlation among invalid instruments and among valid instruments. In
both scenarios, the behavior of the simulation is similar to Section 2.4.4. sisVIVE performs
as well as the oracle for strong instruments. For weak instruments, sisVIVE does better
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Figure 10: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Corre-
lation Only Exists Within Valid and Invalid IVs (Setup 4). We also vary the instrument
strength of valid and invalid instruments. There are ten (L = 10) instruments. Each line
represents the median absolute estimation error (|β∗− βˆ|) after 500 simulations. We fix the
number of invalid instruments to s = 3. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of strengths for valid and invalid instruments, “Stronger Invalid” and “Stronger
Valid”, determined by varying γ∗ while holding the absolute strength fixed. Each row
corresponds to the maximum correlation between instruments, but correlation only exists
within valid and invalid instruments.
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Figure 11: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Corre-
lation Only Exists Between Valid and Invalid IVs (Setup 4). We also vary the instrument
strength of valid and invalid instruments. There are ten (L = 10) instruments. Each line
represents the median absolute estimation error (|β∗− βˆ|) after 500 simulations. We fix the
number of invalid instruments to s = 3. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of strengths for valid and invalid instruments, “Stronger Invalid” and “Stronger
Valid”, determined by varying γ∗ while holding the absolute strength fixed. Each row
corresponds to the maximum correlation between instruments, but correlation only exists
between valid and invalid instruments.
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when the valid instruments are stronger than the invalid instruments (i.e. “Stronger Valid”)
than when the invalid instruments are stronger than the valid instruments (i.e. “Stronger
Invalid”). In both the strong and weak cases, sisVIVE does much better than the next best
alternative, naive TSLS.
Figures 12 and 13 vary s, but fix endogeneity to 0.8. Figure 12 is the case where there is no
correlation between an invalid instrument and valid instrument and Figure 13 is the case
where there is no correlation among invalid instruments and among valid instruments. In
both scenarios, the behavior of the simulation is similar to Section 2.4.4, sisVIVE deviates
from the oracle at s = 4 for the case when the invalid instruments are stronger than the valid
instruments (i.e. “Stronger Invalid”) and at s = 7 for the case when the valid instruments
are stronger than the invalid instruments (i.e. “Stronger Valid”). When sisVIVE deviates
from oracle TSLS, sisVIVE’s performance is no worse than naive TSLS.
Overall, similar to what we saw in Section 2.4.3, the three correlation structures produce
similar results with respect to estimation error, |β∗ − βˆλ|.
2.4.6. Simulation Setup 5: L = 100, Pairwise Correlation Between All IVs and Uniform
IV Strength Between Valid and Invalid IVs
The simulation setup is identical to Section 2.4.2, except we increase the number of instru-
ments to L = 100. We only consider instruments where all the pairwise correlation is set to
µ since results from Sections 2.4.3 and 2.4.5 showed the three different structures of instru-
mental correlation produced similar results in terms of sisVIVE’s estimation performance.
We note that in Mendelian randomization settings, it is rare to have 100 potential genetic
instruments since all 100 of the genetic instruments must affect the exposure (see Sections
2.1 and 2.3.1 for more details). Usually, the number of potential instruments is far less
than 100 (see Section 2.1 for some example MR studies). However, for completeness, we
demonstrate sisVIVE’s performance when L = 100 potential instruments are present.
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Figure 12: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and Where
Correlation Only Exists Within Valid and and Invalid IVs (Setup 4). We also vary the
instrument strength of valid and invalid instruments. There are ten (L = 10) instruments.
Each line represents the median absolute estimation error (|β∗ − βˆ|) after 500 simulations.
We fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of strengths for valid and invalid instruments, “Stronger Invalid” and “Stronger
Valid”, determined by varying γ∗ while holding the absolute strength fixed. Each row
corresponds to the maximum correlation between instruments, but correlation only exists
within valid and invalid instruments.
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Figure 13: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and
Where Correlation Only Exists Between Valid and Invalid IVs (Setup 4). We also vary the
instrument strength of valid and invalid instruments. There are ten (L = 10) instruments.
Each line represents median absolute estimation error (|β∗ − βˆ|) after 500 simulations. We
fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of strengths for valid and invalid instruments, “Stronger Invalid” and “Stronger
Valid”, determined by varying γ∗ while holding the absolute strength fixed. Each row
corresponds to the maximum correlation between instruments, but correlation only exists
between valid and invalid instruments.
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Figure 14: sisVIVE Simulation Study of β∗ With Different Endogeneity and Where Corre-
lation Exists Between All IVs (Setup 5). There are 100 (L = 100) instruments. Each line
represents the median absolute estimation error (|β∗− βˆ|) after 500 simulations. We fix the
number of invalid instruments to s = 30. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are two
types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding
the absolute strength (i.e. concentration parameter) fixed. Each row corresponds to the
maximum correlation between instruments.
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Figure 15: sisVIVE Simulation Study of β∗ With Different Number of Invalid IVs and
Where Correlation Exists Between All IVs (Setup 5). There are 100 (L = 100) instruments.
Each line represents the median absolute estimation error (|β∗ − βˆ|) after 500 simulations.
We fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are
two types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while
holding the absolute strength fixed. Each row corresponds to maximum correlation between
instruments.
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Figures 14 and 15 represent the results of estimation performance of β∗ over 500 simulations.
The behavior of all four estimators is similar to Figures 2 and 3 in Section 2.4.2. For example,
when we vary endogeneity (Figure 14), sisVIVE tends to perform slightly worse when the
overall strength of the instruments is weak. Also, when the number of invalid instruments,
s, is varied (Figure 15), sisVIVE has a sharp peak at s = 50, similar to the sharp peak at
s = 5 in Figure 3.
We also compute the ρ and µ resulting from this simulation study. Tables 5 and 6 show the
results. Notice that again, Corollary 2.2, while interpretable, tends to give very stringent
conditions on s in Table 6.
Instrument
Corr. (µ)
Strong Instru-
ment, Equal
Strength
Strong Instru-
ment, Variable
Strength
Weak Instru-
ment, Equal
Strength
Weak Instru-
ment, Variable
Strength
0 0.15 0.17 0.16 0.17
0.25 0.54 0.54 0.53 0.53
0.5 0.73 0.73 0.53 0.73
0.75 0.87 0.87 0.88 0.87
Table 5: Values of ρ in Corollary 2.2 for sisVIVE Simulation Study (Setup 5)
Instrument
Corr. (µ)
Strong Instru-
ment, Equal
Strength
Strong Instru-
ment, Variable
Strength
Weak Instru-
ment, Equal
Strength
Weak Instru-
ment, Variable
Strength
0 4.2 3.3 4.0 3.4
0.25 0.33 0.33 0.33 0.33
0.5 0.17 0.17 0.17 0.17
0.75 0.11 0.11 0.11 0.11
Table 6: Condition on s in Corollary 2.2 for sisVIVE Simulation Study (Setup 5)
Overall, the simulation study suggests that sisVIVE does scale as L increases and that its
performance at large values of L is similar to its performance at smaller values of L, such
as L = 10.
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2.4.7. Measuring the Performance of sisVIVE’s Estimation of α∗
This simulation setup is identical to Sections 2.4.2, 2.4.3, 2.4.4, 2.4.5, and 2.4.6, except we
examine sisVIVE’s estimation performance of α∗ instead of the estimation performance on
β∗. As we noted before, in Mendelian randomization, the target of estimation is β∗, the
causal effect of the exposure on the outcome, and our procedure, sisVIVE, was designed to
estimate β∗. However, in the process of estimating β∗, sisVIVE does produce an estimate
for α∗ and we explore the relationship between this intermediate estimate for α∗, αˆλ, and
our desired estimate for β∗, βˆλ.
To evaluate the estimate αˆλ, we consider two metrics of error, (a) the proportion of correctly
selected valid instruments and (b) the proportion of correctly selected invalid instruments.
To illustrate the two proportion-based error metrics, consider the following numerical ex-
ample. Suppose there are L = 10 instruments of which the first three instruments are
invalid, i.e. α∗j 6= 0 for j = 1, 2, 3, and the last seven instruments are valid, i.e. α∗j = 0 for
j = 4, 5, . . . , 10. If sisVIVE estimates the first two instruments to be invalid, i.e. αˆj 6= 0
for j = 1, 2, and the last eight to be valid, i.e. αˆj = 0 for j = 3, 4, . . . , 10, the proportion of
correctly selected valid instruments is 7/7 = 1 and sisVIVE makes no error in choosing the
valid instruments. However, the proportion of correctly selected invalid instruments is 2/3
and sisVIVE makes an error in choosing the invalid instruments.
First, we look at simulation setups in Sections 2.4.2 and 2.4.3. When we vary endogeneity
but fix the number of invalid instruments to s = 3 (Figures 16, 18, and 20, each figure
representing different correlation structures between IVs), the proportion of correctly se-
lected invalid instruments is 1 and sisVIVE never makes a mistake in selecting the invalid
instruments. However, sisVIVE does make mistakes in selecting the valid instruments as
the proportion of correctly selected valid instruments is mostly below 1. Also, depending on
the correlation structure between instruments, we get different behaviors for the proportion
of correctly selected valid instruments. For example, when every pair of instruments has
non-zero pairwise correlation (Figure 16), the proportion of correctly selected valid instru-
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ments remains roughly the same for different values of endogeneity. When there is only
pairwise correlation within valid and invalid instruments (Figure 18), the proportion of cor-
rectly selected valid instruments decreases as endogeneity increases, most notably among
weak instruments. Finally, when there is only pairwise correlation between valid and invalid
instruments (Figure 20), the proportion of correctly selected valid instruments increases as
endogeneity increases. Despite these differences in the proportion of correctly selected valid
instruments between different correlation structures, as the simulations in Sections 2.4.3
and 2.4.5, sisVIVE’s median absolute deviation from the truth, |βˆλ−β∗|, remains relatively
small and constant for all values of the endogeneity, irrespective of the different correlation
structures. Note that this constant behavior is also present in the proportion of correctly
selected invalid instruments, which remains at 1 for all correlation structures. This suggests
that there is a strong relationship between correctly selecting the invalid instruments and
sisVIVE’s median absolute deviation from β∗ while there is at most a weak relationship be-
tween correctly selecting valid instruments and sisVIVE’s median absolute deviation from
β∗. In fact, it appears that correctly selecting invalid instruments is more important than
valid instruments if a small median absolute deviation is desired.
When we vary the number of invalid instruments s, but fix the endogeneity (Figures 17, 19,
and 21, each figure representing different correlation structures between IVs), the propor-
tion of correctly selected invalid instrument decreases significantly at the s = 5 boundary,
regardless of the correlation structure between instruments. For example, for strong in-
struments in the three figures, when s < 5, the proportion of correctly selected invalid
instruments remain at 1. However, when s ≥ 5, the proportion of correctly selected invalid
instruments moves sharply away from 1. For weak instruments in the three figures, when
s < 5, the proportion of correctly selected invalid instruments remains close to 1, although
there is a slightly decrease in the proportion when s moves from s = 3 to s = 4 and when
µ is away from zero. But, similar to the strong instruments, when s ≥ 5, the proportion of
correctly selected invalid instruments moves away from 1.
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Figure 16: sisVIVE Simulation Study of α∗ With Different Endogeneity and Where Corre-
lation Exists Between All IVs (Setup 1). There are ten (L = 10) instruments. Each line rep-
resents the average proportions of correctly selected valid instruments and correctly selected
invalid instruments after 500 simulations. We fix the number of invalid instruments to s = 3.
Each column in the plot corresponds to a different variation of instruments’ absolute and
relative strength. There are two types of absolute strengths, “Strong” and “Weak”, mea-
sured by the concentration parameter. There are two types of relative strengths, “Equal”
and “Variable”, measured by varying γ∗ while holding the absolute strength (i.e. concen-
tration parameter) fixed. Each row corresponds to the maximum correlation between all
instruments.
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Figure 17: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Exists Between All IVs (Setup 1). There are ten (L = 10) instru-
ments. Each line represents the average proportions of correctly selected valid instruments
and correctly selected invalid instruments after 500 simulations. We fix the endogeneity
σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different variation of instru-
ments’ absolute and relative strength. There are two types of absolute strengths, “Strong”
and “Weak”, measured by the concentration parameter. There are two types of relative
strengths, “Equal” and “Variable”, measured by varying γ∗ while holding the absolute
strength fixed. Each row corresponds to the maximum correlation between all instruments.
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The proportion of correctly selected valid instruments decreases steadily as s increases, re-
gardless of the type of correlation structure between instruments. For strong instruments
in the three figures, the decrease in the proportion of correctly selected valid instruments
begins immediately after s = 1. For weak instruments in the three figures, there is consid-
erable fluctuation of the proportion of correctly selected valid instruments. For example,
for Figures 17 and Figures 19 under weak IVs, the proportion of correctly selected valid
instruments generally decreases as s increase, with the notable exception in the first row,
third column of both figures. But, for Figure 21 under weak IVs, the proportion of correctly
selected valid instruments decreases when s < 5, but increases again after s ≥ 5.
The behaviors of the proportions of correctly selected invalid and valid instruments from
Figures 17, 19, and 21 reaffirm our observation that there is a strong association between
the proportion of correctly selected invalid instruments and the median absolute deviation
of βˆλ, |βˆλ − β∗|. In particular, from Figures 3, 5 and 7, when s < 5, sisVIVE’s median
absolute deviation is just as small as the oracle TSLS. However, when s ≥ 5, sisVIVE’s
median absolute deviation is just as large as the naive TSLS. The proportion of correctly
selected invalid instruments in Figures 17, 19, and 21 closely corresponds to this sharp
change in behavior between s < 5 and s ≥ 5. In contrast, the proportion of correctly
selected valid instruments does not have this sharp behavior at s = 5 across all the figures.
Overall, in simulation setups in Sections 2.4.2 and 2.4.3, we find that for any type of
correlation structure between instruments and different variations on endogeneity and s,
sisVIVE deviates far from the truth if we incorrectly select the invalid instruments. Hence, it
is much more important to correctly select invalid instruments at the expense of incorrectly
selecting valid instruments for better estimation of β∗. This relationship makes sense since
using invalid instruments creates bias whereas using at least one valid instrument and
not using other valid instruments does not create bias, but just reduces efficiency. The
relationship also suggests that when we choose the tuning parameter λ, which controls the
number of non-zero αˆλ and consequently, controls the proportion of correctly selected valid
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Figure 18: sisVIVE Simulation Study of α∗ with Different Endogeneity and Where Cor-
relation Only Exists Within Valid and Invalid IVs (Setup 2). There are ten (L = 10)
instruments. Each line represents the average proportions of correctly selected valid instru-
ments and correctly selected invalid instruments after 500 simulations. We fix the number
of invalid instruments to s = 3. Each column in the plot corresponds to a different variation
of instruments’ absolute and relative strength. There are two types of absolute strengths,
“Strong” and “Weak”, measured by the concentration parameter. There are two types
of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding the
absolute strength (i.e. concentration parameter) fixed. Each row corresponds to the maxi-
mum correlation between instruments, but correlation only exists within valid and invalid
instruments.
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Figure 19: sisVIVE Simulation Study of α∗ with Different Number of Invalid IVs and
Where Correlation Only Exists Within Valid and and Invalid IVs (Setup 2). There are ten
(L = 10) instruments. Each line represents the average proportions of correctly selected
valid instruments and correctly selected invalid instruments after 500 simulations. We fix
the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are two
types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding
the absolute strength fixed. Each row corresponds to the maximum correlation between
instruments, but correlation only exists within valid and invalid instruments.
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Figure 20: sisVIVE Simulation Study With Different Endogeneity and Where Correlation
Only Exists Between Valid and Invalid IVs (Setup 2). Each line represents the average pro-
portions of correctly selected valid instruments and correctly selected invalid instruments
after 500 simulations. We fix the number of invalid instruments to s = 3. Each column in
the plot corresponds to a different variation of instruments’ absolute and relative strength.
There are two types of absolute strengths, “Strong” and “Weak”, measured by the con-
centration parameter. There are two types of relative strengths, “Equal” and “Variable”,
measured by varying γ∗ while holding the absolute strength (i.e. concentration parame-
ter) fixed. Each row corresponds to the maximum correlation between instruments, but
correlation only exists between valid and invalid instruments.
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Figure 21: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Only Exists Between Valid and and Invalid IVs (Setup 2). There are
ten (L = 10) instruments. Each line represents the average proportions of correctly selected
valid instruments and correctly selected invalid instruments after 500 simulations. We fix
the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different
variation of instruments’ absolute and relative strength. There are two types of absolute
strengths, “Strong” and “Weak”, measured by the concentration parameter. There are two
types of relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding
the absolute strength fixed. Each row corresponds to the maximum correlation between
instruments, but correlation only exists between valid and invalid instruments.
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and invalid instruments, we should choose λ that correctly selects the invalid instruments,
even if some valid instruments are selected as invalid. In particular, λ should generally be
small so that there is less `1 penalty on ‖α‖1, but not too small so that the penalty has no
effect. As a result, few elements of αˆλ will be zero and more instruments will be selected
as invalid. We discuss the choice of λ in more detail in Section 2.4.8.
Second, we look at simulation setups in Section 2.4.4. Figures 22 and 23 represent the case
where we vary endogeneity and s, respectively. The behavior of the two curves are similar
to what we observed before. That is, whenever sisVIVE performs badly in estimating β∗,
there is a large decrease in the proportion of correctly selected invalid instruments. Also,
there is no relationship between sisVIVE’s median absolute bias of βˆλ and the proportion of
correctly selected valid instruments. For example, when we vary endogeneity (Figure 22),
the proportion of correctly selected invalid instruments remain at 1 except when the overall
strength of the instruments is weak and the invalid instruments are stronger than the valid
instruments (i.e. “Stronger Invalid”). Regardless, in all cases, a smaller median absolute
deviation in Figure 8 corresponds with having a high proportion of correctly selected invalid
instruments in Figure 22. In contrast, the proportion of correctly selected valid instruments
remains below 1 if the invalid instruments are stronger than the valid instruments (i.e.
“Stronger Invalid”) and close to 1 if the valid instruments are stronger than the invalid
instruments (i.e. “Stronger Valid”). Furthermore, there does not seem to be any relationship
between the proportion of correctly selected valid instruments and the estimation error of
β∗ in Figure 8.
Similarly, when we vary s (Figure 23) and we are under the case where the invalid instru-
ments are stronger than the valid instruments (i.e. “Stronger Invalid”), the proportion of
correctly selected invalid instruments move away from 1 at s = 4 when the overall strength
of the instruments is strong and at s = 3 when the overall strength of the instruments is
weak. When the valid instruments are stronger than the invalid instruments (i.e. “Stronger
Valid”), the proportion of correctly selected invalid instruments move away from 1 at s = 7
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Figure 22: sisVIVE Simulation Study of α∗ with Different Endogeneity and Wher Corre-
lation Exists Between All IVs (Setup 3). We also vary the instrument strength of valid
and invalid instruments. There are ten (L = 10) instruments. Each line represents the
average proportions of correctly selected valid instruments and correctly selected invalid
instruments after 500 simulations. We fix the number of invalid instruments to s = 3. Each
column in the plot corresponds to a different variation of instruments’ absolute and relative
strength. There are two types of absolute strengths, “Strong” and “Weak”, measured by
the concentration parameter. There are two types of strengths for valid and invalid instru-
ments, “Stronger Invalid” and “Stronger Valid”, determined by varying γ∗ while holding
the absolute strength fixed. Each row corresponds to the maximum correlation between
instruments.
62
for strong instruments and s = 6 for weak instruments. Again, similar to what we observed
before, these points of s correspond to sisVIVE’s deviation from the oracle in Figure 9. In
contrast, the proportion of correctly selected valid instruments vary widely in Figure 23
and there does not seem to be any relationship between it and sisVIVE’s deviation from
the oracle in Figure 9.
Third, we look at the simulation setup in Section 2.4.5. Similar to our observations in Sec-
tion 2.4.5, the pattern of simulations when we have different correlation structure between
instruments is similar to the pattern of simulation when we have equi-correlation between
all instruments in Section 2.4.4 when examining the performance of sisVIVE on α∗ (Figures
24, 25, 26, and 27)
Fourth, we look at the simulation setup in Section 2.4.6. Figures 28 and 29 represent cases
where we vary endogeneity and the number of invalid instruments, respectively. Similar
to what we observed with L = 10 and where all IVs have same pairwise correlation, when
we vary endogeneity (Figure 28), but fix s to 30, we see that the proportion of correctly
selected invalid instruments is 1. When we vary s (Figure 29), we again notice a sharp
decrease in the proportion of correctly selected valid invalid instruments around s = 50 for
all instrument strengths and magnitudes of the correlation.
In summary, measuring sisVIVE’s performance on α∗ shows that a good estimate of β∗ de-
pends strongly on correctly selecting the invalid instruments more than correctly selecting
the valid instruments. This observation remains true regardless of instrument correlation
structure, types of instrument strength, levels of endogeneity, degree of instrument correla-
tion, or the number of invalid instruments.
2.4.8. Choice of λ
In this section, we look at different ways to select λ. As discussed in Section 2.3.4, the
choice of λ impacts the performance of sisVIVE where a high value of λ will push most
elements of αˆλ to zero while a low value of λ will do the opposite. In Section 2.3.4, we
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Figure 23: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Exists Between All IVs (Setup 3). We also vary the instrument strength
of valid and invalid instruments. There are ten (L = 10) instruments. Each line repre-
sents the average proportions of correctly selected valid instruments and correctly selected
invalid instruments after 500 simulations. We fix the endogeneity σ∗ξ to σ
∗
ξ = 0.8. Each
column in the plot corresponds to a different variation of instruments’ absolute and relative
strength. There are two types of absolute strengths, “Strong” and “Weak”, measured by
the concentration parameter. There are two types of strengths for valid and invalid instru-
ments, “Stronger Invalid” and “Stronger Valid”, determined by varying γ∗ while holding
the absolute strength fixed. Each row corresponds to the maximum correlation between
instruments.
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Figure 24: sisVIVE Simulation Study of α∗ With Different Endogeneity and Where Cor-
relation Only Exists Within Valid and Invalid IVs (Setup 4). We also vary the instrument
strength of valid and invalid instruments. There are ten (L = 10) instruments. Each line
represents the average proportions of correctly selected valid instruments and correctly se-
lected invalid instruments after 500 simulations. We fix the number of invalid instruments to
s = 3. Each column in the plot corresponds to a different variation of instruments’ absolute
and relative strength. There are two types of absolute strengths, “Strong” and “Weak”,
measured by the concentration parameter. There are two types of strengths for valid and
invalid instruments, “Stronger Invalid” and “Stronger Valid”, determined by varying γ∗
while holding the absolute strength fixed. Each row corresponds to the maximum correla-
tion between instruments, but correlation only exists within valid and invalid instruments.
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Figure 25: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Only Exists Within Valid and and Invalid IVs (Setup 4). We also vary
the instrument strength of valid and invalid instruments. There are ten (L = 10) instru-
ments. Each line represents the average proportions of correctly selected valid instruments
and correctly selected invalid instruments after 500 simulations. We fix the endogeneity
σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different variation of instru-
ments’ absolute and relative strength. There are two types of absolute strengths, “Strong”
and “Weak”, measured by the concentration parameter. There are two types of strengths
for valid and invalid instruments, “Stronger Invalid” and “Stronger Valid”, determined by
varying γ∗ while holding the absolute strength fixed. Each row corresponds to the maxi-
mum correlation between instruments, but correlation only exists within valid and invalid
instruments.
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Figure 26: sisVIVE Simulation Study of α∗ With Different Endogeneity and Where Corre-
lation Only Exists Between Valid and Invalid IVs (Setup 4). We also vary the instrument
strength of valid and invalid instruments. There are ten (L = 10) instruments. Each line
represents the average proportions of correctly selected valid instruments and correctly se-
lected invalid instruments after 500 simulations. We fix the number of invalid instruments to
s = 3. Each column in the plot corresponds to a different variation of instruments’ absolute
and relative strength. There are two types of absolute strengths, “Strong” and “Weak”,
measured by the concentration parameter. There are two types of strengths for valid and
invalid instruments, “Stronger Invalid” and “Stronger Valid”, determined by varying γ∗
while holding the absolute strength fixed. Each row corresponds to maximum correlation
between instruments, but correlation only exists between valid and invalid instruments.
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Figure 27: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Only Exists Between Valid and and Invalid IVs (Setup 4). We also vary
the instrument strength of valid and invalid instruments. There are ten (L = 10) instru-
ments. Each line represents the average proportions of correctly selected valid instruments
and correctly selected invalid instruments after 500 simulations. We fix the endogeneity
σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different variation of instru-
ments’ absolute and relative strength. There are two types of absolute strengths, “Strong”
and “Weak”, measured by the concentration parameter. There are two types of strengths
for valid and invalid instruments, “Stronger Invalid” and “Stronger Valid”, determined by
varying γ∗ while holding the absolute strength fixed. Each row corresponds to maximum
correlation between instruments, but correlation only exists between valid and invalid in-
struments.
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Figure 28: sisVIVE Simulation Study of α∗ With Different Endogeneity and Where Cor-
relation Exists Between All IVs (Setup 5). There are ten (L = 100) instruments. Each
line represents the average proportions of correctly selected valid instruments and cor-
rectly selected invalid instruments after 500 simulations. We fix the number of invalid
instruments to s = 30. Each column in the plot corresponds to a different variation of
instruments’ absolute and relative strength. There are two types of absolute strengths,
“Strong” and “Weak”, measured by the concentration parameter. There are two types of
relative strengths, “Equal” and “Variable”, measured by varying γ∗ while holding the abso-
lute strength (i.e. concentration parameter) fixed. Each row corresponds to the maximum
correlation between all instruments.
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Figure 29: sisVIVE Simulation Study of α∗ With Different Number of Invalid IVs and
Where Correlation Exists Between All IVs (Setup 5). There are 100 (L = 100) instru-
ments. Each line represents the average proportions of correctly selected valid instruments
and correctly selected invalid instruments after 500 simulations. We fix the endogeneity
σ∗ξ to σ
∗
ξ = 0.8. Each column in the plot corresponds to a different variation of instru-
ments’ absolute and relative strength. There are two types of absolute strengths, “Strong”
and “Weak”, measured by the concentration parameter. There are two types of relative
strengths, “Equal” and “Variable”, measured by varying γ∗ while holding the absolute
strength fixed. Each row corresponds to maximum correlation between all instruments.
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suggested cross-validation with the “one standard error” rule as a data-driven method to
choose the tuning parameter. In addition, in Section 2.3.5, we provided theoretical results
which suggested choosing a λ that is greater than 3‖ZTPDˆ⊥‖∞. We explore these two
possible choices of λ and their impact on estimation.
We begin with a simulation study similar to Sections 2.4.2 and 2.4.4. In particular, we
have L = 10 instruments of which the pairwise correlation between all instruments is 0.75
and the endogeneity is fixed at 0.8. We vary s, the number of invalid instruments and
vary instruments’ absolute strength, relative strength, and other strengths considered in
Section 2.4.4. In short, the simulation setups we consider correspond to the last row of
Figures 3 and 9. We do not simulate other correlation structures or different Ls because
the simulation results in Sections 2.4.3 and 2.4.6 showed sisVIVE behaves similarly as the
cases we consider in this section.
Table 7 shows the different values of λ averaged across 500 simulations where the overall,
absolute instrument strength is strong (see Section 2.4.1 for details on the definition of
absolute instrument strength). The column labeled “CV” denotes the average λs based on
cross validation laid out in Section 2.3.4. The column labeled “Theory” denotes the average
λs based on Theorem 2.2, specifically the average of 3‖ZTPDˆ⊥‖∞ over 500 simulations. We
use the same column heading labels in Figures 3 and 9. In almost all cases, cross validation
tends to choose a smaller λ than one prescribed by Theorem 2.2, with the exception of s = 9
in the “Equal” column and s = 7, 8, and 9 in the “Stronger Valid” column. Except for these
cases, cross validation tends to prefer a small λ, thereby preferring αˆλ to have more non-
zero entries than zero entries and more instruments selected as invalid instruments than
valid instruments.
Table 8 shows the estimation performance of sisVIVE, the median of |β∗ − βˆλ| over 500
simulations, based on two different λs, one based on cross validation and one based on
Theorem 2.2. In most cases, sisVIVE with a cross validated λ performs better than sis-
VIVE with a theory-based λ. For the “Equal” and ”Variable” case, when s < 5, sisVIVE
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Equal Variable Stronger Invalid Stronger Valid
s CV Theory CV Theory CV Theory CV Theory
1 1.88 2.70 2.04 2.71 1.53 2.70 2.06 2.72
2 1.36 2.66 1.39 2.67 0.95 2.65 1.58 2.68
3 1.06 2.64 1.12 2.66 0.84 2.64 1.33 2.68
4 0.84 2.64 0.86 2.65 1.08 2.63 1.16 2.68
5 1.70 2.63 1.33 2.64 0.87 2.62 0.99 2.67
6 1.78 2.62 1.10 2.63 0.85 2.61 0.96 2.67
7 2.02 2.62 0.79 2.64 0.91 2.61 3.40 2.68
8 2.41 2.62 0.86 2.62 1.01 2.61 3.74 2.67
9 3.19 2.62 0.45 2.62 1.31 2.60 6.03 2.67
Table 7: Average λ From Cross Validation (CV) and Theorem 2.2 (Theory) for Strong IVs.
Averages are taken after 500 simulations.
with a cross-validated λ performs better than sisVIVE with a theory-based λ. For the
“Stronger Invalid” case, when s < 3, sisVIVE with a cross validated λ performs better than
sisVIVE with a theory-based λ. However, when s ≥ 3, sisVIVE with a cross validated λ
performs worse than sisVIVE with a theory-based λ, although the differences between the
two decrease as s increases. For the “Stronger Valid” case, sisVIVE with a cross validated
λ always dominates sisVIVE with a theory-based λ, although the differences between the
two are slight when s ≥ 7.
Equal Variable Stronger Invalid Stronger Valid
s CV Theory CV Theory CV Theory CV Theory
1 0.13 0.17 0.14 0.16 0.13 0.19 0.14 0.16
2 0.16 0.27 0.16 0.27 0.16 0.34 0.16 0.24
3 0.18 0.39 0.18 0.37 0.24 0.54 0.18 0.32
4 0.21 0.53 0.22 0.53 1.57 1.34 0.20 0.41
5 0.71 1.15 0.76 1.43 1.43 1.25 0.23 0.55
6 2.43 2.34 2.05 1.93 1.35 1.23 0.28 0.71
7 2.42 2.37 1.83 1.95 1.28 1.21 3.83 3.95
8 2.35 2.34 1.98 2.05 1.22 1.18 4.24 4.39
9 2.29 3.01 1.23 1.37 1.17 1.16 4.34 4.51
Table 8: sisVIVE Estimation Performance of β∗ Between λ by Cross Validation (CV) and
from Theorem 2.2 (Theory) for Strong IVs. Averages are taken after 500 simulations.
Table 9 considers the same setup as Table 7, except we now look at instruments where
their overall, absolute strength is weak. Under this case, we see drastic differences between
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cross validation and Theorem 2.2. For example, for the “Equal” and “Variable” cases, when
s < 5, λ chosen based on cross validation is, on average, smaller than λ chosen based on
Theorem 2.2. When s ≥ 5, λ chosen based on cross validation is, on average, bigger than
λ chosen based on Theorem 2.2. For the “Stronger Invalid” case, when s < 3, λ based on
cross validation is, on average, smaller than λ based on Theorem 2.2. But, when s ≥ 3,
the opposite is the case. Finally, for the “Stronger Valid” case, this transition phenomena
occurs at s = 6.
Equal Variable Stronger Invalid Stronger Valid
s CV Theory CV Theory CV Theory CV Theory
1 1.36 3.20 1.56 3.23 1.05 3.13 1.52 3.24
2 1.25 3.00 1.22 3.01 0.93 2.92 1.47 3.07
3 1.12 2.91 1.11 2.94 3.67 2.81 1.26 3.00
4 2.06 2.86 1.83 2.89 9.47 2.75 1.13 2.97
5 6.30 2.80 4.34 2.84 10.52 2.71 1.20 2.92
6 11.99 2.78 7.48 2.80 10.74 2.69 3.36 2.93
7 14.14 2.76 5.92 2.77 10.58 2.67 7.79 2.93
8 14.04 2.75 5.94 2.75 9.92 2.66 9.70 2.93
9 13.16 2.74 2.02 2.68 9.47 2.64 7.09 2.96
Table 9: Average λ From Cross Validation (CV) and Theorem 2.2 (Theory) for Weak IVs.
Averages are taken after 500 simulations.
Table 10 considers the same setup as Table 8, except we now look at instruments where
their overall, absolute strength is weak. Similar to Table 8, sisVIVE with a cross validated λ
performs better than sisVIVE with a theory-based λ, with the only exception at s = 5 under
the “Equal” column. In fact, sisVIVE with a cross validated λ performs drastically better
than sisVIVE with a λ based on Theorem 2.2 in the following cases: s < 5 (for “Equal”
and “Variable” cases), s < 3 (for “Stronger Invalid” case), and s < 7 (for “Stronger Valid”
case).
Based on these simulations, sisVIVE based on cross validation generally performs better
than sisVIVE based on Theorem 2.2, especially when the overall instrument strength is
weak. We also note that cross validation tends to choose a smaller λ than the one based on
Theorem 2.2, suggesting that for better estimation, it is preferable to set only a few elements
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Equal Variable Stronger Invalid Stronger Valid
s CV Theory CV Theory CV Theory CV Theory
1 0.44 0.63 0.44 0.60 0.43 0.69 0.44 0.61
2 0.51 0.96 0.50 0.94 0.50 1.13 0.52 0.88
3 0.55 1.30 0.55 1.26 0.70 1.86 0.56 1.13
4 0.61 1.74 0.61 1.75 3.19 3.77 0.58 1.43
5 4.10 3.80 3.98 3.93 3.25 3.78 0.62 1.83
6 5.28 6.03 5.28 5.54 3.36 3.79 0.73 2.52
7 5.84 6.55 5.58 5.63 3.47 3.77 7.51 7.68
8 6.29 6.75 6.19 6.19 3.52 3.70 9.69 9.77
9 6.72 6.90 4.18 4.34 3.56 3.64 10.86 10.91
Table 10: sisVIVE Estimation Performance of β∗ Between λ by Cross Validation (CV) and
from Theorem 2.2 (Theory) for Weak IVs. Averages are taken after 500 simulations.
of αˆλ to zero and declare more instruments to be invalid than valid. This observation was
also seen in our simulation in Section 2.4.7 where low median absolute error, |β∗− βˆλ|, was
tied to high proportion of correctly chosen invalid instruments. As an aside, this observation
is in contrast with estimating sparse vectors in typical high dimensional regression settings
where many zeroed elements are desirable in the estimated sparse vector.
Despite the simulation evidence suggesting the use of cross validation to choose λ over
Theorem 2.2 to choose λ, unfortunately, there is little theory to justify the use of cross
validation in `1 penalization settings (Hastie et al., 2009; Bu¨hlmann and van der Geer,
2011). However, Section 2.5.1 of Bu¨hlmann and van der Geer (2011) does provide limited
theoretical results suggesting that λ based on cross validation tends to set few elements of
αˆλ to zero, a desirable property in our setting where we want to select more instruments
to be invalid than valid for better estimation performance of βˆλ.
Besides cross validation and Theorem 2.2, there is another way to choose λ if we assume
Corollary 2.1 holds for our data. Specifically, if we are in the always identified region where
s < U ≤ L/2, one possible method of choosing λ would be to find the λ where exactly
U = L/2, say λL/2. From there, we grid the values of potential λs between 0 and λL/2 and
choose the λ that minimizes the estimating equation ||PZ(Y − Zα −Dβ)||2. It would be
interesting to investigate this method in future research.
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2.4.9. Summary of Simulation Studies
The simulation studies above covered different types of instrument strength, correlation
structure between instruments, and total number of potential instruments. We also explored
different metrics of error, such as the proportion of correctly selected valid instruments and
invalid instruments, to analyze the relationship between estimating β∗ and α∗. In addition,
we also computed the conditions for Corollary 2.2, specifically ρ, µ, and λ required to achieve
the performance bound. In every setting considered, sisVIVE performs no worse than the
next best alternative, naive TSLS. In fact, in most cases, sisVIVE beats naive TSLS and
performs similarly to the oracle TSLS. The only case where sisVIVE’s performance deviated
greatly from the oracle TSLS was when the invalid instruments were stronger than the
valid instruments and s = 4. In addition, we showed that a good estimate of β∗ depends
strongly on correctly selecting the invalid instruments more than correctly selecting the
valid instruments and choosing λ based on cross validation seems to favor this situation.
We also find that choosing λ based on Theorem 2.2 leads to a higher λ than one based on
cross validation. Finally, we find that sisVIVE based on λ chosen by cross validation always
performed at least as well as sisVIVE based on λ chosen by Theorem 2.2. In fact, in most
cases, sisVIVE with a cross-validated λ performs better than sisVIVE with a λ chosen by
Theorem 2.2.
Overall, sisVIVE using a cross-validated λ does much better than naive TSLS, the most
frequently used estimator in MR and IV. In many cases, sisVIVE beats the naive TSLS
and is comparable to oracle TSLS. The promising simulation results suggest that sisVIVE
should be used whenever there is concern about invalid instruments.
2.5. Data Analysis: The Effect of Obesity on Quality of Life
2.5.1. Background
We demonstrate the potential benefit of using sisVIVE in MR by analyzing the effect of
obesity, the exposure, on health-related quality of life, the outcome. An individual’s quality
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of life is the general well-being of the individual; an individual’s health quality of life is the
subset of quality of life related to the individual’s health (Torrance, 1987). Previous non-MR
studies by Trakas et al. (2001) and Sach et al. (2006) have shown that there is a negative
association between obesity and health-related quality of life. However, a fundamental
difficulty with these studies is that the outcome, health-related quality of life, encompasses
various factors about the individual, making it difficult to control for all possible confounders
that may affect obesity and health-related quality of life (Cawley and Meyerhoefer, 2012).
An MR approach offers the potential of controlling for unmeasured confounders.
For the analysis, we use the data from the Wisconsin Longitudinal Study (WLS), a well-
known longitudinal study that has kept track of American high school graduates from
Wisconsin since 1957. We look at graduates that were reinterviewed in 2003-2005 (Hauser,
2005) and who have been genotyped. Similar to another analysis with the WLS genetic
data, we remove individuals with more than 10% missing genotype data (Roetker et al.,
2012). Our analysis of the data set contains n = 3712 individuals with 1913 females and
1799 males born mostly between 1938 to 1940.
To measure health-related quality of life, we use the Health Utility Index Mark 3 (HUI-3)
which was also used in Trakas et al. (2001). HUI-3 is a composite score of utility between
0 and 1, with 1 indicating highest health state and 0 indicating a health state equivalent
to death; negative utility is possible and indicates that the person is alive, but in a state
worse than death.
To measure obesity, we use the body mass index (BMI) and the US National Institute
of Health clinical guidelines (National Institute of Health, 1998) that were also used in
Trakas et al. (2001) and Sach et al. (2006) in their analysis. Specifically, we follow Trakas
et al. (2001) and define the exposure by assigning individuals with BMI less than 30 (i.e.
not obese) to be 0, individuals with BMI between 30 and 35 (i.e. obese class I) to be
1, individuals with BMI between 35 and 40 (i.e. obese class II) to be 2, and individuals
with BMI greater than 40 (i.e. obese class III) to be 3 so that each value of the exposure
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corresponds to the increasing obese classes used in Trakas et al. (2001) and the US National
Institute of Health clinical guidelines (National Institute of Health, 1998). For instance,
exposure value of zero corresponds to non-obese individuals while exposure value of two
corresponds to individuals in obese class II. Hence, the causal effect of interest is the effect
of moving up in the obese class; specifically β∗ in model (2.1) will correspond to the effect
of moving up one obese class on the HUI-3 index of health-related quality of life. In Section
2.5.3, we explore different definitions to quantify obesity and the resulting estimates from
different definitions.
For potential candidate instruments, we use the following single nucleotide polymorphisms
(SNPs) in the WLS that have been previously shown to be associated with obesity: rs1421085,
rs1501299, and rs2241766 (see Table 11). rs1421085 is in the FTO gene and it has been
shown to be strongly associated with obesity (Dina et al., 2007; Price et al., 2008). rs1501299
(i.e. +276G>T) is in the ADIPOQ gene that encodes adiponectin, a protein encoding for
lipid metabolism, and has been associated with obesity (Bouatia-Naji et al., 2006; Yang
et al., 2007). Finally, rs2241766 is also in the ADIPOQ gene that has been associated with
obesity (Ukkola et al., 2003; Yang et al., 2003; Beckers et al., 2009). For all the SNPs, we
follow an MR study done by Timpson et al. (2005) and assume an additive model. Although
we have no particular reason to think any of the SNPs is an invalid IV, we are uncertain due
to the lack of complete knowledge about the biological functions of the SNPs, a common
scenario in MR studies. Our sisVIVE estimator will provide a good estimate as long as
least two of the three SNPs are valid IVs.
Instruments Major alleles Heterozygote Minor alleles MAF (SE)
rs1421085 1281 (34.5%; TT) 1818 (49.0%; CT) 613 (16.5%; CC) 0.39 (0.0057)
rs1501299 1950 (52.5%; CC) 1502 (40.5%; AC) 260 (7.0%; AA) 0.24 (0.0049)
rs2241766 2956 (79.6%; TT) 719 (19.4%; TG) 37 (1.0%; GG) 0.10 (0.0036)
rs6265 2437 (65.7%; GG) 1112 (30.0%; AG) 163 (4.4%; AA) 0.19 (0.0046)
Table 11: Summary of Instruments in the Data Analysis. MAF stands for minor allele
frequency
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2.5.2. Analysis
A simple ordinary least squares analysis estimates that an increase in one obese class is
associated with a 0.052 (SE: 0.0040) decrease in HUI-3 score, which is consistent with prior
literature (Trakas et al., 2001; Sach et al., 2006). If we use TSLS, under the operating
assumption that all the instruments are valid, the estimated causal effect is −0.00094 (SE:
0.081), i.e. climbing up one obese class reduces your health utility quality of life by 0.00094.
Our estimator, sisVIVE, which operates only under the assumption that a proportion of
instruments are invalid, estimates −0.00094 as the causal effect, which is identical to the
estimate by TSLS. Also, sisVIVE does not select any SNPs as an invalid IV.
To further validate our method, we include another instrument, rs6265 (i.e. Val66Met).
rs6265 is in the brain-derived neurotrophic factor BDNF gene and has been shown to not
only be associated with BMI (Thorleifsson et al., 2008; Shugart et al., 2009), but also
neurological and cognitive function (Hwang et al., 2006; Rybakowski et al., 2006). Hence,
there is some reason to believe that rs6265 may be pleiotropic; rs6265 may impact obesity,
but also affect health-related quality of life through mechanisms other than obesity. sisVIVE
should be able to pick up on this instrument being invalid in contrast to TSLS, which will
always assume that all the instruments used are valid.
If we use TSLS under the operating assumption that all the four instruments are valid, the
estimated effect is −0.0086 (SE:0.080). sisVIVE, on the other hand, estimates the causal
effect to be −0.0037, which is closer to the estimates when we used three instruments.
sisVIVE also throws out the instrument, rs6265, which we suspect to be invalid.
The reduced form estimates for both analysis are summarized in Tables 12 and 13. The
reduced form estimates are computed by using ordinary least squares (OLS) where the
genetic instruments are the explanatory variables and the dependent variables are BMI and
Health Utility Index Mark 3 (HUI-3).
Also, for the data analysis with three SNPs, the Sargan overidentification test (Sargan,
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Instruments BMI (SE) HUI-3 (SE)
rs1421085 -0.05 (0.02) 0.0003 (0.004)
rs1501299 0.01 (0.02) 0.002 (0.005)
rs2241766 -0.0007 (0.03) -0.0001 (0.007)
Table 12: Reduced Form Estimates for HUI-3 and BMI for Three SNPs
Instruments BMI (SE) HUI-3 (SE)
rs1421085 -0.05 (0.02) 0.0004 (0.004)
rs1501299 0.01 (0.02) 0.002 (0.005)
rs2241766 -0.0006 (0.03) -0.0004 (0.007)
rs6265 -0.004 (0.02) -0.008 (0.005)
Table 13: Reduced Form Estimates for HUI-3 and BMI for Four SNPs
1958), which tests assumptions (A2) and (A3) in the presence of multiple instruments,
gives a Chi-squared value of 0.12 (p-value: 0.94), retaining the null hypothesis that the
instruments are all valid under the 0.05 significance level. For the data analysis with four
SNPs, the Sargan overidentification test gives a Chi-squared value of 2.53 (p-value: 0.47).
The first stage F statistic with three instruments is 3.16. The first stage F statistic with
four instruments is 2.38. Based on the two F statistics, the instruments are generally weak.
We also estimate the implied structural correlation from our model, specifically the corre-
lation between Di, the exposure, and i. We estimate i by taking the residual from the
estimates of β∗ and α∗, ˆi = Yi −Diβˆλ − ZTi. αˆλ where λ is chosen by cross-validation de-
scribed in Section 2.3.4. We find that our estimate of this correlation is −0.2, suggesting a
mild form of endogeneity.
In both data analyses, sisVIVE operates under the assumption that there may be invalid
instruments, which are typical in MR studies, while TSLS operates under the assumption
that all instruments are valid. In the first data analysis where there was no reason to
believe that the instruments were invalid, sisVIVE provides the same answer as TSLS, but
without assuming that all the instruments were valid. In the second data analysis where
one instrument was suspect, sisVIVE removed the suspected instrument. In both cases,
sisVIVE was robust to possibly invalid instruments compared to TSLS.
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2.5.3. A Digression: Defining Obesity Using BMI
In this section, we carefully look at different methods to quantify obesity, our exposure
in the data set, using BMI. First, we looked at BMI across several categories of obesity.
The categories were based on US National Institute of Health clinical guidelines (National
Institute of Health, 1998) and were also used in Trakas et al. (2001) and Sach et al. (2006) in
their analysis. Table 14 summarizes the relationship between obesity categories and HUI-3
in our data.
Health Utility Index Mark 3
Obesity Categories N 1st quartile Median 3rd quartile
Not obese (BMI < 30) 2581 0.84 0.92 0.97
Obese class I (30 ≤ BMI < 35) 777 0.73 0.91 0.97
Obese class II (35 ≤ BMI < 40) 246 0.66 0.85 0.97
Obese class III (40 ≤ BMI ) 108 0.51 0.72 0.91
All categories 3712 0.78 0.92 0.97
Table 14: Relationship Between Obesity and Health Utility Index Mark 3 (HUI-3)
We notice that among different obese classes, the median HUI-3 scores are different. Hence,
simply classifying individuals as obese vs. not obese ignores the variation of HUI-3 scores
among different obese classes. This led us to explore different ways of quantifying obesity
through BMI as follows.
1. The binary BMI takes a value of one if BMI is greater than or equal to 30 (i.e. obese)
and zero otherwise.
2. BMI A is what we use in the main analysis.
3. BMI B is defined to be similar to Trakas et al. (2001), except the magnitude of the
BMIs is taken into consideration. Specifically, if an individual’s BMI is less than 30,
the individual’s exposure is assigned a value of zero. If an individual’s BMI is between
30 and 35 (i.e. Obese Class I), the individual’s exposure is assigned a value of one.
If an individual’s BMI is between 35 and 40 (i.e. Obese Class II), the individual’s
exposure is assigned a value of three. If an individual’s BMI is above 40 (i.e. Obese
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Class III), the individual’s exposure is assigned a value of six.
4. The censored BMI takes into account the actual value of BMI at the obese range
so that it not only indicates obesity, but also measures its severity. Specifically, the
censored BMI is defined as the maximum of (BMI −30) and 0 (i.e. max(BMI−30, 0)).
For each method of quantifying obesity, we estimate β∗ by using ordinary least squares
(OLS), two stage least squares (TSLS) under the assumption that all the instruments are
valid, and sisVIVE. These results are reported in Tables 15 and 16 for the cases of three and
four instruments used in our main analysis. Overall, we notice that the estimates of OLS,
TSLS, and sisVIVE tend to be similar across different definitions of obesity. Granted, it is
difficult to compare the estimates since each exposure variable measures slightly different
aspects about obesity and its impact on HUI-3. We also note that in the case of four
instruments where one of the instrument, rs6265, was suspect, sisVIVE correctly picks
rs6265 to be an invalid instrument in every method of quantifying obesity.
Exposure OLS (SE) TSLS (SE) sisVIVE, Invalid Instrument
Binary BMI -0.074 (SE: 0.0070) -0.012 (SE: 0.18) -0.012, None
BMI A -0.052 (SE: 0.0040) -0.00094 (SE: 0.081) -0.00094, None
BMI B -0.031 (SE: 0.0024) -0.0011 (SE: 0.051) -0.0011, None
Censored BMI -0.013 (SE: 0.0010) -0.00019 (SE: 0.022) -0.00019, None
Table 15: Different Definitions of Obesity and The Resulting Estimates With Three Instru-
ments
Exposure OLS (SE) TSLS (SE) sisVIVE, Invalid Instrument
Binary BMI -0.074 (SE: 0.0070) -0.097 (SE: 0.17) -0.039, rs6265
BMI A -0.052 (SE: 0.0040) -0.0086 (SE: 0.080) -0.0037, rs6265
BMI B -0.031 (SE: 0.0024) -0.0012 (SE: 0.051) -0.0017, rs6265
Censored BMI -0.013 (SE: 0.0010) 0.00091 (SE: 0.022) -0.00011, rs6265
Table 16: Different Definitions of Obesity and The Resulting Estimates With Four Instru-
ments
2.6. Discussion
This paper demonstrates that proper estimation of causal effects using the IV method is
possible without knowledge of all the instruments’ validity. Our results show that simply
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knowing a proportion of the instrument is valid, without knowing which are valid, is suf-
ficient and we construct the sisVIVE estimator that dominates the naive TSLS in almost
every aspect while performing similarly to the oracle TSLS. Both the simulation result and
data analysis show that sisVIVE is a robust alternative to TSLS in the presence of possibly
invalid instruments.
Future work could involve generalizing the model considered. In particular, the current
paper discusses a model in which treatment effects are constant. Angrist et al. (1996)
discusses the setting in which the treatment effects are not constant and individuals may
select into treatment based on expected gains from treatment. Then, qm and qm′ in Theorem
2.1 might not be equal to each other for different sets of valid instruments and Theorem 2.1
does not apply. It would be useful to understand what sisVIVE is estimating under this
setting of treatment effect heterogeneity. Other useful directions for future work are relaxing
the conditions on Corollary 2.2 to encompass more invalid instruments s and deriving tests
for identification. Also, we have focused on the applications of our method to Mendelian
randomization. In economic applications, it is also common to have multiple candidate
instruments and be concerned that some proportion of the instruments are invalid (Murray,
2006). Our current work demonstrates that instrumental variable estimation is definitely
possible even in the presence of possibly invalid instruments.
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CHAPTER 3 : Robust Confidence Interval Estimation of Causal Effects With
Possibly Invalid Instruments
This is joint work with Tony Cai and Dylan Small
3.1. Introduction
In the previous chapter, we considered violations of (A2) and (A3) and proposed identi-
fication results based on imposing an upper bound on the number of invalid instruments
among the candidate instruments, without knowing exactly which instruments are valid or
knowing the exact number of invalid instruments, or imposing any structure on the instru-
ments. The previous chapter also proposed a point estimator, called sisVIVE, to estimate
the causal effect when invalid instruments are present.
This chapter focuses on the same setting, but we develop robust confidence intervals when
candidate instruments might violate (A2) and (A3). Like before, we only assume that
we know an upper bound on the number of invalid instruments, without knowing exactly
which instruments are invalid. In this setting, we propose a simple and general confidence
interval procedure that theoretically guarantees the correct coverage rate and is robust to
possibly invalid instruments. The confidence interval is based on inverting statistical tests
over a range of subsets of instruments that are potentially valid. We also propose various
ways to obtain short and informative confidence intervals with our procedure by exploring
various tests common in instrumental variables and conducting pretests. The simulation
study shows that our method is robust when invalid instruments are present compared to
other popular methods in the instrumental variables literature. We also demonstrate that
our method can produce valid, short, and informative confidence intervals by analyzing a
data set concerning the causal effect of income on food expenditure.
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3.2. Robust Confidence Intervals by Inverting Tests
3.2.1. Review of Notation
We use the potential outcomes notation (Rubin, 1974) for instruments laid out in Holland
(1988), Small (2007) and Chapter 2. Specifically, let there be L potential candidate instru-
ments and n individuals in the sample. Let Y
(d,z)
i be the potential outcome that individual
i would have if the individual were to have exposure d, a scalar value, and instruments z, an
L dimensional vector. Let Dzi be the potential exposure if the individual had instruments z.
For each individual, only one possible realization of Y
(d,z)
i and D
(z)
i is observed, denoted as
Yi and Di, respectively, based on his/her observed instrument values Zi., an L dimensional
vector, and observed exposure Di. In total, we have n observations of (Yi, Di, Zi.). We
denote Y = (Y1, . . . , Yn), D = (D1, . . . , Dn) and Z to be the n by L matrix where row i
consists of Zi..
For any subset A ⊆ {1, . . . , L} with cardinality c(A), let ZA be an n by c(A) matrix of
instruments where the columns of ZA are from the set A, PZA = ZA(Z
T
AZA)
−1ZTA be the
orthogonal projection matrix onto the column space of ZA and RZA = I − PZA be the
residual projection matrix where I is an n by n identity matrix. We assume that ZTAZA has
a proper inverse unless otherwise stated. Also, for any L dimensional vector pi, let piA only
consist of elements of the vector pi determined by the set A.
3.2.2. Review of Model and Definition of Valid Instruments
For two possible values of the exposure d′, d and instruments z′, z, we assume the following
potential outcomes model
Y
(d′,z′)
i − Y (d,z)i = (z′ − z)Tφ∗ + (d′ − d)β∗, E{Y (0,0)i | Zi.} = ZTi. ψ∗ (3.1)
where φ∗, ψ∗, and β∗ are unknown parameters. The parameter β∗ represents the causal
parameter of interest, the causal effect (divided by d′ − d) of changing the exposure from
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d′ to d on the outcome. The parameter φ∗ represents violation of (A2), the direct effect of
the instruments on the outcome. If (A2) holds, then φ∗ = 0. The parameter ψ∗ represents
violation of (A3), the presence of unmeasured confounding between the instrument and the
outcome. If (A3) holds, then ψ∗ = 0.
Let pi∗ = φ∗+ψ∗ and i = Y
(0,0)
i −E{Y (0,0)i | Zi.}. When we combine equations (3.1) along
with the definition of i, the observed data model becomes
Yi = Z
T
i. pi
∗ +Diβ∗ + i, E(i | Zi.) = 0 (3.2)
The observed model is also known as the under-identified single-equation linear model in
econometrics (page 83 of Wooldridge (2010)). Note that (3.2) is not a usual regression model
because Di might be correlated with i. In particular, the parameter β
∗ measures the causal
effect of changing D on Y rather than an association. As mentioned in Chapter 2, we discuss
extensions of the model (3.2) to include heterogeneous causal effects and non-linear effects.
Also, the model can incorporate exogenous covariates, say Xi. and we can project them
out by using Frisch-Waugh-Lovell Theorem to reduce the model to (3.2) (Davidson and
MacKinnon, 1993). The parameter pi∗ in the observed data model (3.2) combines both the
violation of (A2), represented by φ∗, and the violation of (A3), represented by ψ∗. If both
(A2) and (A3) are satisfied, then φ∗ = ψ∗ = 0 and pi∗ = 0. Hence, the value of pi∗ captures
whether instruments are valid versus invalid. Definition 3.1 formalizes this idea.
Definition 3.1. Suppose we have L candidate instruments along with the models (3.1)–
(3.2). We say that instrument j = 1, . . . , L is valid if pi∗j = 0 and invalid if pi
∗
j 6= 0.
When there is only one instrument, L = 1, Definition 3.1 of a valid instrument is identical
to the definition of a valid instrument in Holland (1988). Specifically, assumption (A2), the
exclusion restriction, which means Y
(d,z)
i = Y
(d,z′)
i for all d, z, z
′, is equivalent to φ∗ = 0 and
assumption (A3), no unmeasured confounding, which means Y
(d,z)
i andD
(z)
i are independent
of Zi. for all d and z, is equivalent to ψ
∗ = 0, implying pi∗ = φ∗ + ψ∗ = 0. Definition 3.1 is
also a special case of the definition of a valid instrument in Angrist et al. (1996) where here
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we assume the model is additive, linear, and has a constant treatment effect β∗. Hence,
when multiple instruments, L > 1, are present, our models (3.1)–(3.2) and Definition 3.1
can be viewed as a generalization of the definition of valid instruments in Holland (1988).
Let s = 0, . . . , L−1 to be the number of invalid instruments and U be an upper bound on s
plus 1, i.e. the number of invalid instruments is assumed to be less than U . We assume that
there is at least one valid IV, even if we don’t know which among the L IV is valid, since
if all L IVs are invalid (i.e. s = L), identification would not be possible. This is the setup
considered in Chapter 2 as a relaxation to traditional instrumental variables setups where
one knows exactly which instruments are valid and invalid. For simplicity, we consider the
case where at less than half of the candidate instruments are invalid, U ≤ L/2, because all
the parameters in the model (3.2) are always identified under this setup (see Chapter 2 for
details). However, the proposed procedures will work for any upper bound U , exceeding
L/2.
3.2.3. A General Procedure for Robust Confidence Intervals
Let I = {1, . . . , L} be the L candidate instruments and B∗ ⊆ {1, . . . , L} be the true set
of valid instruments. Given B∗, consider a test statistic T (β0, B∗) of the null hypothesis
H0 : β
∗ = β0 versus the alternative Ha : β∗ 6= β0. It is well known that inverting a test
based on T (β0, B
∗) that has level α provides a 1− α confidence interval for β∗, denoted as
C1−α(Y,D,Z,B∗).
C1−α(Y,D,Z,B∗) = {β0 | T (β0, B∗) ≤ ν1−α} (3.3)
where ν1−α is the 1− α quantile of the null distribution of T (β0, B∗).
Unfortunately, in our problem, we do not know the true set B∗ of valid instruments, so we
cannot directly use (3.3). However, in our model description in Section 3.2.2, we have an
upper bound on the number of invalid instruments, s, by U where s < U and consequently,
a lower bound for the number of valid instruments, L − s > L − U and thus a lower
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bound on the cardinality of the set B∗, c(B∗), c(B∗) > L − U . Using this lower bound,
we can take unions of C1−α(Y,D,Z,B) over possible sets of valid instruments B ⊆ I where
c(B) > L− U ; the confidence interval using the true set of instruments C(Y,D,Z,B∗) will
be in this union since c(B∗) > L− U . Our proposal is exactly this, except that we restrict
the subsets B to be of size c(B) = L− U + 1.
C1−α(Y,D,Z) = ∪B{C1−α(Y,D,Z,B) | B ⊆ I, c(B) = L− U + 1} (3.4)
The proposed confidence interval C1−α(Y,D,Z) is simple and general; for any test statistic
T (β0, B) with a valid size for B ⊆ B∗, one simply takes unions of confidence intervals of
T (β0, B) over subsets of instruments B where c(B) = L−U + 1. In addition, a key feature
of our procedure is that it is not necessary to go through all the subsets of possible valid
instruments larger than c(B) > L−U ; simply looking at the smallest possible subsets of valid
instruments, i.e. those subsets that are at the lower boundary of L−U , c(B) = L−U + 1,
is sufficient to provide the 1− α coverage.
Theorem 3.1 states that the procedure in (3.4) produces a valid confidence interval since
c(B∗) > L− U , there is some subset of valid instruments with cardinality L− U + 1.
Theorem 3.1. Suppose model (3.2) holds and s < U . Given α, consider any test statistic
T (β0, B) with the property that for any B ⊆ B∗, T (β0, B) has size at most α under the null
hypothesis H0 : β
∗ = β0. Then, C1−α(Y,D,Z) in (3.4) always has at least 1− α coverage.
Proof of Theorem 3.1. By s < U , we have c(B∗) > L− U . Consequently, there is a subset
B˜ ⊆ B∗ where c(B˜) = L−U + 1 and B˜ only contains only valid instruments. Since B˜ only
contains valid instruments, pr{β∗ ∈ C1−α(Y,D,Z, B˜)} ≥ 1 − α for all pi∗, β∗. Hence, we
have
pr{β∗ ∈ C1−α(Y,D,Z)} ≥ pr{β∗ ∈ C1−α(Y,D,Z, B˜)} ≥ 1− α
for all values of pi∗, β∗.
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A potential caveat to our procedure is computational feasibility. Even though we restrict the
union to subsets of exactly size c(B) = L−U+1, if the number of candidate instruments, L,
grows, C(Y,D,Z) becomes computationally burdensome. However, in many instrumental
variables studies, it is difficult to find good candidate instruments and rarely the number of
these candidates instruments exceed L = 20, which modern computing can handle. Hence,
our procedure in (3.4) is computationally tractable for most practical applications.
3.2.4. Choice of Test Statistics
In the instrumental variables literature, there are many tests of causal effects T (β0, B) that
can be used with Theorem 3.1 to construct valid 1−α confidence interval C1−α(Y,D,Z) in
the presence of invalid instruments. A natural question to ask, then, is among these tests,
which test statistic, when used with Theorem 3.1, provides the smallest length confidence
interval and thus, from a practical standpoint, provides the most informative confidence
interval?
The most popular test is the t-test based on based on the asymptotic normal distribution of
the two stage least squares estimator. The two stage least squares estimator of β∗ for a given
B, denoted as βˆB,TSLS , is the solution to the minimization problem ‖PZ˜BRZA(Y −Dβ)‖22
where A is the complement of the set B, A = I \ B, and Z˜B = RZAZB. If uˆ(B) is the
residuals from the fitted model, uˆ(B) = RZA(Y −DβˆB,TSLS) and Dˆ(B) is the projection of
D on to the column space of Z˜B, Dˆ(B) = PZ˜BD, then the t-test is defined as
TSLS(β0, B) =
√
n− c(A)− 1
 βˆB,TSLS − β∗0√‖uˆ(B)‖22/‖Dˆ(B)‖22
 (3.5)
If B ⊆ B∗, standard econometrics arguments show that (3.5) converges to an asymptotic
Normal distribution (Wooldridge, 2010). In practice, the test (3.5) is approximately valid
when all the subset of instruments B among the candidate instruments I are strong, or
in other words, strongly associated with the exposure. Unfortunately, instruments can be
weak in practice and the nominal size of tests based on two stage least squares can be
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misleading (Staiger and Stock, 1997).
Stock et al. (2002) presents a survey of tests that are robust to weak instruments. Specifi-
cally, for a given B, let W (B) be an n by 2 matrix where the first column contains RZAY and
the second column contains RZAD. Let a0 = (β0, 1) and b0 = (1,−β0) to be two-dimensional
vectors and Σˆ = W (B)TMZ˜BW (B)/(n−L). Let Sˆ(B) and Tˆ (B) be two-dimensional vectors
Sˆ(B) =
(Z˜TBZ˜B)
−1/2Z˜TBW (B)b0√
bT0 Σˆb0
, Tˆ (B) =
(Z˜TBZ˜B)
−1/2Z˜TBW (B)Σˆ
−1a0√
aT0 Σˆ
−1a0
along with the following scalar values
Qˆ11(B) = Sˆ(B)
T Sˆ(B), Qˆ12(B) = Sˆ(B)
T Tˆ (B)
Qˆ22(B) = Tˆ (B)
T Tˆ (B)
Based on Qˆ11(B), Qˆ12(B), and Qˆ22(B), we define the following tests, the Anderson-Rubin
test (Anderson and Rubin, 1949), the Lagrangian multiplier test (Kleibergen, 2002), and
the conditional likelihood test (Moreira, 2003).
AR(β0, B) = Qˆ11(B)/c(B) (3.6)
LM(β0, B) = Qˆ
2
12(B)/Qˆ22(B) (3.7)
CLR(β0, B) =
1
2
{
Qˆ11(B)− Qˆ22(B)
}
(3.8)
+
1
2
√
{Qˆ11(B) + Qˆ22(B)}2 − 4{Qˆ11(B)Qˆ22 − Qˆ212(B)}
Each of the three tests have their unique robustness characteristics and properties, but all
of them have been shown to be robust to weak instruments(Staiger and Stock, 1997; Stock
et al., 2002; Kleibergen, 2002; Moreira, 2003; Dufour, 2003; Andrews et al., 2006). There
is no uniformly most powerful test among the three tests, but Andrews et al. (2006) and
Mikusheva (2010) have suggested using (3.8) due to its generally favorable power compared
to (3.6) and (3.7) in most cases when weak instruments are present. However, the La-
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grangian multiplier test (3.7) and the Anderson-Rubin test (3.6) have the unique feature
where both tests (or derivatives of) can be used as a pretest to check whether the candi-
date subset of instruments B contain only valid instruments. This feature is particularly
useful for our problem where we have possibly invalid instruments (see Section 3.2.6). Also,
among the three tests, the Anderson-Rubin test is the simplest in that it can be written
as a standard F -test in regression where the outcome is RZA(Y −Dβ0), the regressors are
Z˜B, and we are testing whether the coefficients associated with Z˜B are zero or not with the
standard F-test. Finally, the Lagrangian multiplier test and the conditional likelihood ratio
test require an assumption that the exposure, D, is linearly related to the exposure Z by
Di = Z
T
i. γ
∗ + ξi where γ∗ is an L dimensional vector and ξi is a random error term with
mean zero, homoscedastic variance, and is independent of Z; the Anderson-Rubin test does
not require this linearity assumption.
3.2.5. Empty Confidence Intervals and the Anderson-Rubin test
Our procedure C1−α(Y,D,Z) involves taking the union of confidence intervals, at least
one of which is based on valid instruments, but some of which may be based on invalid
instruments. For instance, if we have a subset B with c(B) = L−U + 1, but it is not a the
subset of B∗, B contains at least one true invalid instruments from A∗ = I \B∗ and we may
end up with confidence intervals C1−α(Y,D,Z,B) that are biased. Such a potentially biased
interval is included in the interval for C1−α(Y,D,Z). Even though C1−α(Y,D,Z) will have
correct coverage regardless of this inclusion, the unnecessary inclusion of the biased interval
may elongate the interval C1−α(Y,D,Z) and produce an uninformative interval.
One method to deal with this problem is to choose a test statistic where for B 6⊆ B∗,
C1−α(Y,D,Z,B) will usually produce an empty interval. For example, the Anderson-Rubin
test statistic in (3.6) has this feature. To illustrate, suppose we assume Di = Z
T
i γ
∗+ξi where
i, ξi are independent and bivariate Normal with mean 0 and covariance Σ. If we subtract
Dβ0 and multiply by RZA from both sides of (3.2) and substitute Di with Di = Z
T
i γ
∗+ ξi,
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we obtain
RZA(Y −Dβ0) = Z˜Bκ∗ +RZA, κ = pi∗B + γB(β∗ − β0) (3.9)
where γ∗B and pi
∗
B are the components of γ
∗ and α∗ vectors for the indices that belong to the
subset B. As explained in Section 3.2.4, the Anderson–Rubin test can also be written as
an F test where the null is H0 : κ
∗ = 0. This null corresponds to testing both whether the
instruments are valid, pi∗B = 0, and whether the treatment effect is β0, β
∗ = β0. Rejecting
H0 : κ
∗ = 0 in favor of the alternative would imply that one is rejecting the null because the
treatment effect is not β0 or because the instruments in set B are not valid. Thus, when a
candidate set of instruments B contains an invalid instrument, the Anderson–Rubin test will
likely reject when β∗ = β0, and so the inversion of the Anderson–Rubin test will produce an
empty confidence interval or a short confidence interval (see Kadane and Anderson (1977)
and Small (2007) for the exact circumstances under which the Anderson–Rubin test will
have this property).
3.2.6. Pretest for Invalid Instruments
Another method to avoid taking unions of unnecessary intervals is by conducting a prelim-
inary test that checks whether each of the subsets B where c(B) = L−U + 1 contains any
invalid instruments before proceeding to construct a confidence interval with B. Specifi-
cally, for a desired confidence interval 1 − α, consider the null hypothesis that B contains
only valid instruments, pi∗B = 0, and the corresponding test statistic S(B), which serve as a
pretest for the validity of the instruments in B. For any α1 < α, suppose the test based on
S(B) has level α1 under the null hypothesis that B only contains valid instruments with
q1−α1 as the 1 − α1 quantile of S(B) under the null hypothesis. Then, a 1 − α confidence
interval can be constructed based on S(B) as follows.
P1−α(Y,D,Z) = ∪B{C1−α2(Y,D,Z,B) | B ⊆ I, c(B) = L− U + 1, S(B) ≤ q1−α1} (3.10)
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where α = α1 +α2. For example, if the desired confidence level is 95% where α = 0 · 05, we
can set α1 = 0.01 and α2 = 0.04.
Given α, α1, and α2 where α = α1 +α2, Theorem 3.2 shows that C˜1−α achieves the desired
1− α coverage in the presence of possibly invalid instruments.
Theorem 3.2. Suppose we have the same assumptions about the model and the test statistic
T (β0, B) as in Theorem 3.1. For any pretest S(B) that has the correct size under the null
hypothesis that B contains only valid instruments, P1−α(Y,D,Z) always has at least 1− α
coverage.
Proof of Theorem 3.2. Consider B˜ ⊆ B∗ where c(B˜) = L − U + 1. Since S(B) has the
correct size, under the null hypothesis, pr{S(B˜) ≥ q1−α1} ≤ α1. Then, for S(B) and
T (β0, B), we can use Bonferroni’s inequality to obtain
pr{β∗ ∈ P1−α(Y,D,Z)} ≥ pr{β∗ ∈ C1−α2(Y,D,Z, B˜) ∩ S(B˜) ≤ q1−α1}
≥ 1− pr{β∗ /∈ C1−α2(Y,D,Z, B˜)} − pr{S(B˜) ≥ q1−α1}
= 1− α1 − α2 = 1− α
thereby guaranteeing the correct coverage.
Similar to Theorem 3.1, the procedure in (3.10) is general in the sense that any pretest
S(B) with the correct size under the null hypothesis that B contains only valid instruments
will guarantee that the pretest confidence interval P1−α(Y,D,Z) will have the desired level
of coverage. For example, the test statistic proposed by Kleibergen (2007), which is simply
the difference between the Anderson-Rubin test in (3.6) and the Lagrangian multiplier test
in (3.7)
JLM(β0, B) = AR(β0, B)− LM(β0, B) (3.11)
satisfies the size criterion in Theorem 3.2 under some assumptions, most notably the linear
modeling assumption between Di and Zi.. Furthermore, Kleibergen (2007) proved that un-
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der the null hypothesis for H0 : β
∗ = β0, (3.11) is independent of the Lagrangian multiplier
test and converges to a χ2c(B)−1. Hence, we can use the two tests, JLM(β0, B) and LM(β0, B),
to construct P1−α(Y,D,Z) in (3.10) by first conducting a pretest with JLM(β0, B) at α1
level where q1−α1 would be the 1 − α1 quantile of χ2c(B)−1. If the test fails to reject the
null hypothesis that B contains only valid instruments, we can then proceed to construct a
1− α2 confidence interval using this B and the Lagrangian multiplier test of LM(β0, B).
Another pretest that can be used is the Sargan test for overidentification (Sargan, 1958),
which tests, among other things, whether the instruments B contain only valid instruments
(Dufour, 2003). The Sargan test is
SAR(B) =
‖PZ˜B uˆ(B)‖22
‖uˆ(B)‖22/n
(3.12)
where the uˆ(B) corresponds to the residual from the two stage least squares estimator in
(3.5). Under model (3.2) and the null hypothesis that ZB is independent of i, SAR(B)
converges to a χ2c(B)−1 distribution. In other words, as long as B contains a set of valid
instruments, S(B) converges to a χ2c(B)−1. Thus, if we use the Sargan test as a pretest for
P1−α(Y,D,Z), then q1−α1 in (3.10) would be the 1 − α1 quantile of a χ2c(B)−1 distribution
and we would only proceed to construct a confidence interval with the test statistic T (β0, B)
at 1− α2 if the null hypothesis is retained.
3.2.7. Prior Information About s and U
Throughout our discussion, we used the U = L/2 upper bound, that is given L candidates,
less than 50% are invalid, out of simplicity along with the fact that at U ≤ L/2, the
parameters in our model (3.2) are always identifiable (see Chapter 2). However, in practice,
practitioners may be able to use their subject matter knowledge to assume a smaller upper
bound on the number of invalid instruments and we want to be able to incorporate this
information into our confidence interval procedures. By having a tighter upper bound on s
by U than U = L/2, our methods in (3.4) and (3.10) are only left with smaller number of
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subsets of possibly valid instruments to go through. Specifically, in (3.4), we take less unions
over possibly unnecessary intervals and this provides more informative intervals. In (3.10),
having a tighter bound on s translates to doing fewer pretests and having less subsets to
take unions of, leading to more informative intervals. In Section 3.3.2, we examine the effect
of having more prior information about s via U on our methods producing more informative
intervals through a simulation study.
3.3. Simulation
3.3.1. Robustness With Invalid Instruments
We first compare in the simulation study the robustness of our method compared to popular
methods for confidence intervals in the instrumental variables literature when there are
concerns for invalid instruments.
The simulation setup is similar to the traditional single-equation linear models. We have
n = 5000 individuals with L = 10 candidate instruments where each pair of instruments
are correlated with correlation 0.6. For the data generating model, we assume the model
in (3.2) and a linear model between Di and Zi., specifically Di = Z
T
i γ
∗ + ξi where i, ξi
are either (i) independent and bivariate Normal with mean 0, marginal variance 1, and
correlation 0.99, (ii) bivariate t with 3 degrees of freedom with the same moments as (i) and
(iii) where the log of the error terms is bivariate Normal with the same moments as (i) so
that the error distributions are skewed. The individuals i = 1, . . . , n are independent. We
vary the number of invalid instruments, s, from 0 to 5. We consider the setting where less
than 50% of the instruments are invalid since β∗ is always identified under this case (see
Chapter 2). We set γ∗ based on the concentration parameter, which is the expected value
of the F statistic for the coefficients ZB∗ in the regression of D and Z and is a measure
of instrument strength (Stock et al., 2002). Specifically, γ∗ is set so that either (i) the
instruments are strong with a concentration parameter above 1000 or (ii) the instruments
are weak with a concentration parameter below 10.
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We compare our methods in (3.4) and (3.10) to “naive” and “oracles” methods. Naive
methods are methods that assume all candidate instruments are valid, which is typically
done in practice; we use the four tests described in Section 3.2.4, specifically the two-stage
least squares test in (3.5), the Anderson-Rubin test in (3.6), the Lagrange multiplier test
in (3.7), and the conditional likelihood ratio test in (3.8), all with B = {1, . . . , L} (Murray,
2006). Oracles correspond to knowing exactly which instruments are valid and invalid,
specifically using the four procedures with B = B∗; these methods typically cannot be
used in practice because of the incomplete knowledge about exactly which instruments are
invalid versus valid. Also, for our methods involving pretests in (3.10), we use the Sargan
test as the pretests for the two stage least squares test and the conditional likelihood ratio
test, both at level α1 = 0.01 for the pretest, and α2 = 0.04 for the subsequent tests. For the
Lagrange multiplier test, we use the pretest in (3.11) at level α1 = 0.01 and construct the
confidence interval with α2 = 0.04. We do not use the pretesting method for the Anderson-
Rubin test since the test produces informative intervals by encouraging empty intervals for
subsets B that contain invalid instruments (see Section 3.2.5). We repeat the simulation
1000 times for each setting. For interpretability, among all our methods, we take the convex
hull of the union of confidence intervals to obtain non-disjoint intervals.
Tables 17, 18, and 19 show the coverage proportion of the four procedures when we vary
s and assume that at most 50% of the instruments are invalid, U = L/2 = 5, for the
bivariate Normal, the bivariate t, and the skewed errors, respectively. When there are no
invalid instruments, s = 0 and the instruments are strong, the naive procedures have the
desired 95% coverage. Our methods have higher than 95% coverage because they need to
overcompensate to allow for the possibility that not all candidate instruments are valid.
When the instruments are weak and there are no invalid instruments, s = 0, any procedure
using two stage least squares undercovers, which is to be expected from the literature
on two stage least squares’ poor performance in the presence of weak instruments (see
references in Section 3.2.4). As the number of invalid instruments, s, increases, regardless
of the strength of the instruments, the naive methods fail to have any coverage. The oracle
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Naive TSLS 94 0 0 0 0
AR 95 0 0 0 0
LM 98 0 0 0 0
CLR 95 0 0 0 0
Our method TSLS 100 100 100 100 96
AR 100 100 100 100 95
LM 100 100 100 100 97
CLR 100 100 100 100 97
SAR + TSLS 100 100 100 100 94
JLM + LM 100 100 100 100 92
SAR + CLR 100 100 100 100 95
Oracle TSLS 94 95 94 95 94
AR 95 96 95 95 95
LM 98 98 97 97 97
CLR 95 95 94 95 94
Weak Naive TSLS 5 0 0 0 0
AR 96 0 0 0 0
LM 98 0 0 0 0
CLR 98 0 0 0 0
Our method TSLS 30 43 39 30 17
AR 100 100 100 100 96
LM 100 100 100 100 97
CLR 100 100 100 100 97
SAR + TSLS 31 44 41 32 18
JLM + LM 99 96 92 77 42
SAR + CLR 100 100 98 91 56
Oracle TSLS 5 7 10 13 17
AR 96 96 96 96 96
LM 98 97 97 97 97
CLR 98 97 97 97 97
Table 17: Comparison of Coverage Between 95% IV Confidence Intervals Under Normal
Errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM, Lagrange multiplier
test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM, pretest in (3.11). There
are L = 10 candidate instruments and U is set to L/2 = 5. Strong instruments correspond
to concentration parameter exceeding 100. Weak instruments correspond to concentration
parameter value around 2. The standard error for all the coverage proportions do not exceed
2%.
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methods have proper coverage, except two stage least squares when the instruments are
weak. Our methods have the desired level of coverage, with the coverage level reaching
nominal levels when s is at the boundary of s < U , i.e. s = 4. The only notable exceptions
to our methods having correct coverage are in the presence of weak instruments when the
two stage least squares t-test is used as test statistics or when pretests are used. This
is not surprising because the two stage least squares t-test and Sargan test are known to
have actual Type I error rate that can differ greatly from the nominal Type I error rate
in the presence of weak instruments (Staiger and Stock, 1997). The simulations suggest
that methods with pretests are only useful when the instruments are sufficiently strong. By
contrast, our method using the Anderson-Rubin’s test is valid regardless of the strength of
the instruments.
In short, in the presence of possibly invalid instruments, the naive, popular approach of sim-
ply assuming all the instruments are valid would lead to misleading inference. In contrast,
our methods, especially the method in (3.4), provide honest coverage regardless of whether
instruments are invalid or valid (as long as the number of invalid instruments is less than
the assumed upper bound U) and should be used whenever there is concern for possibly
invalid instruments. In particular, (3.4) works regardless of the strength of the instruments
while our method in (3.10) provides a desired level of coverage so long as the instruments
are strong.
3.3.2. Informative Intervals and Median Length
While our methods provide the desired level of coverage, both theoretically and in simula-
tion, it is unclear whether the resulting robust intervals would be informative in terms of
not being too long. It is expected that our methods will produce longer confidence intervals
than the oracles since the oracles know more about instrument validity than our methods
assumes. In this section, we quantify this difference through a simulation study.
The first simulation setup is identical to Section 3.3.1 and we look at the median length
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Naive TSLS 95 0 0 0 0
AR 95 0 0 0 0
LM 98 0 0 0 0
CLR 95 0 0 0 0
Our method TSLS 100 100 100 100 97
AR 100 100 100 100 96
LM 100 100 100 100 98
CLR 100 100 100 100 98
SAR + TSLS 100 100 100 100 96
JLM + LM 100 100 100 100 94
SAR + CLR 100 100 100 100 96
Oracle TSLS 95 95 95 96 96
AR 95 96 95 96 96
LM 98 98 97 98 98
CLR 95 95 96 96 95
Weak Naive TSLS 5 0 0 0 0
AR 96 0 0 0 0
LM 98 0 0 0 0
CLR 98 0 0 0 0
Our method TSLS 30 45 41 32 16
AR 100 100 100 100 97
LM 100 100 100 100 98
CLR 100 100 100 100 98
SAR + TSLS 31 47 45 34 17
JLM + LM 99 95 94 79 45
SAR + CLR 100 100 98 90 58
Oracle TSLS 5 6 8 12 15
AR 96 96 96 96 96
LM 98 97 98 97 98
CLR 98 97 98 97 98
Table 18: Comparison of Coverage Between 95% IV Confidence Intervals Under Bivariate t
Errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM, Lagrange multiplier
test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM, pretest in (3.11). There
are L = 10 candidate instruments and U is set to L/2 = 5. Strong instruments correspond
to concentration parameter exceeding 100. Weak instruments correspond to concentration
parameter value around 2. The standard error for all the coverage proportions do not exceed
1%.
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Naive TSLS 94 0 0 0 0
AR 95 0 0 0 0
LM 98 0 0 0 0
CLR 95 0 0 0 0
Our method TSLS 100 100 100 100 95
AR 100 100 100 100 95
LM 100 100 100 100 97
CLR 100 100 100 100 97
SAR + TSLS 100 100 100 100 94
JLM + LM 100 100 100 100 92
SAR + CLR 100 100 100 100 94
Oracle TSLS 94 94 94 93 94
AR 95 95 94 94 95
LM 98 97 97 97 97
CLR 95 94 94 94 94
Weak Naive TSLS 0 0 0 0 0
AR 96 45 1 0 0
LM 98 15 0 0 0
CLR 97 15 0 0 0
Our method TSLS 17 60 60 48 26
AR 100 100 100 100 99
LM 100 100 100 100 100
CLR 100 100 100 100 100
SAR + TSLS 18 55 56 48 25
JLM + LM 100 100 99 97 87
SAR + CLR 100 100 100 100 89
Oracle TSLS 0 0 0 1 2
AR 96 96 96 95 96
LM 98 97 96 96 96
CLR 97 97 96 96 96
Table 19: Comparison of Coverage Between 95% IV Confidence Intervals Under Skewed
Errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM, Lagrange multiplier
test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM, pretest in (3.11). There
are L = 10 candidate instruments and U is set to L/2 = 5. Strong instruments correspond
to concentration parameter exceeding 100. Weak instruments correspond to concentration
parameter value around 2. The standard error for all the coverage proportions do not exceed
2%.
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Our method TSLS 0 · 28 0 · 73 0 · 59 0 · 51 0 · 44
AR 0 · 38 0 · 22 0 · 15 0 · 11 0 · 07
LM 1 · 18 1 · 13 1 · 09 1 · 07 1 · 05
CLR 0 · 29 0 · 67 0 · 58 0 · 50 0 · 44
SAR + TSLS 0 · 29 0 · 17 0 · 12 0 · 08 0 · 05
JLM + LM 0 · 28 0 · 16 0 · 11 0 · 08 0 · 05
SAR + CLR 0 · 29 0 · 17 0 · 12 0 · 08 0 · 05
Oracle TSLS 0 · 04 0 · 04 0 · 04 0 · 05 0 · 05
AR 0 · 06 0 · 06 0 · 06 0 · 07 0 · 07
LM 1 · 03 1 · 03 1 · 03 1 · 03 1 · 04
CLR 0 · 04 0 · 04 0 · 04 0 · 05 0 · 05
Weak Our method AR ∞ ∞ ∞ ∞ ∞
LM ∞ ∞ ∞ ∞ ∞
CLR ∞ ∞ ∞ ∞ ∞
JLM + LM ∞ 300 · 12 160 · 80 115 · 12 101 · 89
SAR + CLR ∞ ∞ ∞ ∞ 46 · 12
Oracle AR ∞ ∞ ∞ ∞ ∞
LM 10 · 22 18 · 79 ∞ ∞ ∞
CLR 9 · 45 17 · 97 ∞ ∞ ∞
Table 20: Comparison of Median Lengths Between Different 95% IV Confidence Intervals
Under Normal Errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM,
Lagrange multiplier test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM,
pretest in (3.11). There are L = 10 candidate instruments and U is set to L/2 = 5. Strong
instruments correspond to concentration parameter exceeding 100. Weak instruments cor-
respond to concentration parameter value around 2. The interquartile range of our intervals
and strong oracle intervals do not exceed 0 · 05 and 0 · 02, respectively. The interquartile
range of all weak intervals are infinite except for JLM + LM, which range from 1774 · 62
(s = 0) to 55 · 73 (s = 4).
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Our method TSLS 0 · 28 0 · 73 0 · 58 0 · 50 0 · 44
AR 0 · 37 0 · 22 0 · 15 0 · 11 0 · 07
LM 1 · 17 1 · 13 1 · 09 1 · 07 1 · 05
CLR 0 · 28 0 · 67 0 · 58 0 · 50 0 · 44
SAR + TSLS 0 · 28 0 · 17 0 · 12 0 · 08 0 · 05
JLM + LM 0 · 28 0 · 16 0 · 11 0 · 08 0 · 05
SAR + CLR 0 · 29 0 · 17 0 · 12 0 · 08 0 · 05
Oracle TSLS 0 · 04 0 · 04 0 · 04 0 · 05 0 · 05
AR 0 · 06 0 · 06 0 · 07 0 · 07 0 · 07
LM 1 · 03 1 · 03 1 · 03 1 · 03 1 · 04
CLR 0 · 04 0 · 04 0 · 04 0 · 05 0 · 05
Weak Our method AR ∞ ∞ ∞ ∞ ∞
LM ∞ ∞ ∞ ∞ ∞
CLR ∞ ∞ ∞ ∞ ∞
JLM + LM ∞ 282 · 38 163 · 28 113 · 81 101 · 88
SAR + CLR ∞ ∞ ∞ ∞ 46 · 53
Oracle AR ∞ ∞ ∞ ∞ ∞
LM 9 · 40 15 · 34 130 · 38 ∞ ∞
CLR 8 · 98 14 · 11 167 · 52 ∞ ∞
Table 21: Comparison of Median Lengths Between Different 95% IV Confidence Intervals
Under Bivarate t errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM,
Lagrange multiplier test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM,
pretest in (3.11). There are L = 10 candidate instruments and U is set to L/2 = 5. Strong
instruments correspond to concentration parameter exceeding 100. Weak instruments cor-
respond to concentration parameter value around 2. The interquartile range of our intervals
and strong oracle intervals do not exceed 0 · 05 and 0 · 02, respectively. The interquartile
range of all weak intervals are infinite except for JLM + LM, which range from 2684 · 6
(s = 1) to 58 · 48 (s = 4).
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of the confidence intervals in Table 17. We exclude the naive methods since they do not
provide the desired level of coverage. Also, for weak instruments, we exclude two stage least
squares since it is not robust to weak instruments and does not provide correct coverage.
In Tables 20 and 21, for both bivariate Normal errors and bivariate t errors, we see that the
discrepancy between our method and the oracles shrinks as s grows for strong instruments,
especially when s = 3 and s = 4. The one notable exception is our method using two stage
least squares, which still has wide intervals as s increases. We also find that our method
using pretests tends to provide the shortest intervals among the various versions of our
method under the strong instrument case. This is to be expected since the motivation for
the pretesting was to remove taking unnecessary unions of intervals in (3.10). For weak
instruments, our method and the oracles are generally in agreement by providing infinite
length intervals, with our method almost always producing infinite length intervals. This
agreement is to be expected since using tests that are robust to weak instruments must
produce infinite intervals (Dufour, 1997).
Table 22 presents the same simulation results as Tables 20 and 21, except the errors are
skewed. While the patterns of simulations are mostly the same as the two preceding tables,
one notable exception is when the instruments are strong and s = 0. In this case, two
stage least squares dominates our pretesting method as well as the Anderson and Rubin
confidence intervals. Otherwise, the patterns of the simulations are similar across the three
tables.
The second simulation study examines the strategy in Section 3.2.7 where prior information
on s and U are available and whether the prior information provides informative intervals.
The simulation setup is, again, identical as above, except we fix s = 2 and vary U from
3, 4 and 5; if U were to be less than s where U ≤ s, our methods cannot produce the right
coverage since U was mis-specified. We compare our methods to the oracle intervals in
Table 20, specifically the column corresponding to s = 2.
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Strength Case Test s = 0 s = 1 s = 2 s = 3 s = 4
Strong Our method TSLS 0 · 62 0 · 84 0 · 66 0 · 56 0 · 47
AR 0 · 94 0 · 50 0 · 34 0 · 24 0 · 16
LM 1 · 46 1 · 28 1 · 19 1 · 14 1 · 10
CLR 0 · 67 0 · 81 0 · 66 0 · 56 0 · 48
SAR + TSLS 0 · 64 0 · 37 0 · 25 0 · 18 0 · 11
JLM + LM 0 · 66 0 · 36 0 · 24 0 · 17 0 · 10
SAR + CLR 0 · 69 0 · 38 0 · 26 0 · 18 0 · 11
Oracle TSLS 0 · 08 0 · 09 0 · 09 0 · 10 0 · 11
AR 0 · 14 0 · 14 0 · 15 0 · 15 0 · 16
LM 1 · 06 1 · 06 1 · 07 1 · 07 1 · 07
CLR 0 · 08 0 · 09 0 · 09 0 · 10 0 · 11
Weak Our method AR ∞ ∞ ∞ ∞ ∞
LM ∞ ∞ ∞ ∞ ∞
CLR ∞ ∞ ∞ ∞ ∞
JLM + LM ∞ ∞ ∞ ∞ 2220 · 55
SAR + CLR ∞ ∞ ∞ ∞ ∞
Oracle AR ∞ ∞ ∞ ∞ ∞
LM ∞ ∞ ∞ ∞ ∞
CLR ∞ ∞ ∞ ∞ ∞
Table 22: Comparison of Median Lengths Between Different 95% IV Confidence Intervals
Under Skewed Errors. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM,
Lagrange multiplier test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM,
pretest in (3.11). There are L = 10 candidate instruments and U is set to L/2 = 5. Strong
instruments correspond to concentration parameter exceeding 100. Weak instruments cor-
respond to concentration parameter value around 2. The interquartile range of our intervals
and strong oracle intervals do not exceed 0 · 20 and 0 · 05, respectively. The interquartile
range of all weak intervals are infinite except for JLM + LM when s = 4 which is 9349 · 87.
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Strength Case Test U = 3 U = 4 U = 5
Strong Our method TSLS 0 · 51 0 · 55 0 · 59
AR 0 · 07 0 · 11 0 · 15
LM 1 · 05 1 · 07 1 · 09
CLR 0 · 50 0 · 54 0 · 58
SAR + TSLS 0 · 05 0 · 08 0 · 12
JLM + LM 0 · 04 0 · 08 0 · 11
SAR + CLR 0 · 04 0 · 08 0 · 12
Weak Our method AR ∞ ∞ ∞
LM ∞ ∞ ∞
CLR ∞ ∞ ∞
JLM + LM 102 · 22 124 · 24 160 · 80
SAR + CLR 59 · 73 ∞ ∞
Table 23: Comparison of Median Lengths Between Different 95% IV Confidence Intervals
With Prior Information on s and U . TSLS, two stage least squares; AR, Anderson–Rubin
test ; LM, Lagrange multiplier test; CLR, conditional likelihood ratio test; SAR, Sargan
test; JLM, pretest in (3.11). There are L = 10 candidate instruments and U is set to
L/2 = 5. Strong instruments correspond to concentration parameter exceeding 100. Weak
instruments correspond to concentration parameter value around 2. The interquartile range
of our intervals do not exceed 0 ·02. The interquartile range of all weak intervals are infinite
except for JLM + LM (for all U) and SAR + CLR (U = 3), which range from 160 · 55
(U = 3) to 42 · 75 (U = 5).
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Table 23 shows the result from the simulation. We see that if U is close to the true s = 2,
our interval lengths are very close to the oracle intervals in Table 20 for strong instruments.
Again, the notable exception is our method using two stage least squares which produces
wide intervals. As U increases, our methods tend to produce longer intervals, which is
expected since our prior information about s at U = 5 is not as accurate as when U = 3.
Also, similar to Table 20, our method with pretesting seems to produce the most informative
interval compared to our method without pretesting. For weak instruments, our intervals
produce the same type of non-informative intervals as the oracle intervals in Table 20. Prior
information does not help, perhaps because the instruments are already weak and no extra
information can be gained by having more accurate ideas about s.
3.4. Data Analysis
We reanalyze the instrumental variables analysis done in Bouis and Haddad (1990), Bouis
and Haddad (1992), and Small (2007) to demonstrate our method in a practical setting.
The goal is to study the causal effect of income on food expenditures among Philippine
farm households from a survey of n = 406 Philippine farm households. The exposure is the
household’s log income, Di and the outcome is the household’s food expenditures, Yi. We
have four candidate instruments, cultivated area per capita, Zi1, worth of assets, Zi2, a bi-
nary dummy variable on presence of electricity at the household, Zi3, and quality of flooring
at the house, Zi4. Page 82 of Bouis and Haddad (1990) states that the reasoning behind
proposing these variables as instrumental variables is that “land availability is assumed to
be a constraint in the short run, and therefore exogenous to the household decision making
process”. We also control for the measured covariates, which are mother’s education, fa-
ther’s education, mother’s age, father’s age, mother’s nutritional knowledge, price of corn,
price of rice, population density of the municipality, and number of household members in
adult equivalents; see Bouis and Haddad (1990) and Bouis and Haddad (1992) for further
details on the data.
The F-statistic for instrument strength is 103·77, indicating reasonably strong instruments.
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Case Test 95% Confidence Interval
Naive TSLS ( 0 · 043, 0 · 053)
AR ( 0 · 044, 0 · 054)
LM (−0 · 031, 0 · 055)
CLR ( 0 · 043, 0 · 055)
Our Method TSLS ( 0 · 031, 0 · 059)
AR ( 0 · 037, 0 · 058)
LM (−0 · 037, 0 · 067)
CLR ( 0 · 034, 0 · 066)
SAR + TSLS ( 0 · 031, 0 · 058)
JLM + LM ( 0 · 034, 0 · 067)
SAR + CLR ( 0 · 034, 0 · 066)
Table 24: Comparison of Median Lengths Between Different 95% IV Confidence Intervals
for the Agricultural Data. TSLS, two stage least squares; AR, Anderson–Rubin test ; LM,
Lagrange multiplier test; CLR, conditional likelihood ratio test; SAR, Sargan test; JLM,
pretest in (3.11). There are four candidate instruments and we assume that at most one is
invalid.
The Sargan test for overidentification, which tests assumptions (A2) and (A3), produces a
p-value of 0·079. Even though the p-value is low, usually practitioners of the instrumental
variables method would naively assume (A2) and (A3) are true since the p-value is above
0·0.5, the typical threshold for significance level and use one of the four procedures in (3.5)–
(3.8) to obtain confidence intervals. In contrast, our methods do not take for granted that
the four instruments are valid. Instead, we assume there may be invalid instruments, specif-
ically we consider that there may be at most one invalid instruments, which corresponds to
U = L/2 = 2. The results from both the naive method and our methods are in Table 23.
For tests that produced multiple, disjoint intervals, we took the lowermost and uppermost
values of all the confidence intervals (i.e. the convex hull) to obtain a non-disjoint confidence
interval. Also, for procedures with pretests, we used the same α1 and α2 thresholds as we
did in Section 3.3.1.
As long as the modeling assumption is true and that no more than one instruments is
invalid, we have a theoretical guarantee that our methods provide the correct 95% confidence
interval, which cannot be said for the four naive intervals in Table 23. Also, even though
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our confidence interval is longer than the the naive intervals, it is still informative in the
sense that most of our intervals do not contain β∗ = 0 and therefore, the null hypothesis of
no causal effect can be rejected at the usual 5% significance level. The notable exception
is the confidence interval based on the Lagrange multiplier test without any pretests. For
this test, both the naive method and the method based on (3.4) contain zero. Among the
intervals that are theoretically guaranteed to have 1−α coverage, our method in (3.4) using
the Anderson–Rubin provides the shortest interval.
The data example illustrates the usefulness of our procedure whenever there is a concern for
invalid instruments in practice. Our procedures yield confidence intervals that are honest
with respect to coverage and can be informative.
3.5. Discussion
This paper proposes a simple and general method to construct robust confidence intervals
for causal effects using instrumental variables estimates when the instruments are possibly
invalid, with theoretical guarantees with respect to coverage. We propose two methods in
(3.4) and (3.10), with the latter using pretests tending to produce informative intervals
when the instruments are strong. Our data analysis example illustrates that our method
can be a robust alternative to confidence interval estimation that has the proper coverage
whenever there is concern for possibly invalid instruments.
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CHAPTER 4 : A Nonparametric, Full Matching Approach to Instrumental
Variables Estimation
This is joint work with Benno Kreuels, Ju¨rgen May, and Dylan Small.
4.1. Instrumental Variables With Measured Covariates
4.1.1. Two Stage Least Squares (TSLS)
As mentioned before, instrumental variables (IVs) is a popular method to estimate the
causal effect of an exposure on the outcome when there is unmeasured confounding, provided
that a valid instrument is available (Angrist, Imbens, and Rubin, 1996; Herna´n and Robins,
2006; Brookhart and Schneeweiss, 2007; Cheng, Qin, and Zhang, 2009; Swanson and Herna´n,
2013; Baiocchi, Cheng, and Small, 2014). The core assumptions for a variable to be a
valid instrumental variable are that the variable (A1) is associated with the exposure, (A2)
has no direct pathways to the outcome, and (A3) is not associated with any unmeasured
confounders. If measured covariates are available, which is frequently the case in many
IV studies, the plausibility of the instrument satisfying the three core assumptions can be
improved, especially (A3), by conditioning on the covariates.
The most popular and well-studied method that use an IV and measured covariates to
estimate causal effects is two stage least squares (TSLS) (Angrist and Krueger, 1991; Card,
1995; Wooldridge, 2010). For example, in Card (1995), which studied the effect of education
on wages, TSLS with proximity to a 4-year college as an IV was used to control for measured
covariates such as race and parents’ education. Specifically, TSLS first estimates, via least
squares, the predicted exposure (education) given the instrument, (proximity to 4-year
college) and the measured covariates, and second, regresses the outcome (earnings) on this
predicted exposure and the measured covariates; the TSLS estimate of the causal effect
is the coefficient on the predicted exposure in the second regression. Standard results in
econometrics show TSLS estimator is consistent and efficient under linear single-variable
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structural equation models with a constant treatment effect (Wooldridge, 2010). When
treatment effects are not constant, Angrist and Imbens (1995) showed that under certain
monotonicity assumptions, TSLS converges to a weighted average of the covariate-specific
treatment effects with the weights proportional to the average conditional variance of the
expected value of the treatment given the covariates and the instrument. Other IV methods
to estimate causal effects in the presence of measured covariates include Bayesian methods
(Imbens and Rubin, 1997), semiparametric methods (Abadie, 2003; Tan, 2006; Ogburn
et al., 2015), and nonparametric methods (Fro¨lich, 2007).
Despite its attractive estimation properties, TSLS has some drawbacks, specifically in (i)
lack of transparency of the population to which the estimate applies, (ii) lack of blinding
of the analyst/researcher and (iii) dependence on parametric assumptions. First, with
regards to transparency, suppose that there are some values of the covariates for which the
instrument is almost always low, some values for which the instrument is almost always
high and some values of the covariates for which the instrument takes on both low and
high values. Then, the TSLS estimate will put most of its weight on the causal effect for
subjects with the values of the covariates for which the instrument takes on both low and
high values, and little weight on subjects with the values of the covariates for which the
instrument usually takes on low (or high) values. For example, in the case of education on
earnings, this would mean that there might be some states (a measured covariate) that are
receiving little weight in the TSLS estimate; consequently, the TSLS estimate might not be
helpful for understanding the effect of education on earnings in some states even though
these states might have contributed many subjects to the analysis. Although the weighting
function in TSLS can be studied, there is nothing in the TSLS estimation procedure itself
that warns us when some values of the covariates are receiving little weight and it is rare
to see discussion of the weighting function for TSLS in empirical papers.
Second, TSLS lacks blinding with respect to the outcome data when adjusting for covariates.
Cochran (1965), Rubin (2007) and Rosenbaum (2010) argue that the best observational
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studies resemble randomized experiments. An important feature of the design of randomized
experiments is that when designing the study and planning the analysis, the researcher is
blinded to the outcome data. However, in regression based procedures for adjusting for
covariates like TSLS, there is often judgment that needs to be exercised in choosing covariate
adjustment models and this requires one to look at the outcome data along with estimates
of causal effects. It is difficult even for the most honest researcher to be completely objective
in comparing models when the researcher has an a priori hypothesis or expectation about
the direction of the causal effect (Rubin and Waterman, 2006).
Third, TSLS relies on proper specification of how the measured covariates affect the out-
come. Often, parametric modeling assumptions are made for how the measured confounders
affect the outcome. In particular, TSLS, as usually implemented, relies on the measured
confounders having a linear effect on the expected outcome.
4.1.2. Instrumental Variables With Full Matching
Matching is an alternative method to adjust for measured covariates. A matching algorithm
groups individuals in the data with different values of the instrument but similar values of
the observed covariates, so that within each group, the only difference between the individ-
uals is their values of the instrument (Haviland, Nagin, and Rosenbaum, 2007; Rosenbaum,
2010; Stuart, 2010). We can then compare the outcome between individuals with high and
low values of the instrument within a matched set to assess the causal effect of the exposure
on the outcome (Baiocchi et al., 2010).
Matching addresses the drawbacks of TSLS discussed in the previous section. First, if there
are values of covariates for which almost all subjects have a high (or low) value of the
IV, then the matching algorithm and associated diagnostics will tell us that matched sets
cannot be formed when subjects in the matched sets have certain values of the covariates but
different levels of the IV; thus, it will be transparent that for these values of the covariates,
the causal effect cannot be estimated without extrapolation. Relatedly, matching allows
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us to control the weighting of subjects with different values of the covariates to make the
weighting transparent, such as weighting the covariates in proportion to their population
frequency. Second, matching is blind to the outcome data; a matching algorithm only
requires the measured covariates and the instrument values for each individual in the data.
Diagnostics can be done and the matching can be adjusted until it is adequate, all without
looking at the outcome data. Finally, when estimating the causal effect, matching makes
non-parametric inference; it does not use any parametric modeling assumptions such as
linearity.
Previous work using matching in studying causality is abundant in non-IV settings; see
Stuart (2010) for a complete overview. In contrast, work on using matching methods on IV
estimation is limited to pair matching (Baiocchi et al., 2010) and fixed control matching,
i.e. each unit with level 1 of the IV is matched to a fixed number of units with level 0 of the
IV (Kang et al. (2013)). A drawback to these matching methods is that they do not use the
full data (Keele and Morgan, 2013; Zubizarreta et al., 2013). In particular, the method in
Kang et al. (2013) was limited to matching with fixed controls and the method had to drop
roughly 25% of individuals in the final statistical inference from a total of 884 individuals.
In this paper, we develop an IV full matching approach that uses the full data. Full
matching is the most general, flexible, and optimal type of matching (Rosenbaum, 1991;
Hansen, 2004; Rosenbaum, 2010). Specifically, full matching is the generalization of any
type of matching, such as pair matching, matching with fixed controls, or matching with
variable controls. Full matching is also flexible in that it can incorporate constraints on
matched set structures, such as limiting the number of individuals in each matched set, to
improve statistical efficiency. Finally, full matching is optimal in the sense that it produces
matched sets where within each set, measured covariates between individuals with different
instrument values are most similar (Rosenbaum, 1991).
Under IV estimation with full matching, we derive a randomization-based testing procedure
and sensitivity analysis based on the proposed test statistic. We conduct simulation studies
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to study the performance of TSLS versus full matching IV estimation, specifically analyzing
the robustness of both methods to non-linearity (see Section 4.3.1).
4.2. Method
4.2.1. Notation
To introduce the idea of matching in IV estimation, we introduce the following notation.
Let i = 1, . . . , I index the I total matched sets that individuals are matched into. Each
matched set i contains ni ≥ 2 subjects who are indexed by j = 1, . . . , ni and there are
a total of N =
∑I
i=1 ni individuals in the data. Let Zij denote a binary instrument for
subject j in matched set i. In each matched set i, there are mi subjects with Zij = 1 and
ni −mi subjects with Zij = 0. Let Z be a random variable that consists of the collection
of Zij ’s, Z = (Z11, Z12, ...., ZI,nI ). Define Ω as the set that contains all possible values z of
Z, so z ∈ Ω if zij is binary and
∑ni
j=1 zij = mi for all I matched sets. Thus, the cardinality
of Ω, denoted as |Ω|, is |Ω| = ∏Ii=1 (nimi). Denote Z to be the event that Z ∈ Ω. Also define
χ(·) to be an indicator function.
For individual j in matched set i, define d1ij and d0ij to be the potential exposure values
under Zij = 1 or Zij = 0, respectively. Also, define r
(k)
1ij to be the outcome individual j
would have if she were assigned instrument value 1 and level k of the exposure, and r
(k)
0ij to
be the outcome individual j would have if she were assigned instrumental value 0 and level
k of the exposure. Then, r
(d1ij)
1ij and r
(d0ij)
0ij are the potential outcomes if the individual were
assigned levels 1 and 0 of the instrument, respectively, and the exposure took its natural
levels given the instrument resulting in d1ij and d0ij , respectively. The potential outcome
notations assume the Stable Unit Treatment Value Assumption that an individual’s outcome
and exposure depend only on her own value of the instrument and not on other people’s
instrument values (Rubin, 1980).
For individual j in matched set i, let Rij be the binary observed outcome and Dij be the
observed exposure. The potential outcomes r
(d1ij)
1ij , r
(d0ij)
0ij , d1ij , and d0ij and the observed
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values Rij , Dij , and Zij are related by the following equation:
Rij = r
(d1ij)
1ij Zij + r
(d0ij)
0ij (1− Zij) Dij = d1ijZij + d0ij(1− Zij) (4.1)
For individual j in matched set i, let Xij be a vector of observed covariates and uij be
the unobserved covariates. We define the set F = {(r(d1ij)1ij , r(d0ij)0ij , d1ij , d0ij ,Xij , uij), i =
1, ..., I, j = 1, ..., ni} to be the collection of potential outcomes and all covariates/confounders,
observed and unobserved.
4.2.2. Full Matching Algorithm
A matching algorithm controls the bias resulting from different observed covariates by
creating I matched sets indexed by i, i = 1, . . . , I such that individuals within each matched
set have similar covariate values xij and the only difference between individuals in each
matched set is their instrument values, Zij . In a full matching algorithm, each matched set
i either contains mi = 1 individual with Zij = 1 and ni − 1 individuals with Zij = 0 or
mi = ni − 1 individuals with Zij = 1 and 1 individual with Zij = 0.
Rosenbaum (2002, 2010), Hansen (2004), and Stuart (2010) provide an overview of matching
and a discussion on various distance metrics and tools to measure similarity for observed
and missing covariates. Once we have obtained the distance matrix, we use an R package
available on CRAN called optmatch developed by Hansen and Klopfer (2006) to find the
optimal full matching.
4.2.3. Definition of a Valid Instrument
Using the notation in 4.2.1, we formalize the core assumptions of an instrumental variable
below (Holland, 1988; Angrist et al., 1996; Yang et al., 2014).
(A1) The instrument must be associated with the exposure, or in F , ∑Ii=1∑nij=1(d1ij −
d0ij) 6= 0
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(A2) The instrument can only affect the outcome if it affects the exposure, or in F , r(k)1ij =
r
(k)
0ij ≡ r(k)ij for all k, where the last equality drops the r’s dependence on Zij (exclusion
restriction)
(A3) The instrument is effectively randomly assigned within a matched set, P (Zij =
1|F ,Z) = mi/ni for each i.
One assumption worth mentioning within the context of observed covariates is assumption
(A3). Assumption (A3) is more plausible if we control for observed variables. Specifically,
within the framework of full matching, for each matched set i, if the observed variables xij
are similar among all ni individuals, it may be more plausible that the unobserved variable
uij plays no role in the distribution of Zij among the ni individuals. If (A3) exactly holds
and subjects are exactly matched for Xij , then within each matched set i, Zij is simply
a result of random assignment where Zij = 1 with probability mi/ni and Zij = 0 with
probability (ni − mi)/ni when we condition on the number of units in the matched sets
with Zij = 1 being mi. In Section 4.2.7, we discuss a sensitivity analysis that allows for the
possibility that even after matching for observed variables, an unobserved variable uij may
still influence the assignment of Zij in each matched set i, meaning that assumption (A3)
is violated.
There are also other assumptions associated with instrumental variables, most notably the
Stable Unit Treatment Value Assumption (SUTVA) in Section 4.2.1 and the monotonicity
assumption in Angrist et al. (1996). SUTVA, within the framework of MR, states that
one’s individual potential outcomes are not affected by the genotype assignment of another
individual. This is fairly reasonable in MR since the instrument was determined at the
conception of the child and a child’s genotype only affects his exposure and outcome, and
not the exposures and outcomes of other children.
Monotonicity, within the framework of MR, states that there are no individuals who would
have an adverse effect on the exposure from inheriting the genotype which is purported to
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bring positive effect on the exposure. In MR where the chosen genetic instruments usually
bring about a positive effect on the exposure, monotonicity is reasonable (see Chapter 5 for
an example with malaria and stunted growth in children).
4.2.4. Effect Ratio and the Local Average Treatment Effect
We define the parameter of interest, called the effect ratio, which is a parameter of the finite
population of N =
∑I
i=1 ni individuals characterized by F .
λ =
∑I
i=1
∑ni
j=1 r
d1ij
1ij − rd0ij0ij∑I
i=1
∑ni
j=1 d1ij − d0ij
(4.2)
The effect ratio is the change in the outcome caused by the instrument divided by the
change in the exposure caused by the instrument. The effect ratio can be identified by
taking the ratio of the differences in expected values.
λ =
∑I
i=1
∑ni
j=1E(Rij |Zij = 1,F ,Z)− E(Rij |Zij = 0,F ,Z)∑I
i=1
∑ni
j=1E(Dij |Zij = 1,F ,Z)− E(Dij |Zij = 0,F ,Z)
(4.3)
The effect ratio also admits a well-known interpretation in IV literature if all the IV as-
sumptions, (A1)-(A3), and the monotonicity assumption whereby d1ij ≥ d0ij for every i, j
in F , are satisfied. Specifically, suppose d1ij and d0ij are discrete values from 0 to M . Then
Theorem 4.1 shows that we can identify the effect ratio and interpret it as the weighted
average of the unit causal effect of the exposure on the treatment among individuals whose
exposure was affected by the instrument
Theorem 4.1. Suppose the IV assumptions, (A1)-(A3), in Section 4.2.4 holds and the
exposure ranges from 0, 1, 2, . . . ,M where M is an integer. Further suppose that the mono-
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tonicity assumption where d1ij ≥ d0ij holds for all i, j. Then,
λ =
∑I
i=1
∑ni
j=1E(Rij |Zij = 1,F ,Z)− E(Rij |Zij = 0,F ,Z)∑I
i=1
∑ni
j=1E(Dij |Zij = 1,F ,Z)− E(Dij |Zij = 0,F ,Z)
=
∑I
i=1
∑ni
j=1
∑M
k=1(r
(k)
ij − r(k−1)ij )χ(d1ij ≥ k > d0ij)∑I
i=1
∑ni
j=1
∑M
k=1 χ(d1ij ≥ k > d0ij)
=
I∑
i=1
ni∑
j=1
M∑
k=1
(r
(k)
ij − r(k−1)ij )wijk
where
wijk =
χ(d1ij ≥ k > d0ij)∑I
i=1
∑ni
j=1
∑M
l=1 χ(d1ij ≥ l > d0ij)
In words, with the IV assumptions and the monotonicity assumption, Theorem 4.1 states
that the effect ratio can be interpreted as the weighted average of the causal effect of a one
unit change in the exposure among the individuals in the study population whose exposure
would be affected by a change in the instrument. Each weight wijk represents whether an
ijth individual exposure would be moved from below k to at or above k by the instrument,
relative to the number of people in the study population whose exposure would be changed
by the instrument. The interpretation of λ is akin to Theorem 1 in Angrist and Imbens
(1995), except that our result is for the finite-sample case and is specific to matching.
Also, with regards to identification, technically speaking, only assumptions (A1) and (A3)
are necessary to identify the ‘bare-bone’ interpretation of λ in (4.2), the ratio of causal
effects of the instrument on the outcome (numerator) and on the exposure (denominator)
since the numerator and the denominator can both be identified by the differences in expec-
tations in (4.3). However, without (A2), i.e. the exclusion restriction, and the monotonicity
assumption, this ratio of differences in expectations in (4.3) cannot identify the weighted
average of effects of the exposure described in the above paragraph.
When full matching is used so that all subjects are used in the matching, the effect ratio (4.2)
and its equivalent expression in Theorem 4.1 are defined for the whole study population.
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Additionally, the effect ratio is invariant to the particular full match it used, e.g. if a different
distance between pairs of subjects were used that resulted in a different full match, the effect
ratio would remain the same. In fact, one of the advantages of using full matching compared
to other matching algorithms that discard some data, such as pair matching, matching
with fixed controls, and matching with variable controls, is that full matching estimates the
effect ratio (4.2) (or equivalently in Theorem 4.1) for the whole study population whereas
for the matching methods that discard data, these methods only estimate (4.2) for the
data that was not discarded, making the estimated parameter dependent on the individuals
that were discarded from the matching algorithm. In contrast, the full matching algorithm
incorporates all the individuals in the data and the effect ratio parameter, specifically the
subscripts i, j are meant to count all the individuals in the data. On a related note, the
effect ratio (4.2) generalizes previous expressions for the effect ratio with pair matching,
ni = 2, by Baiocchi et al. (2010) or matching with fixed controls, ni = k, by Kang et al.
(2013) to accommodate full matching.
4.2.5. Inference for Effect Ratio
We would like to conduct the following hypothesis test for the effect ratio λ.
H0 : λ = λ0, Ha : λ 6= λ0 (4.4)
To test the hypothesis in (4.4), we propose the following test statistic
T (λ0) =
1
I
I∑
i=1
Vi(λ0) (4.5)
where
Vi(λ0) =
ni
mi
ni∑
j=1
Zij(Rij − λ0Dij)− ni
ni −mi
ni∑
j=1
(1− Zij)(Rij − λ0Dij)
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and S2(λ0), the estimator for the variance of the test statistic, V ar{T (λ0)|F ,Z}
S2(λ0) =
1
I(I − 1)
I∑
i=1
{Vi(λ0)− T (λ0)}2 (4.6)
Each variable Vi(λ0) is the difference in adjusted responses, Rij−λ0Dij , of those individuals
with Zij = 1 and those with Zij = 0. Under the null hypothesis in (4.4), these adjusted
responses have the same expected value for Zij = 1 and Zij = 0 and thus, deviation of
T (λ0) from zero suggests H0 is not true.
Theorem 4.2 states that under regularity conditions, the asymptotic null distribution of
T (λ0)/S(λ0) is standard Normal.
Theorem 4.2. Assume that for every I, (i) ni remains bounded and (ii)
1
I
∑I
i=1
∑ni
j=1 r
(d1ij)
1ij −
r
(d0ij)
0ij and
1
I
∑I
i=1
∑ni
j=1 d1ij−d0ij remains fixed at r¯ and d¯ 6= 0, respectively, so that λ¯ = r¯/d¯.
In addition, we assume the following moment conditions
I∑
i=1
E{V 4i (λ¯)|F ,Z} = o(I2), lim sup
I→∞
∑I
i=1E|Vi(λ¯)− µi,λ¯|3[∑I
i=1 V ar{Vi(λ¯)}
]3/2 = 0 (4.7)
Then, under the null hypothesis H0 : λ = λ¯, for all t > 0,
lim sup
I→∞
P
{
T (λ¯)
S(λ¯)
≤ −t|F ,Z
}
≤ Φ(−t), lim sup
I→∞
P
{
T (λ¯)
S(λ¯)
≥ t|F ,Z
}
≤ Φ(−t)
where Φ(·) is the standard normal distribution.
Theorem 4.2 provides a point estimate as well as a confidence interval for the effect ratio.
For the point estimate, in the spirit of Hodges and Lehmann (1963), we find the value of λ
that maximizes the p-value, Specifically, setting T (λ)/S(λ) = 0 and solving for λ gives an
estimate for the effect ratio, λˆ
λˆ =
∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Rij − R¯i.)∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Dij − D¯i.)
(4.8)
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where Z¯i., R¯i., and D¯i. are averages of the instrument, response, and exposure, respectively,
within each matched set. For confidence interval estimation, say 95% confidence interval,
we can solve the equation T (λ)/S(λ) = ±1.96 for λ to get the confidence interval for the
effect ratio. A closed form solution for the confidence interval is provided by Corollary 4.1.
Corollary 4.1. For any value q, the solution to T (λ)/S(λ) = q is a solution to the quadratic
equation A2λ
2 +A1λ+A0 = 0 where
A2 = H¯
2
. −
q2
I(I − 1)
I∑
i=1
(Hi − H¯.)2
A1 = −2G¯.H¯. + 2q
2
I(I − 1)
{
I∑
i=1
(Gi − G¯.)(Hi − H¯.)
}
A0 = G¯
2
. −
q2
I(I − 1)
I∑
i=1
(Gi − G¯.)2
where
Gi =
n2i
mi(ni −mi)
ni∑
j=1
(Zij − Z¯i.)(Rij − R¯i.)
Hi =
n2i
mi(ni −mi)
ni∑
j=1
(Zij − Z¯i.)(Dij − D¯i.)
Z¯i. =
1
ni
ni∑
j=1
Zij , D¯i. =
1
ni
ni∑
j=1
Dij , R¯i. =
1
ni
ni∑
j=1
Rij
H¯. =
1
I
I∑
i=1
Hi, G¯. =
1
I
I∑
i=1
Gi
4.2.6. Formula for Efficiency in Instrumental Variables With Full Matching
One of the advantages of full matching is its flexibility to accommodate various sizes of
matched sets. All things being equal in terms of covariate balance, we would like an estima-
tor of the effect ratio λ that is as efficient as possible. This is particularly the case with full
matching where an unconstrained full matching can create large matched sets which reduces
efficiency (Hansen, 2004). However, we can constrain full matching to increase efficiency by
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restricting matched sets to have a maximum number of controls and/or treated units per
matched set (Hansen, 2004). This section studies statistical efficiency of the estimator for
λ under different constraints on full matching.
To study the efficiency of the effect ratio estimator for different ni and mi, we study a
simple version of the structural equations model popular in econometrics and widely used
to study the properties of TSLS, the most popular IV estimator (Wooldridge, 2010). Let
(Rij , Dij , Zij) be i.i.d. observations from an infinite population following this model.
Rij = αi + βDij + ij , E(ij |Zij) = 0 (4.9)
Dij = τi + γZij + ξij , E(ξij |Zij) = 0 (4.10)
with the following moment conditions.
V ar(ij |Zij) = σ2i,R, V ar(ξij |Zij) = σ2i,D, E(ijξij |Zij) = σi,RD
The parameters αi, i = 1, . . . , I measure the effect on the outcome from being in matched
set i. The parameter β is the effect of interest, the effect of the exposure on the outcome.
Note that the treatment effect in (4.9) is assumed to be homogeneous for everyone, which is
not necessary for the analysis of the effect ratio in general. The parameters τi, i = 1, . . . , I
measure the effect on the exposure from being in matched set i. The parameter γ is the
effect of the instrument on the exposure. By including αi and τi, the models (4.9) and
(4.10) incorporate the matching aspect of IV estimation since each matched set i has effects
on Rij and Dij via αi and τi, respectively, that are unique to that matched set.
The effect ratio, λ, is related to parameters found in standard structural equation models
in (4.9) and (4.10). To illustrate this, note that the potential outcomes notation can be
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rewritten under the models (4.9) and (4.10) as follows.
Rij =

r
(d1ij)
1ij = αi + βτi + βγ + βξij + ij if Zij = 1
r
(d0ij)
0ij = αi + βτi + βξij + ij if Zij = 0
Dij =

d1ij = τi + γ + ξij if Zij = 1
d0ij = τi + ξij if Zij = 0
Then, the effect ratio in (4.2) turns out to be
λ =
∑I
i=1
∑ni
j=1 r
(d1ij)
1ij − r(d0ij)0ij∑I
i=1
∑ni
j=1 d1ij − d0ij
=
∑I
i=1
∑ni
j=1 βγ∑I
i=1
∑ni
j=1 γ
=
βγ
γ
= β
Hence, λ = β and because of this equivalence, inferences for the effect ratio is equivalent to
inference for β. For example, the parameter β can be estimated by the effect ratio estimator
discussed in Section 4.2.5, specifically equation (4.8)
βˆ =
∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Rij − R¯i.)∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Dij − D¯i.)
Theorem 4.3 computes the asymptotic variance of βˆ to study the efficiency of the effect
ratio estimator under the models (4.9) and (4.10).
Theorem 4.3. Suppose we have models (4.9) and (4.10) with γ 6= 0 and the third moment
of ij is bounded for all i, j. Define the following variables
Ji =
ni∑
j=1
(Zij − Z¯i.)(ij − ¯i.), Hi =
ni∑
j=1
(Zij − Z¯i.)(Dij − D¯i.), ¯i. = 1
ni
ni∑
j=1
ij
s2I =
I∑
i=1
n3i
mi(ni −mi)σ
2
i,R
Assume that (i) Zij are fixed, (ii) ni remain bounded for all i, and the following moment
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conditions are met for Ji and Hi
lim sup
I→∞
1
s3I
I∑
i=1
n6i
m3i (ni −mi)3
E(|Ji|3) = 0,
I∑
i=1
V ar
(
n2i
mi(ni −mi)H
2
i
)
= o(I2)
Then, the asymptotic variance of the effect ratio estimator in (4.8) is
√
I(βˆ − β)→ N
0,
(
limI→∞ sI√I
)2
γ2
(
limI→∞ 1I
∑I
i=1 ni
)2

Theorem 4.3 provides an easy way to compare between different types of full matching
methods and their effect on the estimation of the effect ratio. For example, in the simple
case of homoscedastic variance, the approximate variance of λˆ is
V ar(λˆ) ≈ K
∑I
i=1
n3i
ni−1(∑I
i=1 ni
)2
where K is some constant that depends on the variance of Rij and the strength of the
instrument. Since K will be identical for all full matched designs, we can simply look at
the quantities to the right of K to tweak our full matching algorithm to produce the most
efficient estimator. In Section 4.3.3, we examine this strategy more closely with a simulation
study.
4.2.7. Sensitivity Analysis
Sensitivity analysis attempts to measure the influence of unobserved confounders on the
inference on λ. In the case of instrumental variables, a sensitivity analysis quantifies how a
violation of assumption (A3) in Section 4.2.3 would impact the inference on λ (Rosenbaum,
2002). Specifically, under assumption (A3), the instrument is assumed to be free from
unmeasured confounders or free after conditioning on observed confounders via matching.
The latter implies that the instruments are assigned randomly, P (Z = z|F ,Z) = (|Ω|)−1,
i.e. that within each matched set i, P (Zij = 1|F ,Z) = mi/ni.
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However, as discussed in Section 4.2.3, even after matching for observed confounders, un-
measured confounders may influence the viability of assumption (A3). For example, within
a matched set i , two individuals, j and k, may have identical covariates (xij = xik), but
have different probabilities for instrument assignment, P (Zij = 1|F) 6= P (Zik = 1|F) due
to unmeasured confounders, denoted as uij and uik for the jth and kth individuals, respec-
tively. Despite our best efforts to minimize the observed differences in covariates and to
adhere to assumption (A3) after conditioning on the matched sets, unmeasured confounders
could still be different between the jth and kth child, and this difference could make the
instrument Zij depart from randomized assignment, violating assumption (A3).
To model this deviation from randomized assignment due to unmeasured confounders, let
piij = P (Zij = 1|F) and piik = P (Zik = 1|F) for each unit j and k in the ith matched set.
The odds that unit j will receive Zij = 1 instead of Zij = 0 is piij/(1− piij). Similarly, the
odds for unit k is piik/(1− piik). Suppose the ratio of these odds is bounded by Γ ≥ 1
1
Γ
≤ piij(1− piik)
piik(1− piij) ≤ Γ (4.11)
If unmeasured confounders play no role in the assignment of Zij , then piij = piik and Γ = 1.
If there are unmeasured confounders that affect the distribution of Zij , then piij 6= piik
and Γ > 1. For a fixed Γ > 1, we can obtain lower and upper bounds on piij , which can
be used to derive the null distribution of T (0)/S(0) under H0 : λ = 0 in the presence
of unmeasured confounding and be used to compute a range of possible p-values for the
hypothesis H0 : λ = 0 (Rosenbaum, 2002). The range of p-values indicates the effect of
unmeasured confounders on the conclusions reached by the inference on λ. If the range
contains α, the significance value, then we cannot reject the null hypothesis at the α level
when there is an unmeasured confounder with an effect quantified by Γ.
Specifically, consider Fisher’s sharp null hypothesis, H0 : r
(d1ij)
1ij = r
(d0ij)
0ij for all i = 1, . . . , n
and j = 1, . . . , ni. Note that this hypothesis implies the hypothesis H0 : λ = 0. Further-
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more, the test statistic in (4.5) simplifies to
T (0) =
1
I
I∑
i=1
 nimi
ni∑
j=1
ZijRij − ni
ni −mi
ni∑
j=1
(1− Zij)Rij

=
1
I
I∑
i=1
n2i
mi(ni −mi)
ni∑
j=1
ZijRij − 1
I
I∑
i=1
ni
ni −mi
ni∑
j=1
Rij
Regardless of the distribution of P (Z|F ,Z), 1I
∑I
i=1 ni/(ni−mi)
∑ni
j=1Rij is constant since
r
(d1ij)
1ij = r
(d0ij)
0ij under Fisher’s sharp null hypothesis. Hence, we can use the simpler statistic,
T˜ (0),
T˜ (0) =
1
I
I∑
i=1
ni
mi(ni −mi)
ni∑
j=1
ZijRij (4.12)
to test the Fisher’s sharp null hypothesis. If the responses are binary, equation (4.12) is
the sign-score test statistic for which exact bounds on p-values exist (Rosenbaum, 2002).
If the responses are continuous, Gastwirth et al. (2000) and Small et al. (2009) provide an
approximate bound on p-values.
In addition, we can amplify the interpretation of Γ using Rosenbaum and Silber (2009) to
get a better understanding of the impact of the unmeasured confounding on the outcome
and the instrument. To do this , consider a binary unmeasured confounder with two values
∆ and Λ where ∆ and Λ have the following property
Γ =
∆Λ + 1
∆ + Λ
, ∆ > 0,Λ > 0 (4.13)
The parameter Λ refers to the odds of having one instrument value over another. The
parameter ∆ refers to the odds of having one outcome over another. For each Γ, we can use
equation (4.13) and translate the interpretation of Γ as the combined effect an unmeasured
confounder must have on the instrument, Λ, and on the outcome, ∆, to change the inference.
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4.3. Simulation
4.3.1. Comparison to TSLS
One of the advantages of matching based IV estimation versus traditional IV estimation,
such as conventional TSLS without matching, is its robustness to parametric assumptions
between the outcome and the covariates. Specifically, for conventional TSLS, in order for
the estimate to be consistent, the covariates must have a linear effect on the expected
outcome. In contrast, matching-based IV estimation puts no constraints on the structure
of the relationship between the outcome and the covariates. In this section, we study this
phenomena in detail through a simulation study.
Let the outcome Rij , the exposure Dij , the observed covariates Xij , and the instrument
Zij be generated based on the following model known as the structural equations model in
econometrics (Wooldridge, 2010).
Rij = α+ βDij + f(Xij) + ij
Dij = κ+ piZij + ρ
TXij + ξij
,
ij
ξij
 iid∼ N

0
0
 ,
 1 0.8
0.8 1


where the parameters α, β, κ and ρ are all fixed throughout the simulation. The parameters
α and κ are intercepts. The parameter β is the quantity of interest, the effect of the exposure
on the outcome, and is also equal to the effect ratio (see Section 4.2.6). The parameter pi
quantifies the strength of the instrument. The function f(·) is a pre-defined function that
takes in a vector of observed covariates Xij and produces a scalar value that affects the
outcome, Rij . In the simulation, Xij , are five-dimensional vectors or Xij = (Xij1, . . . , Xij5).
Also, we consider the following list of functions parametrized by γ ∈ R5
(a) Linear function: f(Xij) =
∑5
k=1 γkXijk
(b) Quadratic function: f(Xij) =
∑5
k=1 γkX
2
ijk
(c) Cubic function: f(Xij) =
∑5
k=1 γkX
3
ijk
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(d) Exponential function: f(Xij) =
∑5
k=1 γk exp(Xijk)
(e) Log function: f(Xij) =
∑5
k=1 γk log(|Xijk|)
(f) Logistic function: f(Xij) =
1
1+exp(−∑5k=1Xijkγk)
(g) Truncated function: f(Xij) =
∑5
k=1 γkχ(Xijk ≥ 0) where χ(·) is an indicator function.
(h) Square root function: f(Xij) =
∑5
k=1 γk
√|Xijk|
To generate Xij , we adopt the following scheme. For individuals with Zij = 0, Xij comes
from a five-dimensional multivariate Normal distribution with mean (0, . . . , 0) and an iden-
tity covariance matrix. For individuals with Zij = 1, Xij comes from a five-dimensional
multivariate Normal with mean (1, 0, . . . , 0) and an identity covariance matrix. The instru-
ments, Zij , are generated randomly with P (Zij = 1) = 1/8 and P (Zij = 0) = 7/8, similar
to the ratio observed in our malaria data (see Chapter 5). For each generated data set, we
compute the estimate of β using TSLS and our procedure. TSLS is based on (i) regressing
Dij on Zij and Xij to obtain the predicted value of Dij , say Dˆij , and (ii) regressing Rij on
Dˆij and Xij . We simulate this process 5000 times and compute the estimates of β produced
by the two procedures. We measure the performance of the two procedures by computing
the median absolute deviation, the absolute bias of the median (i.e. the absolute value of
the bias of the median estimate with respect to β), and the Type 1 error rate over 5000
simulations. For each simulation study, we vary the function f(·) and pi.
Figures 30, 31 and 32 compare performances between TSLS and our method when we fix
the sample size, but vary the strength of the instrument (i.e. the strength of the effect
of the instrument on the treatment) via pi. Specifically, we evaluate the strength of the
instrument using a popular measure known as the concentration parameter (Bound et al.,
1995). High values of the concentration parameter indicate a strong instrument while low
values of it indicate a weak instrument. The concentration parameter is the population
value of the first stage partial F statistic for the instrument when the treatment is regressed
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Figure 30: Absolute Bias of the Median Between Our Full Matching Method and TSLS
for Different Concentration Parameters. The solid line indicates TSLS and the dashed line
indicates our method.
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on the instrument and the measured covariates Xij ; this first stage F statistic is often used
to check instrument strength where an F below 10 suggests that the instruments are weak
(Stock et al., 2002). The sample size is fixed at 800 where 100 individuals have Zij = 1
and 700 individuals have Zij = 0. We also vary f(·) based on the functions listed in the
previous paragraph.
Figure 30 measures the absolute bias of the median for TSLS and our method. When
f(·) is a linear function of the observed covariates xij , TSLS does slightly better than our
method. TSLS doing well for the linear function is to be expected since TSLS is consistent
when the model is linear. However, if f(·) is non-linear, our matching estimator does better
than TSLS and is never substantially worse for all instrument strengths. For example, for
quadratic, cubic, exponential, log, and square root functions, our method has lower bias
than TSLS for all strengths of the instrument. For logistic and truncated functions, our
method is similar in performance to TSLS for all strengths of the instrument.
Figure 31 measures the median absolute deviation (MAD) of TSLS and our method. Our
method tends to have a slightly higher MAD than TSLS. This higher variability of our
method is to be expected since our method uses a nonparametric approach whereas TSLS
is a parametric approach. However, as the instrument gets stronger (i.e. high concentration
parameter), the gap between the two MADs shrinks quickly.
Finally, Figure 32 measures the Type I error rate of TSLS and our method. Regardless
of the function type and the instrument strength, our method retains the nominal 0.05
rate. In fact, even for the linear case where TSLS is designed to excel, our estimator has
the correct Type I error rate for all instrument strengths while TSLS has higher Type I
error for weak instruments. For all the non-linear functions, the Type I error rate for TSLS
remains above the 0.05 line while our estimator maintains the nominal Type I error rate.
This provides evidence that our estimator will have the correct 95% coverage for confidence
intervals regardless of non-linearity or instrument strength.
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Figure 31: Median Absolute Deviation Between Our Full Matching Method and TSLS for
Different Concentration Parameters. The solid line indicates TSLS and the dotted line
indicates our method.
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Figure 32: Type I Error Rate Between Our Full Matching Method and TSLS for Different
Concentration Parameters. The solid line indicates TSLS and the dashed line indicates our
method.
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In summary, the simulation study shows promise that our method is generally more ro-
bust to assumptions about instrument strength and linearity between the outcome and the
covariates than TSLS at the expense of a small increase in dispersion.
4.3.2. Comparison to Fro¨lich (2007)
In addition to comparing our method against the most popular IV estimator, TSLS, we
also compare our method to the non-parametric IV method of Fro¨lich (2007) implemented
by Fro¨lich and Melly (2010). The simulation setup is identical to Section 4.3.1, except that
we discretize the exposure value Di so that we can compare our method to the method in
Fro¨lich (2007). Specifically, let D∗ij be defined as Dij in Section 4.3.1, i.e. D
∗
ij = κ+ piZij +
ρTXij + ξij . Then, we define
Dij = χ(D
∗
ij < −1) + 2χ(−1 ≤ D∗ij < 1) + 3χ(1 ≤ D∗ij)
The response Rij is generated from the same model as in Section 4.3.1, except with a
discretetized Dij . The rest of the data generating process is identical to Section 4.3.1.
For each simulated data, we use the code provided by Fro¨lich and Melly (2010) to generate
an estimate for β∗, the local average treatment effect, with the default settings for the
tuning parameters. We also use our method to estimate β∗. Finally, for comparison, we
run TSLS on the simulate data. As before, we measure the absolute bias of the median and
the median absolute deviation (MAD). For each simulation study, we vary the function f(·)
and pi, the strength of the instrument.
Figures 33 and 34 show the absolute bias and median absolute deviation, respectively,
between the three methods. Generally speaking, both our method and method by Fro¨lich
(2007) do better than TSLS when f(·) is non-linear. Between our method and one by Fro¨lich
(2007), in most cases, our method is better or similar to the method of Fro¨lich (2007) when
it comes to bias. With regards to variability, our method and the method of Fro¨lich (2007)
are very similar to each other. For the quadratic, cubic, and exponential functions, our
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Figure 33: Absolute Bias of the Median Between Our Full Matching Method, TSLS, and
Fro¨lich’s Method for Different Concentration Parameters. The solid line indicates 2SLS,
the dashed line indicates our method, and the dotted line indicates Fro¨lich’s method.
simulations show that our method dominates both in bias and variance compared to Fro¨lich
(2007).
Unfortunately, we were not able to produce Type I error results for the method of Fro¨lich
(2007) because of a coding error in the code provided by Fro¨lich and Melly (2010) which
provided negative standard errors on the estimates produced by it. Fro¨lich (personal com-
munication) is aware of the issue and will be releasing a new version in the future.
4.3.3. Approximations of Efficiency
In this section, we assess the accuracy of the efficiency formula provided in Section 4.2.6
by the following simulation study. The variables Rij , Dij and Zij are generated via the
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Figure 34: Median Absolute Deviation Between Our Full Matching Method, TSLS, and
Fro¨lich’s Method for Different Concentration Parameters. The solid line indicates 2SLS,
the dashed line indicates our method, and the dotted line indicates Fro¨lich’s method.
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I Theoretical Variance Simulated Variance
Strong Weak Strong Weak
50 0.024 0.59 0.028 3224.30
100 0.012 0.30 0.012 181.06
110 0.011 0.27 0.012 2506.92
500 0.0024 0.060 0.0025 2.05
1000 0.0012 0.030 0.0012 0.037
5000 0.00024 0.0060 0.00024 0.0063
10000 0.00012 0.0030 0.00012 0.0030
Table 25: Comparison of Simulated Variance and Theoretical Variance for Different
Strength of Instruments and Matched Sets
model in (4.9) and (4.10) with Zij assumed to be fixed. We randomly pick αi, τi, and β.
We pick γ to be 1 for the strong instrument case and −0.2 for the weak instrument case.
We assume a homoscedastic variance for the error terms where all the σ2i,R, σ
2
i,D, and σi,RD
are the same for every i. We compute the effect ratio estimator, repeat this process 1000
times, and compute the simulated variance. The theoretical variance is calculated based on
the formula provided in Theorem 4.3. Table 25 shows the results.
Table 25 shows us that for strong instruments, the agreement between theoretical formula
in Theorem 4.3 and simulation is quite good for all values of I. On the other hand, for
weak instruments, there is substantial deviation between the theoretical variance and the
simulated variance until I is above 5000.
4.4. Discussion
Overall, in contrast to regression-based IV estimation procedures like TSLS, our full match-
ing IV method provide a clear way to assess the balance of observed covariates and design
the study without looking at the outcome data along with a way to quantify the effect of
unmeasured confounders on our inference of the causal effect. Our method made it ex-
plicitly clear how these covariates were adjusted by stratifying individuals based on similar
covariate values. Finally, like in a randomized experiment, our method only looks at the
outcome data once the balance was acceptable. If the balance was unacceptable, then com-
paring the outcomes between the two groups would not provide reliable causal inference
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since any differences in the outcome can be attributed to the differences in the covariates.
In contrast, conventional TSLS can only analyze the causal relationship in the presence of
outcome data, making the outcome data necessary throughout the entire analysis. Finally,
our method is robust to parametric modeling assumptions between the outcome and the
covariates with respect to Type I error and point estimate, which cannot be said about
TSLS.
At the expense of these benefits, especially blinding and transparency with regards to
covariate balance, unfortunately matching estimators tend to be less efficient than TSLS or
some of the semiparametric methods mentioned in Section 4.1.1 when the semiparametric
methods’ assumptions hold. In practice, our estimator’s blinding and transparency can be
a powerful design and visual tool for applied researchers to assess the validity of the causal
conclusions. However, a more careful exploration of the trade-offs between the efficiency of
our estimator and the efficiency of some of the semiparametric and non-parametric methods
is an interesting direction for future research.
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CHAPTER 5 : An Application: The Causal Effect of Malaria on Stunting in
Children from Ghana
This is joint work with Benno Kreuels, Ohene Adjei, Ralf Krumkamp, Ju¨rgen May, and
Dylan Small.
5.1. Background: Malaria and Childhood Development in sub-Saharan Africa
In 2013 alone, there were 128 million estimated cases of malaria in sub-Saharan Africa,
with most cases occurring in children under the age of 5 (World Health Organization,
2014). In addition to being one of the major causes of death in early childhood, repeated
malaria episodes are a major cause of chronic anemia and may impair child development
(Korenromp et al., 2004). Consequently, it is important to study the impact of malaria on
child development to prioritize public health resources.
Previous epidemiological studies on the association between malaria and child growth have
produced inconsistent results, which is partly rooted in different methodological approaches.
Several studies assessed growth using the mean height-for-age Z-score, while other studies
used the prevalence of stunting (height-for-age Z-score < −2) as an indicator of insuffi-
cient growth. Stunting is a common condition in African children and is one of the main
determinants of childhood morbidity and mortality (Rice et al., 2000). In 1956 a study
from the Gambia first showed a tendency to higher mean Z-scores in infants who received
malaria prophylaxis compared to children who did not (McGregor et al., 1956). Later an
association between malaria and child growth or risk of stunting was also seen in Nigeria
(Bradley-Moore et al., 1985), Kenya (ter Kuile et al., 2003), The Gambia (Deen et al., 2002),
Ghana Ehrhardt et al. (2006), and Uganda Arinaitwe et al. (2012). Other studies, however,
found no association (Snow et al., 1991; Fillol et al., 2009; Deribew et al., 2010; Crookston
et al., 2010) or even a higher risk of malaria in children with better z-scores (Genton et al.,
1998). Finally, one study demonstrated that the association between stunting and malaria
might be strongest in young children (Nyakeriga et al., 2004).
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A major limitation common to all previous studies is the inability to fully adjust for con-
founding. Specifically, nutritional deficiencies are important potential confounders because
they are an important determinant of stunting and they also compromise immune func-
tion, which could result in a higher risk of infection (Fillol et al., 2009). Further potential
confounders are socioeconomic status, living conditions, and other infections. In addition,
reverse causality in the association of stunting and malaria seems possible. Randomized tri-
als recruiting children at birth could account for potential confounders and reverse causality
but are impractical in this context.
In this paper, we seek to control for confounders in estimating the causal effect of malaria
on stunting by using a combination of Mendelian randomization (MR) and matching (in
Chapter 4). The basic idea of MR is to extract variation in an exposure (i.e. malaria) that is
due to a Mendelian gene, which is independent of confounders, and use this confounder-free
variation to estimate the effect of the exposure on the outcome (i.e. stunting) (Davey Smith
and Ebrahim, 2003, 2004; Lawlor et al., 2008). The hemoglobin variant HbS, which is
caused by a point-mutation at the 6th position of the β-Globin gene (β6Glu Val), serves
as the paradigm for balanced polymorphisms; while people homozygote for HbS (HbSS)
have sickle cell disease with an increased mortality, heterozygote carriers (HbAS, sickle cell
trait) are asymptomatic and protected from malaria (May et al., 2007; Kreuels et al., 2010).
A previous analysis of the current data showed a negative association between the HbAS
genotype and stunting in an area of high malaria endemicity and computed the magnitude
of the association (Kreuels et al., 2009). However, the study did not analyze the effect of
malaria on stunting and the magnitude of such an effect. In this analysis, we use HbAS as
a Mendelian gene to expand on this finding and estimate the effect of malaria on stunting.
To control for measured confounders (e.g. birth weight, ethnic group, mosquito protection),
we will use matching laid out in Chapter 4.
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5.2. Methods
5.2.1. Study Population and Design
The study was conducted in the Ashanti region in Ghana. A cohort of 1070 infants was re-
cruited as part of a clinical trial on intermittent preventative treatment with Sulphadoxine-
Pyrimethamine (SP) (Kobbe et al., 2007). Infants were recruited at three months of age
and followed-up monthly until age two with comprehensive examinations including a stan-
dardized medical history, a measurement of body temperature, and a thick-and-thin smear
for microscopic malaria diagnostics. Passive case detection was performed between sched-
uled visits. A child was diagnosed with malaria if he/she had a parasite-density of more
than 500 parasites/µl and a body temperature greater than 38◦C or the mother reported
a fever within the last 48 hours. In three monthly intervals, standardized anthropometric
measurements, including height and weight, were performed. A child was deemed stunted
if her/his length/height-for-age z-score was less than -2 (i.e. moderate or severe stunting)
(WHO Multicentre Growth Reference Study Group, 2006). Further details of the study
population are published in a previous paper (Kobbe et al., 2007).
5.2.2. Definition of Instrument, Exposure, and Outcome
For this analysis only infants with heterozygote HbAS or wildtype HbAA were considered.
Children with homozygote mutation (HbSS) or a different mutation on the same gene
leading to hemoglobin C (HbAC, HbCC, HbSC) were excluded. The instrument was a
binary variable indicating the HbAS or HbAA genotype. The exposure of interest was
the malarial history defined as the total number of malaria episodes during the study. A
malaria episode, as stated before, was defined as having a parasite density of more than
500 parasites/µl and a body temperature greater than 38◦C or the mother reported a fever
within the last 48 hours. The outcome of interest was whether the child was stunted at the
last recorded visit, which took place when the child was approximately two years old.
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5.2.3. Assumptions for Instrumental Variables with the Sickle Cell Trait
We formalize the core assumptions of an instrumental variable below (Holland, 1988; Angrist
et al., 1996; Yang et al., 2014) (see Figure 1)
(A1) The sickle cell is associated with malaria episodes
(A2) All directed pathways from the sickle cell trait to stunting passes through malaria
episodes (i.e. there is no pathway that goes directly from the sickle cell genotype to
stunted growth)
(A3) There are no unmeasured confounders that are associated with the sickle cell trait
and stunted growth
We now assess the validity of (A1)-(A3) for the sickle cell trait, the instrument for our
analysis on the effect of malaria on stunting. For assumption (A1), there is substantial
evidence that the sickle cell trait does provide protection against malaria as compared to
people with two normal copies of the HBB gene (HbAA) (Aidoo et al., 2002; Williams et al.,
2005; May et al., 2007; Cholera et al., 2008; Kreuels et al., 2010). Also, with this data, when
we characterize the effect of the sickle cell trait on malaria based on a Poisson regression,
the difference in episodes of malaria between children with HbAS and HbAA is significant
(Risk ratio: 0.82, p-value: 0.02, 95% CI: (0.70, 0.97)), indicating that the sickle cell trait
instrument satisfies (A1) of being associated with the exposure. This is also in alignment
with previous literature on the relationship between sickle cell genotype and malaria for
this data (Kreuels et al., 2010).
For assumption (A2), this could be violated if the sickle cell trait had effects on stunting
other than through causing malaria, for instance, if the sickle cell trait was pleiotropic
(Davey Smith and Ebrahim, 2003). We can partially test this assumption by examining
individuals who carry the sickle cell trait, but who grew up in a region where malaria is not
present. That is, if assumption (A2) were violated, heights between individuals with HbAS
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and HbAA in such a region would be different since there would be a direct arrow between
the sickle cell trait and height. Studies among African American children and children from
the Dominican Republic and Jamaica for whom the sickle cell trait is common, but there is
no malaria in the area, found no evidence that the sickle cell trait affected a child’s physical
development (Ashcroft et al., 1976; Kramer et al., 1978; Ashcroft et al., 1978; Rehan, 1981).
This supports the validity of assumption (A2). Note, however, that although the results of
this test support the validity of (A2), (A2) could still be violated. For example, the sickle
cell trait could have a direct effect that interacts with the environment in such a way that
the direct effect is only present in Africa, but not in the Dominican Republic or Jamaica.
For assumption (A3), this assumption would be questionable in our data if we did not
control for any population stratification covariates. Population stratification is a condition
where there are subpopulations, some of which are more likely to have the sickle cell trait,
and some of which are more likely to be stunted through mechanisms other than malaria
(Davey Smith and Ebrahim, 2003). For example, in Table 26 which provides the baseline
characteristics for our data, we observed that the village Tano-Odumasi had more children
with HbAA than HbAS. It is possible that there are other variables besides HbAA that
differ between the village Tano-Odumasi and other villages and affect stunting. Hence,
assumption (A3) is more plausible if we control for observed variables, like village of birth,
and we use full matching in Chapter 4 to achieve this. Specifically, within the framework
of matching, for each matched set, if the observed confounders in Table 26 are similar
among all individuals in that matched set, it may be more plausible that the unobserved
variable, say u, plays no role in the distribution of the sickle cell genotype among all the
individuals in the matched set. If (A3) exactly holds and subjects are exactly matched
for their observed confounders, then within each matched set, sickle cell is simply assigned
by a random mechanism. In Section 4.2.7, we discuss a sensitivity analysis that allows for
the possibility that even after matching for observed variables, the unobserved variable u
may still influence the assignment of the sickle cell trait in each matched set, meaning that
assumption (A3) is violated.
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Other notable IV assumptions, such as Stable Unit Treatment Value Assumption (SUTVA)and
monotonicity, are fairly reasonable in this data. SUTVA states that one’s individual poten-
tial outcomes are not affected by the genotype assignment of another individual (Angrist
et al., 1996). Our instrument, the sickle cell genotype, was determined at the conception
of the child and hence, a child’s genotype only affects his exposure and outcome, and not
the exposures and outcomes of other children. Monotonicity, within the framework of MR,
states that there are no individuals who would have an adverse effect on the exposure from
inheriting the genotype which is purported to bring positive effect on the exposure. In MR
where the chosen genetic instruments usually bring about a positive effect on the exposure,
monotonicity is reasonable, especially with our instrument, the sickle cell genotype, where
it is widely believe that inheriting the trait provides individuals protection from malarial
infection compared to not inheriting the trait.
5.2.4. Full Matching on Malaria Data and Efficiency Simulation
We conduct full matching on all observed covariates. In particular, we group children with
HbAS and HbAA based on all the observed characteristics in Table 26 as well as match
for patterns of missingness. To measure similarity of the observed and missing covariates,
we use the rank-based Mahalanobis distance as the distance metric for covariate similarity
(Rosenbaum, 2010). In addition, we compute propensity scores by logistic regression. Here,
the propensity score is an instrumental propensity score, which is the probability of having
the sickle cell trait given the measured confounders (Cheng, 2011). In addition, children
with missing values in their covariates were matched to other children with similar patterns
of missing data (Rosenbaum, 2010). Once covariate similarity was calculated, the matching
algorithm optmatch in R (Hansen and Klopfer, 2006) matched children carrying HbAS with
children carrying HbAA in a way that within each matched set, their covariates are similar.
Hansen (2004) discusses how the size of matched sets in full matching can be restricted to
gain efficiency and Section 4.2.6 provides a method to compute efficiency. Unfortunately,
for us to use the formula in that section, it requires, among other things, a linear model
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between the outcome and the exposure. In our study where stunting, the outcome, is a
binary variable and malaria, the exposure, is a whole number, it is unreasonable to assume
that the binary outcome is a linear function of malaria exposures.
To tackle this, we propose a simulation study to analyze efficiency for different full matching
schemes. For our malaria data, we fix the instruments and the measured covariates, which,
in turn, fixes the matched sets. We assume a Poisson relationship between the number
of malaria episodes and the instrument and a logistic relationship between the number of
episodes and the stunting outcome. In particular, we use the following model
P (Rij = 1) =
1
1 + e−(αi+βDij+uij)
, E(Dij) = e
τi+γZij
where Rij is the outcome, Dij is the exposure, and Zij is the instrument. We fix β, the
effect of malaria on stunting, to be 0.32 and γ, the strength of the instrument, to be −0.20
based on the estimates in Kang et al. (2013); the estimate of γ was based on the risk ratio
estimate. We also randomly choose αi and τi, the intercepts, from Normal distributions
with means −1.67 and −0.19, respectively, and variances 0.12 and 0.027, respectively. The
mean and the variance for αi are from the estimated intercept term and its corresponding
standard error of the logistic regression between Rij and Dij . Similarly, the mean and the
variance for τi are from the estimated intercept term and its corresponding standard error
of the Poisson regression between Dij and Zij . Once all the parameters are set, we sample
884 observations of (Rij , Dij) (i.e. the sample size of the malaria data set) and compute
the effect ratio estimator based on the sample of 884. Note that the effect ratio estimator
should be able to estimate β since it doesn’t rely on the functional form between stunting
(i.e. outcome) and malaria episodes (i.e. exposure). We repeat the simulation 5000 times
and compute the median absolute deviation as a robust proxy for variance of the effect ratio
estimator.
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5.2.5. Estimator of the Effect Ratio
After matching, we estimate the effect ratio, as described in Section 4.2.4. In the malaria
data, the effect ratio parameter can be interpreted as the weighted average reduction in
stunting from a one-unit reduction in malaria episodes among individuals who were pro-
tected from malaria by the sickle cell trait. Similarly, each weight represents each individ-
ual’s protection from at least k malaria episodes by carrying the sickle cell trait compared
to the overall number of individuals who are protected from varying degrees of malaria
episodes by carrying the sickle cell trait.
We use the test statistic described in Section 4.2.5 to estimate the effect ratio and obtain
inferential quantities like p-values and 95% confidence intervals. We note that the regularity
conditions, specifically the moment conditions in Theorem 4.2 of Section 4.2.5 (i.e. V 4i (λ¯) is
uniformly bounded), are automatically met because the responses are binary (i.e. stunted
or not stunted) and the malaria episodes are bounded whole numbers. Hence, Theorem 4.2
and the subsequent Corollary 4.1 are used to compute the point estimate, the p-value, and
the confidence intervals for the casual effect of malaria on stunting.
Also, for comparison, we computed the multiple regression estimate of the effect ratio, an
estimate that only adjusts for measured confounding, but not unmeasured confounding.
This estimate is derived from a multiple linear regression with stunting as the dependent
variable and all measured confounders and the number of malaria episodes as independent
variables. From the regression, we take the estimated slope coefficient for malaria episodes,
which is the reduction in the risk of stunting per malaria episode.
5.2.6. Sensitivity Analysis
Despite our best efforts to minimize the observed differences in covariates and to adhere
to assumption (A3) after conditioning on the matched sets, unmeasured confounders such
as a child’s family’s ancestry could still be different between the jth and kth child, and
this difference could make the inheritance of the sickle cell trait depart from randomized
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assignment, violating assumption (A3). To quantify the effect of unmeasured confounders
on the obtained inference, a sensitivity analysis outlined in Section 4.2.7 was performed.
Specifically, we consider a binary unmeasured confounder that has a specified effect on the
odds of inheriting HbAS over HbAA and specified effect on the odds of stunting (conditional
on measured confounders), and evaluate the effect such an unmeasured confounder would
have on the inference we make. Also following Section 4.2.7, we amplify our sensitivity
analysis to increase interpretability.
5.3. Results
5.3.1. Basic Data
The analysis was conducted on 884 children with HbAA or HbAS genotype. 774 children
were HbAA homozygotes while 110 children were HbAS heterozygotes. 35 children (4.0%)
were already stunted at the beginning of the trial and by the end, 168 children (19.0%) were
stunted. The t-statistic to test the difference in the time of the last recorded visit amongst
HbAA and HbAS did not indicate any variation (p=0.21, 95% CI: (-3.70,16.68)).
Table 26 shows the baseline characteristics of the HbAS and HbAA subjects before match-
ing. Before matching, most characteristics at recruitment were similar between children
with HbAS and HbAA. The notable exception is birth weight. There was evidence that
birth weight of children with HbAA was lower than of children with HbAS (p=0.006, 95%
CI: (-228.27,-39.14)).
5.3.2. Matching and Efficiency
Figure 35 shows covariate balance before and after full matching using absolute standardized
differences. Absolute standardized differences before matching are computed by taking the
difference of the means between children with HbAS and HbAA for each covariate, taking
the absolute value of it, and normalizing it by the within group standard deviation before
matching (the square root of the average of the variances within the groups). Absolute
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                                                 Absolute standardized differences of covariates
Absolute standardized differences
Mosquito protection missing
Mother’s financial status missing
Mother’s education missing
Mother’s occupation missing
Alpha−globin genotype missing
Ethnicity missing
Birth weight missing
Missing Covariates:                                                                
Sulphadoxine pyrimethamine
Other:                                                                
Mosquito protection (Nets)
Mosquito protection (Screen)
Mother’s financial status
Mother’s education
Mother’s occupation
Mother and Household:                                                                
Wiamoase
Tano−Odumasi
Kona
Jamasi
Bipoa
Bedomase
Asamang
Agona
Village of Residence:                                                                
Alpha−globin genotype (Homo)
Alpha−globin genotype (Hetero)
Ethnicity
Birth season
Gender
Birth weight
Birth:                                                                
0.00 0.05 0.10 0.15 0.20
Figure 35: Absolute Standardized Differences Before and After Full Matching for the
Malaria Data. Unfilled circles indicate differences before matching and filled circles indicate
differences after matching.
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Matching Median absolute deviation Standardized bias
Full matching (max strata size is 9) 0.90 0.23
Full matching (max strata size is 10) 0.96 0.19
Full matching (max strata size is 15) 0.97 0.10
Full matching (unrestricted) 0.98 0.055
Table 27: Trade-off Between Efficiency and Balance for Different Full Matching Schemes in
the Malaria Data
standardized differences after matching are computed by taking the differences of the means
between children with HbAS and HbAA within each strata, averaging this difference across
strata, taking the absolute value of it, and normalizing it by the same within group standard
deviation before matching as before. Before matching, there are differences in birth weight,
mosquito protection, and village of residence between children with HbAS and HbAA.
After matching, these covariates are balanced. Specifically, the standardized differences for
birth weight, village of residence, and mosquito protection, are under 0.1 indicating balance
(Normand et al., 2001). In fact, all the covariates are balanced after matching and the
p-values used to test the differences between HbAS and HbAA in Table 26 are no longer
significant after matching.
Table 27 shows the trade-off between efficiency and covariate balance for different full match-
ing schemes that use all 884 samples of the malaria data. In particular, we restrict the
matched set sizes to different values to see the impact on efficiency and standardized bias.
The standardized bias is the instrumental propensity score (Cheng, 2011) and is calculated
as the difference in propensity scores before and after matching normalized by the within
group standard deviation before matching (the square root of the average of the variances
within the group). We see that unrestricted full matching has the lowest bias among all
other full matching schemes. However, full matching with restricted strata size of 9 has
the lowest median absolute deviation, albeit by a little in comparison to other matching
schemes. Given the large bias reduction by using unrestricted full matching with a small
gain in median absolute deviation, we use unrestricted full matching for our analysis.
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Methods Estimate P-value 95% confidence interval
Our method 0.22 0.011 (0.044, 1)
Two stage least squares 0.21 0.14 (-0.065, 0.47)
Multiple regression 0.018 0.016 (0.0034, 0.033)
Table 28: Estimate of the Effect Ratio in the Malaria Data.
5.3.3. Effect Ratio
Table 28 shows the estimates of the causal effect of malaria on stunting from different
methods, specifically our method, conventional two stage least squares (TSLS), and multiple
regression. Our method computed the estimate by the procedure outlined in Section 4.2.5.
TSLS computed the estimate by regressing all the measured covariates and the instrument
on the exposure and using the prediction from that regression and the measured covariates
to obtain the estimated effect. Inference for TSLS was derived using standard asymptotic
Normality arguments (Wooldridge, 2010). Finally, the multiple regression estimate was
derived by regressing the outcome on the exposure and the covariates and the inference on
the estimate was based on a standard t test.
We see that the full matching method estimates λ to be 0.22. That is, the risk of stunting
among children with the sickle cell trait is estimated to decrease by 0.22 for every malaria
episode prevented by the sickle cell trait. Furthermore, we reject the hypothesis H0 : λ = 0,
that malaria does not cause stunting, at the 0.05 significance level. The confidence interval
for λ is (0.044, 1.0). Even the lower limit of this confidence interval of 0.044 means that
malaria has a substantial effect on stunting; it would mean that the risk of stunting among
children with the sickle cell trait decreases by 0.044 for every malaria episode prevented by
the sickle cell trait.
The estimate based on TSLS is 0.21, similar to our method. However, our method achieves
statistical significance but TSLS does not. Also, multiple regression, which does not control
for unmeasured confounders, estimates a much smaller effect of 0.018.
We also compute the strength of the instrument for our matching method by regressing the
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Γ Range of significance
1.1 (0.0082, 0.041)
1.2 (0.0034, 0.074)
1.3 (0.0015, 0.12)
Table 29: Sensitivity Analysis for the Malaria Data. The range of significance is the range
of p-values over the different possible distributions of the unmeasured confounder given a
particular value of Γ, which represents the effect of unobserved confounders on the inference
of λ.
exposure (malaria episodes) onto the sickle cell trait and dummy variables that indicate
which matched group a child belongs to and evaluating the F statistics from this regression.
For instrument strength for full matching, the F statistic is 4.15 and its R2 is 0.21. For
instrument strength for TSLS, the F statistic is 4.36 and its R2 is 0.22.
5.3.4. Sensitivity Analysis
Table 29 shows the sensitivity analysis due to unmeasured confounders. Specifically, we
measure how sensitive our method in Table 28 is to violation of assumption (A3) in Section
4.2.3, even after matching. We see that our results are somewhat sensitive to unmeasured
confounders at the 0.05 significance level. If there is an unmeasured confounder that in-
creases the odds of inheriting HbAS over HbAA by 10%, i.e. Γ = 1.1, then we would still
have strong evidence that malaria causes stunting. But, if an unmeasured confounder in-
creases the odds of inheriting HbAS over HbAA in a child by 20% (i.e. Γ = 1.2), the range
of possible p-values includes 0.05, the significance level, meaning that we would not reject
the null hypothesis of H0 : λ = 0, that malaria does not cause stunting.
Figure 36 shows the result of applying the amplification of Γ by looking at the effect by
unmeasured confounders on the odds of stunting and odds of inheriting HbAS over HbAA.
Specifically, the different values of Γ in the sensitivity analysis provides us with range of
possible p-values. Also, each Γ is associated with two other sensitivity parameters ∆, odds
of stunting, and Λ, odds of inheriting HbAS over HbAA, and can be presented as a two-
dimensional plot with each axis representing ∆ and Λ. For example, the point (∆ = 1.5,Λ =
1.5) on Figure 36 represents an unmeasured confounder that increases the odds of stunting
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Sensitivity Analysis to Unmeasured Confounders
Change of Odds of Stunting by Unmeasured Confounders
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Figure 36: Amplification of Sensitivity Analysis in the Malaria Data. Each point on the
graph represents an effect by an unmeasured confounder on the instrument (HbAS) and on
the outcome (stunting) to change the inference, specifically the p-value. Points within the
two bold curves correspond to effects by unmeasured confounders that will give us p-values
< 0.05 and points outside the two bold curves correspond to effects that will give us p-values
> 0.05, thereby retaining our null hypothesis.
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and inheriting HbAS over HbAA by a factor of 1.5 and produces a p-value in between 0.025
and 0.05, which does not contain the significance level of 0.05. Hence, the null hypothesis
would still be rejected despite having such an unmeasured confounder. In contrast, if the
unmeasured confounder had an effect of (2.0, 2.0) specified on the plot, the null hypothesis
would be retained since the p-value contains the significance level of 0.05.
5.4. Discussion
By using Mendelian randomization with sickle cell trait as the instrument and matching
techniques to account for potential confounders, we found evidence of a causal effect of
malarial episodes on stunting. Roughly speaking, each increase by one malaria episode
increased the risk of stunting by 0.22 (95% CI: (0.044, 1)), indicating that the effect of
malaria on stunting is substantial in our cohort of infants under two years of age.
Our results confirm findings about an association between malaria and stunting from pre-
vious studies (Deen et al., 2002; Ehrhardt et al., 2006; Arinaitwe et al., 2012) as well
as findings from earlier studies on an association between mean height-for-age z-scores and
malaria (McGregor et al., 1956; Bradley-Moore et al., 1985; ter Kuile et al., 2003). Previous
studies were unable to fully adjust for confounding; a large number of personal characteris-
tics, such as nutritional deficiencies, low socioeconomic status, and poor living conditions,
are likely to be predictors for both malaria and stunting. Differing levels of confounding in
previous studies may have led to findings of no association between malaria and stunting or
mean Z-scores (Snow et al., 1991; Deribew et al., 2010; Crookston et al., 2010) or a negative
correlation (Genton et al., 1998) or false conclusions about associations. In our study the
large difference between the estimate for the effect ratio from the multiple regression and the
estimate derived after matching (0.018 vs. 0.22) indicates a substantial level of confounding
in multiple regression. MR takes into account unmeasured confounders that are frequently
present in observational studies and are not controlled for in standard regression. Under
the assumptions stated in the methods section, MR will control for both unmeasured and
measured confounding and provide an unbiased estimate (Lawlor et al., 2008; Sheehan et al.,
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2008; Glymour et al., 2012). The necessity of these assumptions is a potential limitation
that is inherent to our approach. However, we are convinced that the assumptions of an
association between HbAS and malaria (May et al., 2007; Allison, 1964; Willcox et al., 1983;
Hill et al., 1991; Aidoo et al., 2002) and no association between HbAS and stunting other
than through malaria (Kramer et al., 1978; Rehan, 1981; Ashcroft et al., 1976, 1978) are
valid. Ghansah et al. (2012) have described the HbAS haplotype in a Ghanaian population
as an extended haplotype of 1.5 Mb containing 25 additional genes. Their analysis shows
that this genomic region has a considerable degree of linkage disequilibrium, which poten-
tially could violate our assumption that HbAS is independent of unmeasured confounders.
To identify a potential violation, we searched PubMed for reports on associations between
stunting or malnutrition and any of the other 25 genes on the extended haplotype, including
possible alternative gene names, allelic variants and resulting phenotypes, based on searches
in the National Center for Biotechnology Information (NCBI) gene database and the Online
Mendelian Inheritance in Man database (OMIM) (see Kang et al. (2013) for details). These
searches did not reveal any reports of an association between genes or genetic variants on
the haplotype and stunting.
A further limitation to previous studies is potential reverse causality in the association of
stunting and malaria. As discussed by Arinaitwe et al. it is difficult to distinguish whether
stunting increases the risk of malaria or whether malaria increases the risk of stunting
(Arinaitwe et al., 2012). The Mendelian randomization design of this study solves part
of this limitation. It enables us to see whether an increased frequency of malaria causes
stunting. Specifically, any association between the sickle cell trait and stunting must come
from an effect of malaria on stunting rather than the reverse. The sickle cell trait, which is
determined at conception, only affects stunting through its effect on malaria. If malaria did
not affect stunting, there would be no association between the sickle cell trait and stunting.
However, there are several additional factors that we cannot analyze or adjust for in our
analysis that may have contributed to the differing findings between studies. For example,
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several studies were of cross-sectional design (Ehrhardt et al., 2006; Deribew et al., 2010;
Crookston et al., 2010) and looked at a potential association between current malaria and
stunting prevalence. Malaria at the time point of the study may or may not correlate to
previous exposure. This correlation is likely to differ by transmission intensity of malaria
and this varied from low-seasonal to high-perennial transmission. While the assessment
of malaria incidence in the longitudinal studies was probably a more accurate measure of
exposure, it seems plausible that the effect of malaria on growth is modulated by immunity
and thereby may vary with age (McGregor et al., 1956; Bradley-Moore et al., 1985; ter
Kuile et al., 2003; Deen et al., 2002; Arinaitwe et al., 2012; Snow et al., 1991; Fillol et al.,
2009; Genton et al., 1998). In fact, a study from Tanzania found an effect modification
by age with the strongest effect of malaria on stunting in children less than 1 year of age
(Nyakeriga et al., 2004).
A further potential limitation of our model is the measurement of exposure. We have
assumed that the simple sum of malaria episodes over a child’s life is what affects the child
being stunted at age two. It may be that a more complex function of a child’s malaria history
affects stunting; we plan to investigate this in future work. In addition, the population in
this study was enrolled in a clinical trial and seen by medical personnel at close intervals.
Prompt medical treatment and nutritional interventions were available free of charge during
follow-up. It is possible that the effect of malaria on stunting in this population may differ
from the general population and especially from populations where nutritional deficiencies
are more common.
The interpretation of the effect ratio assumes that the effect HbAS has on stunting is solely
mediated by a reduction of the number of malaria episodes. However, HbAS also reduces
the severity of every malaria episode and the effect on stunting may partly be due to this
(Kreuels et al., 2010). This would lead to an overestimation of the effect that is attributable
to each malaria episode. However, the causality conclusion would not change and even
the lower boundary of the 95% confidence interval for the effect, 0.044, still indicates a
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substantial effect of malaria on stunting.
Our analysis demonstrates the applicability of HbAS as an instrumental variable for the
analysis of conditions related to malaria. As in all observational studies, research on the
association of malaria with other medical conditions is often difficult due to the strong
influence of confounders and randomized trials are almost always impractical. The method
we propose can be applied to reanalyze previous studies in this area, specifically those where
the genotyping of the sickle cell gene has already been performed (ter Kuile et al., 2003;
Nyakeriga et al., 2004). We hope that our findings will encourage the application of MR
to such analyses in the future. A potential further application of MR using HbAS is the
elucidation of associations between malaria and other infections. One such analysis was
performed by Scott et al. (2011) who used MR to analyze an association between malaria
and bacteremia caused by Salmonella spp.
Our analysis provides evidence of a substantial causal effect of malaria episodes on stunting,
at least in children less than 2 years of age in an area of high endemicity. Our findings will
hopefully spur further research on this important epidemiological concern in sub-Saharan
Africa and increase the application of sickle cell trait as an instrumental variable in malaria
research.
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CHAPTER 6 : Discussions
Throughout Chapters 2 to 4, we established results concerning the estimation of causal
effects of the exposure on the outcome when invalid instruments are present. In Chapter
2 and 3, we provided results when we have multiple candidate instruments and proposed
theoretical limits as well as propose an estimator that can consistently estimate the true
causal effect and a confidence interval that has honest coverage. In Chapter 4, we dealt
with the case when we have one single candidate instrument and proposed a nonparametric
matching estimator. In Chapter 5, we applied our new method to a real data set concerning
the causal effect of malaria on stunted growth.
As we seen in our work, there is much room for future work in the area of IV estimation with
invalid instruments. Each chapter laid out some potential future works in each scenarios
and the list below is a summary of those future directions.
1. Further extend our method on estimation with invalid instruments, specifically under
the framework in Chapter 2, to encompass a wider class of models. Our current work
is limited to linear, constant effects model and as such, our problem boils down to a
mathematical problem of solving system of under-determined linear equations with
constraints on the parameter space. We want to explore the theoretical limits and
methods for estimation and identification under more general models that include
arbitrary transformations of the instruments, such as g(Zi.) in some function class G,
heterogeneous effects (i.e. β∗i instead of a global β
∗), and nonlinear outcome models
(e.g. binary outcomes or survival outcomes). All these generalizations would be a de-
parture from the usual system of under-determined linear equations and it is unknown
whether estimation is possible. In line with this goal, developing an estimator that is
robust to model mis-specification would be useful for researchers using IV methods.
2. Develop confidence intervals for IV methods that are both robust to weak instruments
and invalid instruments. Weak instruments are, in essence, a near violation of (A1)
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and there is a huge literature on weak instruments (see Stock et al. (2002) for a
survey). However, there is very little literature on estimation in the presence of
invalid instruments, except our work and work by Kolesa´r et al. (2013). Chapter 3
laid out some preliminary work, but it is currently unknown whether our CIs can be
improved.
3. Explore sensitivity analysis when core IV assumptions are violated. In our work in
Chapter 4, we used matching to controll for covariates to make assumption (A3) more
plausible and we developed sensitivity analysis of our IV estimate should matching
fail to make (A3) plausible. We would like to develop sensitivity analysis for other
types of violations in IV assumptions, such as (A2), or other assumptions that may
arise when we start considering heterogeneous causal effects.
4. Extend our method in Chapter 4 to multiple instruments. Currently, our matching
algorithm in IV estimation can only handle binary instruments. However, non-binary
instruments are also common in IV studies and we want to explore how to extend our
method to this setting.
5. Apply our IV methods to various problems in the social sciences and health-related
disciplines. Our work with the malaria data in Chapter 5 was a collaborative effort
with medical professional where we applied our new IV matching method to solve
a problem of interest in the medical community. We are interested in applying our
methods to other settings in social science.
In conclusion, the current theory and methods behind IV estimation with invalid instru-
ments, specifically instruments that violate (A2) and (A3), are very limited and there are
many unanswered questions. Also, the work in this area has wide applications in fields where
instrumental variables methods are used, which includes economics, biology, epidemiology,
psychology, political science, sociology, and many others. It is our hope that the research
in the area of IV estimation with invalid instruments will further the field of making causal
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conclusions from observational data, especially when one only has imperfect instruments.
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APPENDIX
A.1. Proofs from Chapter 2
We adopt the following notations for the proofs. For any sets A,B ⊆ {1, . . . , L}, denote
A ∩B to be the intersection of sets A and B, A ∪B to be the union of sets A and B, and
AC and BC to be the complement of sets A and B, respectively. If A ⊆ B, denote B \A to
be the set that comprises of all the elements of B except those that are in A. Let |A| and
|B| denote the cardinality of the sets A and B, respectively.
For any vector α ∈ RL and set A ⊆ {1, . . . , L}, denote αA ∈ RL to be the vector where all
the elements except whose indices are in A are zero. Also, denote the jth element as αj . Let
supp(α) ⊆ {1, . . . , L} to be the support of the vector α and supp(α)C be the complement
set. For any matrix M ∈ Rn×L and set A ⊆ {1, . . . , p}, let MA ∈ Rn×L be an n by |A|
matrix where the columns are specified by set A.
A.1.1. Proof of Theorem 2.1
First, we prove that, β∗ is a unique solution if and only if α∗ is a unique solution. Suppose
β∗ has a unique solution; that is, for any two solutions α(1) β(1) and α(2), β(2), in equation
(2.7)
α(1) + γ∗β(1) = Γ∗ (A.1a)
α(2) + γ∗β(2) = Γ∗ (A.1b)
we have β(1) = β(2). Subtracting γ∗β(1) from equations (A.1) gives α(1) = α(2). Now,
suppose α∗ is unique, which implies α(1) = α(2). Again, subtracting α(1) from (A.1)
reveals β(1) = β(2).
Second, we prove the necessary and sufficient conditions for Theorem 2.1. Suppose the con-
ditions on γ∗ and Γ∗ hold, specifically qm = qm′ for any m 6= m′, but there are two distinct
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sets of parameters, α(1), β(1) and α(2), β(2) that solve the moment equation in equation
(A.1). Let A(1) =supp(α(1)) and A(2) =supp(α(2)) be the sets of invalid instruments for
the two distinct parameter sets, not equal to each other; if the supports are equal to each
other, we have the degenerate case whereby from equation (A.1), for any j ∈ A(1) = A(2)
γ∗j β
(1) = Γ∗j and γ
∗
j β
(2) = Γ∗j , which implies that β
(1) = β(2) and α(1) = α(2), a con-
tradiction. Because the number of invalid instruments, s, is less than U , s < U , the
number of valid instruments, L − s, must be greater than L − U , L − s > L − U . Thus,
|(A(1))C |, |(A(2))C | > L− U .
Now, pick any subsets, (A(1
′))C and (A(2
′))C , of (A(1))C and (A(2))C , respectively, where
|(A(1′))C | = |(A(2′))C | = L−U+1. These subsets (A(1′))C and (A(2′))C inherit the following
property from their larger sets (A(1))C and (A(2))C , respectively.
α
(1)
j + γ
∗
j β
(1) = γ∗j β
(1) = Γ∗j , j ∈ (A(1
′))C ⊆ (A(1))C
α
(2)
k + γ
∗
kβ
(2) = γ∗kβ
(2) = Γ∗k, k ∈ (A(2
′))C ⊆ (A(2))C
The condition on γ∗ and Γ∗ in Theorem 2.1 state that for any sets Cm with size |Cm| =
L − U + 1 and with the property that γjqm = Γj , j ∈ Cm, we have qm = qm′ for any
m,m′. The subsets we constructed, (A(1′))C and (A(2′))C , satisfy these condition with
constants q1′ = β
(1) and q2′ = β
(2). Hence, β(1) = q1′ = q2′ = β
(2), which is a contradiction.
Hence, the two sets of parameters α(1), β(1) and α(2), β(2) are identical to each other and
the solution is unique.
Now, suppose the solution is unique. Then, we show that the conditions on γ∗ and Γ∗
must hold. Pick any two sets A(1), A(2) ⊆ {1, . . . , L} with their complements having the
size |(A(1))C | = |(A(2))C | = L− U + 1 and corresponding constants q1 and q2, respectively,
defined in the theorem. We have to show that q1 = q2 for any pair of two sets.
Note that at least one set of these sets and its corresponding constant q must exist be-
cause at the true parameter values, α∗ and β∗, equation (2.7) is satisfied. Specifically, if
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A∗ =supp(α∗) where, by s < U , |(A∗)C | = |supp(α∗)C | > L − U , we can take any subset
(A(∗′))C ⊆ (A∗)C of size |(A(∗′))C | = L − U + 1. For any j ∈ (A(∗′))C , by equation (2.7),
γ∗j β
∗ = Γ∗j and thus, its corresponding constant q∗′ is q∗′ = β
∗. If there is exactly one set
A(1), the condition holds automatically.
Suppose there are two or more sets and let A(1) and (2) be any pair of the sets. Based on the
sets A(1) and A(2) and their corresponding constants q1 and q2, we construct the following
sets of parameters α(1), β(1) and α(2), β(2)
β(1) = q1, α
(1)
j =

0 j ∈ (A(1))C
Γ∗j − q1γ∗j j ∈ A(1)
β(2) = q2, α
(2)
j =

0 j ∈ (A(2))C
Γ∗j − q2γ∗j j ∈ A(2)
The cardinality of α(1) and α(2) are less than U . In addition, they satisfy the moment
equation in equation (2.7).
α
(1)
j + γ
∗
j β
(1) =

γ∗j q1 = Γ
∗
j j ∈ (A(1))C
Γ∗j − q1γ∗j + γ∗j q1 = Γ∗j j ∈ A(1)
α
(2)
j + γ
∗
j β
(2) =

γ∗j q2 = Γ
∗
j j ∈ (A(2))C
Γ∗j − q2γ∗j + γ∗j q2 = Γ∗j j ∈ A(2)
Since the equation has only one unique solution, this implies that β(1) = β(2), or q1 = q2.
Since this holds for any two sets (A(1))C , (A(2))C with constants q1 and q2 and cardinality
L− U + 1, we arrive at the condition qm = qm′ for any m,m′.
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A.1.2. Proof of Corollary 2.1
Consider any two sets Cm and Cm′ with the constants qm and qm′ in Theorem 2.1. Take an
element j from the intersection Cm ∩ Cm′ ; this intersection is non-empty because |Cm| =
|Cm′ | = L − U + 1 ≥ L/2 + 1. At element j ∈ Cm ∩ Cm′ , we have γ∗j qm = Γ∗j and
γ∗j qm′ = Γ
∗
j , which implies qm = qm′ . Since this holds for any two sets Cm and Cm′ ,
qm = qm′ for m,m
′, the condition in Theorem 2.1 always holds whenever U ≥ L/2 and we
have identification.
A.1.3. Proof of Theorem 2.2
We begin by introducing some notations and terminologies. For α ∈ Rp and s ∈ {1, . . . , p},
αmax(s) is defined as the vector where all but the largest s elements set to zero and α−max(s)
is defined as α−αmax(s).
Definition A.1. The restricted orthogonal constant (ROC) of single matrix of order k1
and k2, denoted as θk1,k2(M), is the smallest θk1,k2(M) where for any k1-sparse vector α1
and k2-sparse vector α2 with non-overlapping support, we have
|〈Mα1,Mα2〉| ≤ θk1,k2(M)‖α1‖2‖α2‖2.
Next, we introduce two lemmas. The first lemma relates the RIP and ROC constants.
Lemma A.1. For any matrix M and positive integers s1 and s2,
θs1,s2(M) ≤
1
2
(
δ+s1+s2(M)− δ−s1+s2(M)
)
.
Proof. For any vectors x and y with disjoint supports and ‖x‖2 = ‖y‖2 = 1, we must have
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x+ y, x− y are both (s1 + s2)-sparse and ‖x+ y‖22 = ‖x− y‖22 = 2. Hence,
|〈Mx,My〉| =1
4
∣∣‖M(x+ y)‖22 − ‖M(x− y)‖22∣∣
=
1
4
max
{‖M(x+ y)‖22 − ‖M(x− y)‖22, ‖M(x− y)‖22 − ‖M(x+ y)‖22}
≤1
4
max
{
δ+s1+s2(M)‖x+ y‖22 − δ−s1+s2(M)‖x− y‖22,
δ+s1+s2(M)‖x− y‖22 − δ−s1+s2(M)‖x+ y‖22
}
≤1
2
(
δ+s1+s2(M)− δ−s1+s2(M)
)
,
which implies θs1,s2(M) ≤ 12
(
δ+s1+s2(M)− δ−s1+s2(M)
)
.
The second lemma proves a standard property of the Lasso.
Lemma A.2. Suppose we have the model Yi = Z
T
i.α
∗ + i where α∗ is s-sparse. Further
suppose that matrix Z has upper and lower RIP constants δ+s (Z) and δ
−
s (Z), respectively.
Define αˆ as the Lasso estimator
αˆλ = argmin
α
1
2
‖Y − Zα‖22 + λ‖α‖1 (A.2)
and let h = αˆλ −α∗ measure the errors of the estimator.
If r‖ZT ‖∞ ≤ λ for some r > 1, we have
‖h−max(s)‖1 ≤
r + 1
r − 1‖hmax(s)‖1. (A.3)
Furthermore, if (r + 1)δ+2s(Z) < (3r − 1)δ−2s(Z),
‖hmax(s)‖2 ≤
2λ
√
s(r − 1)(r + 1)/r
(3r − 1)δ−2s(Z)− (r + 1)δ+2s(Z)
. (A.4)
Proof. Since αˆλ is the minimizer of (A.2) , we have
1
2
‖Y − Zαˆλ‖22 + λ‖αˆλ‖1 ≤
1
2
‖y − Zα∗‖22 + λ‖α∗‖1.
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By the assumed model Yi = Z
T
i α
∗ + i, we have
1
2
(‖− Zh‖22 − ‖‖22) ≤ λ(‖α∗‖1 − ‖αˆλ‖1). (A.5)
For the upper bound of (A.5), the fact that α∗ is s-sparse gives a useful bound. Specifically,
‖α∗‖1 − ‖αˆλ‖1 = ‖α∗supp(α∗)‖1 − ‖αˆsupp(α∗)‖1 − ‖αˆsupp(α∗)c‖1
≤ ‖α∗supp(α∗) − αˆsupp(α∗)‖1 − ‖hsupp(α∗)c‖1
≤ ‖hsupp(α∗)‖1 − ‖hsupp(α∗)c‖1
≤ ‖hmax(s)‖1 − ‖h−max(s)‖1.
For the lower bound of (A.5), ‖− Zh‖22 − ‖‖22, we can simplify as
1
2
(‖− Zh‖22 − ‖‖22) = −12(Zh)T (2− Zh) ≥ −hTZT  ≥ −‖ZT ‖∞‖h‖1
= −‖ZT ‖∞(‖hmax(s)‖1 + ‖h−max(s)‖1).
Hence, by (A.5) and the condition r‖ZT ‖∞ ≤ λ where r > 1, we have
r(‖hmax(s)‖1 − ‖h−max(s)‖1) ≥ −(‖hmax(s)‖1 + ‖h−max(s)‖1).
which yields (A.3), the first part of the theorem.
For (A.4), the second part of the theorem, suppose (r + 1)δ+2s(Z) < (3r − 1)δ−2s(Z) holds.
By the Karush-Kuhn-Tucker (KKT) condition of the minimization problem in (A.2), we we
have ‖ZT (y − Zαˆ)‖∞ ≤ λ and
‖ZTZh‖∞ ≤ ‖ZT (y − Zαˆ)‖∞ + ‖ZT (y − Zα∗)‖∞ ≤ λ+ ‖ZT ‖∞.
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Lemma 5.1 in Cai and Zhang (2013a) with λ = max(‖h−max(s)‖∞, ‖h−max(s)‖1/s) implies
|〈Zhmax(s),Zh−max(s)〉| ≤ θs,s(Z)‖hmax(s)‖2 ·
√
s ·max(‖h−max(s)‖∞, ‖h−max(s)‖1/s)
≤ √sθs,s(Z)‖hmax(s)‖2 ·
r + 1
r − 1‖hmax(s)‖1/s
≤ θs,s(Z)r + 1
r − 1‖hmax(s)‖
2
2,
where the last inequality uses (A.3). We then have
√
s(λ+ ‖ZT ‖∞)‖hmax(s)‖2 ≥ (λ+ ‖ZT ‖∞)‖hmax(s)‖1 ≥ 〈ZTZh, hmax(s)〉
= 〈Zhmax(s),Zhmax(s)〉+ 〈Zhmax(s),Zh−max(s)〉
≥ ‖Zhmax(s)‖22 − θs,s
r + 1
r − 1‖hmax(s)‖
2
2
=
(
δ−2s(Z)− θs,s(Z)
r + 1
r − 1
)
‖hmax(s)‖22
≥
(
3r − 1
2(r − 1)δ
−
2s(Z)−
r + 1
2(r − 1)δ
+
2s
)
‖hmax(s)‖22,
where the last inequality uses Lemma A.1. Moving ‖hmax(s)‖ to the right hand side and
using the condition r‖ZT ‖∞ ≤ λ where r > 1 yields (A.4).
Now we move on to the proof of Theorem 2.2. Section 2.3.6 in the main paper states that
the original estimation method can be reinterpreted as a two-step method where the first
step is the Lasso step and the second step is a dot product. The proof will first analyze
step 1 using the lemmas about Lasso performance and use it to analyze step 2.
First, in lieu of step 1, the model in equation (2.3) from the original paper can be modified
to
PDˆ⊥PZY = PDˆ⊥Zα
∗ + PDˆ⊥PZ. (A.6)
Here, PDˆ⊥Z becomes the design matrix, PDˆ⊥PZY becomes the outcome, and PDˆ⊥PZ is
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the new error term. In addition, from the condition 3‖ZTPDˆ⊥‖ ≤ λ, we have
λ ≥ 3‖ZT (I−PDˆ)‖∞ = 3‖ZT (PZ−PDˆ)‖∞ = 3‖ZT (I−PDˆ)PZ‖∞ = 3‖(PDˆ⊥Z)TPZ‖∞.
Second, note that (A.9) is in terms of the RIP constants of PDˆ⊥Z. To relate the RIP
constants of PDˆ⊥Z with that of Z, we see that for any 2s-sparse vector x ∈ RL, ‖PDˆ⊥Zx‖22 =
‖Zx‖22 − ‖PDˆZx‖22 ≤ ‖Zx‖22 ≤ δ+2s(Z)‖x‖22. By the definition of δ+2s(PDˆ⊥Z), this implies
δ+2s(PDˆ⊥Z) ≤ δ+2s(Z). (A.7)
In addition, we have ‖PDˆ⊥Zx‖22 = ‖Zx‖22 − ‖PDˆZx‖22 ≥ δ−2s(Z)‖x‖22 − δ+2s(PDˆZ)‖x‖22. By
the definition of δ−2s(PDˆ⊥Z), this also implies
δ−2s(PDˆ⊥Z) ≥ δ−2s(Z)− δ+2s(PDˆZ). (A.8)
Combining (A.7), (A.8) with assumption that 2δ−2s(Z) > δ
+
2s(Z) + 2δ
+
2s(PDˆZ), we know
2δ−2s(PDˆ⊥Z) > δ
−
2s(PDˆ⊥Z). By Lemma A.2, where we set r = 3 in assumption r‖ZT ‖∞ ≤ λ
and the model is rewritten as (A.6),
‖hmax(s)‖2 ≤
4/3λ
√
s
2δ−2s(PDˆ⊥Z)− δ+2s(PDˆ⊥Z)
(A.9)
and
‖h−max(s)‖1 ≤ 2‖hmax(s)‖1. (A.10)
Combining the RIP relations established by (A.7) and (A.8), we can rewrite (A.9) as
‖hmax(s)‖2 ≤
4/3λ
√
s
2δ−2s(Z)− δ+2s(Z)− 2δ+2s(PDˆZ)
. (A.11)
Third, we establish a bound for ‖PDˆZh‖2. This bound is needed to bound step 2 in Section
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2.3.5 of the original paper because
βˆλ =
DˆTPDˆ(Y − Zαˆλ)
‖Dˆ‖22
=
DˆTPDˆ(Zα
∗ + Dβ∗ + − Zαˆλ)
‖Dˆ‖22
= β∗ − Dˆ
TPDˆZh
‖Dˆ‖22
+
DˆTPDˆ
‖Dˆ‖22
.
Rearranging terms and taking norms on both sides give
‖βˆλ − β∗‖2 ≤
‖DˆTPDˆZh‖2
‖Dˆ‖22
+
‖DˆTPDˆ‖2
‖Dˆ‖22
≤ ‖PDˆZh‖2‖Dˆ‖2
+
|DˆT |
‖Dˆ‖22
. (A.12)
Hence, a bound on ‖PDˆZh‖2 is necessary to bound ‖βˆλ−β∗‖2. To start off, we apply Lemma
1.1 in Cai and Zhang (2013b) to represent h−max(s) as a weighted mean of s-sparse vectors.
This lemma allows us to convert the bound for hmax(s) in (A.11) to the bound for ‖PDˆZh‖2.
Specifically, the lemma states we can find λi ≥ 0 and s-sparse vi ∈ RL where i = 1, . . . , N
such that
∑N
i=1 λi = 1 and h−max(s) =
∑N
i=1 λivi. Hence, h =
∑N
i=1 λi(hmax(s) + vi).
Furthermore, we have
supp(vi) ⊆ supp(h−max(s)), ‖vi‖∞ ≤ max
(
‖h−max(s)‖∞,
‖h−max(s)‖1
s
)
and
‖vi‖1 = ‖h−max(s)‖1,
which yields
‖vi‖∞ ≤ max
(‖hmax(s)‖1
s
,
2‖hmax(s)‖1
s
)
=
2‖hmax(s)‖1
s
, ‖vi‖1 ≤ 2‖hmax(s)‖1
and ‖hmax(s) + vi‖22 = ‖hmax(s)‖22 + ‖vi‖22 ≤ ‖hmax(s)‖22 + ‖vi‖1‖vi‖∞ ≤ 5‖hmax(s)‖22. Com-
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bining all these together with (A.11), we have
‖PDˆZh‖2 ≤
N∑
i=1
λi‖PDˆZ(hmax(s) + vi)‖2 ≤
N∑
i=1
λi
√
5δ+2s(PDˆZ)‖hmax(s)‖2
≤
√
5δ+2s(PDˆZ)
4/3λ
√
s
2δ−2s(Z)− δ+2s(Z)− 2δ+2s(PDˆZ)
=
4
√
5/3λ
√
sδ+2s(PDˆZ)
2δ−2s(Z)− δ+2s(Z)− 2δ+2s(PDˆZ)
.
Finally, using the relation (A.12) gives us the desired bound for Theorem 2.2.
Of independent interest is that the proof of Theorem 2.2 can be generalized to a matrix
of D instead of a vector of D. That is, the proof can consider models where there are
more than one endogenous variables in the data-generating model. However, for clarity of
presentation, we don’t explore this route.
A.1.4. Proof of Corollary 2.2
Now, we establish Corollary 2.2 as a corollary to Theorem 2.2. Specifically, the task is to
convert the RIP constants δ+2s(Z), δ
−
2s(Z), δ
+
2s(PDˆZ) and the constraint of 2δ
−
2s(Z)−δ+2s(Z)−
2δ+2s(PDˆZ) > 0 into µ and a similar constraint on s. To do this, note that for any s-sparse
vector α
‖Zα‖22 =
∑
j∈supp(α)
‖Z.j‖22α2j +
∑
i<j,i,j∈supp(α)
2αiαj〈Z.i,Z.j〉
≤
∑
j∈supp(α)
α2j +
∑
i<j,i,j∈supp(α)
(α2i +α
2
j )µ
= (1 + (s− 1)µ)
∑
j∈supp(α)
α2j = (1 + (s− 1)µ)‖α‖22
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and
‖Zα‖22 =
∑
j∈supp(α)
‖Z.j‖22α2j +
∑
i<j,i,j∈supp(α)
2αiαj〈Z.i,Z.j〉
≥
∑
j∈supp(α)
α2j −
∑
i<j,i,j∈supp(α)
(α2i +α
2
j )µ
= (1− (s− 1)µ)‖α‖22.
The upper and lower bounds on ‖Zα‖22 imply
δ+s (Z) ≤ (1 + (s− 1)µ), and δ−s (Z) ≥ (1− (s− 1)µ);
For PDˆ⊥Z and all 2s-sparse vector x, we have
‖PDˆZx‖22 ≤
 ∑
j∈supp(x)
‖PDˆZ.jxj‖2
2 ≤ 2s ∑
j∈supp(x)
‖PDˆZ.jxj‖22
= 2s
∑
j∈supp(x)
‖PDˆZ.j‖22x2j = 2s
∑
j∈supp(x)
‖PDˆZ.j‖22
‖Z.j‖22
‖Z.jxj‖22
≤ 2sρ2δ+1 (Z)
∑
j∈supp(x)
x2j ≤ 2sρ2δ+2s(Z)‖x‖22.
Again, by the definition of δ+2s(PDˆZ), this implies that
δ+2s(PDˆZ) ≤ 2sρ2δ+2s(Z). (A.13)
Under the condition s < min
(
1
12µ ,
1
10ρ2
)
, the denominator of the bound in Theorem 2.2
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becomes
2δ−2s(Z)− δ+2s(Z)− 2δ+2s(PDˆZ) ≥ 2δ−2s(Z)− (1 + 4sρ2)δ+2s(Z)
≥ 2(1− (2s− 1)µ)− (1 + 4sρ2)(1 + (2s− 1)µ)
= 1− 6sµ+ 3µ− 4sρ2 − 8s2ρ2µ+ 4sρ2µ
≥ 1− 6sµ− 5sρ2 > 0.
For the numerator of the bound in Theorem 2, we have
4
√
5
3
λ
√
sδ+2s(PDˆZ) ≤
4
√
5
3
λ
√
2s2ρ2δ+2s(Z) ≤
4
√
10
3
λsρ
√
1 + (2s− 1)µ
≤ 4
√
10
3
λsρ
√
1 + 2sµ ≤ 4
√
10
3
λsρ
√
1 + 1/6 =
4
√
105
9
λsρ.
Combining them together leads to the desired bound. Note that one can improve the
constants in the constraint of s with a bit more care on the above inequalities.
A.1.5. Proof of Theorem 2.3
The original estimation method can be rewritten as follows
αˆλ, βˆλ =argmin
α,β
1
2
‖PZ(Y − Zα−Dβ)‖22 + λ||α||1
=argmin
α,β
1
2
||(PDˆ + PDˆ⊥)PZ(Y − Zα−Dβ)||22 + λ||α||1
=argmin
α,β
1
2
||PDˆPZ(Y − Zα−Dβ)||22 +
1
2
||PDˆ⊥PZ(Y − Zα−Dβ)||22 + λ||α||1
=argmin
α,β
1
2
||PDˆ(Y − Zα)− Dˆβ||22 +
1
2
||PDˆ⊥PZY −PDˆ⊥Zα||22 + λ||α||1.
The first term, 12 ||PDˆ(Y − Zα) − Dˆβ||22 is always zero for any given α ∈ RL because
PDˆ(Y−Zα) lies in the span of Dˆ and thus, we can pick β such that the first term is zero.
The second term, 12 ||PDˆ⊥PZ(Y − Zα)||22 + λ||α||1, is the traditional Lasso problem where
the outcome is PDˆ⊥PZY and the design matrix is PDˆ⊥Z. Hence, the minimizer for this
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Lasso problem is also the minimizer for the original method.
A.2. Proofs from Chapter 4
A.2.1. Proof of Theorem 4.1
Proof. By (A3), we have
E(Rij |Zij = 1,F ,Z)− E(Rij |Zij = 0,F ,Z)
=r
(d1ij)
1ij − r(d0ij)0ij
=
M∑
k=0
r
(k)
1ijχ(d1ij = k)−
M∑
k=0
r
(k)
0ijχ(d0ij = k)
=
M∑
k=0
r
(k)
1ij{χ(d1ij ≥ k)− χ(d1ij ≥ k + 1)} −
M∑
k=0
r
(k)
0ij{χ(d0ij ≥ k)− χ(d0ij ≥ k + 1)}
By (A2), r
(k)
1ij = r
(k)
0ij for all k. Then, we have
M∑
k=0
r
(k)
ij {χ(d1ij ≥ k)− χ(d1ij ≥ k + 1)− χ(d0ij ≥ k) + χ(d0ij ≥ k + 1)}
=
M∑
k=0
r
(k)
ij {χ(d1ij ≥ k)− χ(d0ij ≥ k)} −
M∑
k=0
r
(k)
ij {χ(d1ij ≥ k + 1)− χ(d0ij ≥ k + 1)}
=
M∑
k=1
r
(k)
ij {χ(d1ij ≥ k)− χ(d0ij ≥ k)} −
M∑
k=1
r
(k−1)
ij {χ(d1ij ≥ k)− χ(d0ij ≥ k)}
=
M∑
k=1
(r
(k)
ij − r(k−1)ij ){χ(d1ij ≥ k)− χ(d0ij ≥ k)}
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By monotonicity, d1ij ≥ d0ij for all i, j. Then,
M∑
k=1
(r
(k)
ij − r(k−1)ij ){χ(d1ij ≥ k)− χ(d0ij ≥ k)}
=
M∑
k=1
(r
(k)
ij − r(k−1)ij )χ{χ(d1ij ≥ k)− χ(d0ij ≥ k) = 1}
=
M∑
k=1
(r
(k)
ij − r(k−1)ij )χ(d1ij ≥ k > d0ij)
Similarly, by (A3), the expected differences between Zij = 1 and Zij = 0 for the exposure
Dij can be written as
E(Dij |Zij = 1,F ,Z)− E(Dij |Zij = 0,F ,Z)
=d1ij − d0ij
=
M∑
k=0
kχ(d1ij = k)−
M∑
k=0
kχ(d0ij = k)
=
M∑
k=0
k{χ(d1ij ≥ k)− χ(d1ij ≥ k + 1)} −
M∑
k=0
k{χ(d0ij ≥ k)− χ(d0ij ≥ k + 1)}
=
M∑
k=0
k{χ(d1ij ≥ k)− χ(d1ij ≥ k + 1)− χ(d0ij ≥ k) + χ(d0ij ≥ k + 1)}
=
M∑
k=0
k{χ(d1ij ≥ k)− χ(d0ij ≥ k)} −
M∑
k=0
k{χ(d1ij ≥ k + 1)− χ(d0ij ≥ k + 1)}
=
M∑
k=1
k{χ(d1ij ≥ k)− χ(d0ij ≥ k)} −
M∑
k=1
(k − 1){χ(d1ij ≥ k)− χ(d0ij ≥ k)}
=
M∑
k=1
{χ(d1ij ≥ k)− χ(d0ij ≥ k)}
By monotonicity, we have
M∑
k=1
{χ(d1ij ≥ k)− χ(d0ij ≥ k)} =
M∑
k=1
χ(d1ij ≥ k > d0ij)
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Thus, we end up with
∑I
i=1
∑ni
j=1E(Rij |Zij = 1,F ,Z)− E(Rij |Zij = 0,F ,Z)∑I
i=1
∑ni
j=1E(Dij |Zij = 1,F ,Z)− E(Dij |Zij = 0,F ,Z)
=
∑I
i=1
∑ni
j=1 r
(d1ij)
1ij − r(d0ij)0ij∑I
i=1
∑ni
j=1 d1ij − d0ij
=
∑I
i=1
∑ni
j=1
∑M
k=1(r
(k)
ij − r(k−1)ij )χ(d1ij ≥ k > d0ij)∑I
i=1
∑ni
j=1
∑M
k=1 χ(d1ij ≥ k > d0ij)
A.2.2. Proof of Theorem 4.2
We require the following two Lemmas. Lemma A.3 characterizes the moments of the test
statistics in (4.5). Lemma A.4 derives the bias of S2(λ0) in estimating the variance of T (λ0).
Lemma A.3. The expected value and the variance of the test statistic in equation (4.5) are
E{T (λ0)|F ,Z} = 1
I
(λ− λ0)
I∑
i=1
ni∑
j=1
(d1ij − d0ij)
V ar{T (λ0)|F ,Z} = 1
I2
I∑
i=1
1
ni
ni∑
i=1
(aij,λ0 − a¯i,λ0)2
where
aij,λ0 =
ni
mi
y1ij,λ0 +
ni
ni −mi y0ij,λ0 , a¯i,λ0 =
1
ni
ni∑
i=1
aij,λ0
Proof. Let y0ij,λ0 = r
(d0ij)
0ij − λ0d0ij and y1ij,λ0 = r(d1ij)1ij − λ0d1ij . Then, Vi(λ0) becomes
Vi(λ0) =
ni
mi
ni∑
j=1
Zij(Rij − λ0Dij)− ni
ni −mi
ni∑
j=1
(1− Zij)(Rij − λ0Dij)
=
ni
mi
ni∑
j=1
Zijy1ij,λ0 −
ni
ni −mi
ni∑
j=1
(1− Zij)y0ij,λ0
By assumption (A3) of IV in the main manuscript, Zij are independent within each strata.
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Then, for any i = 1, . . . , I and for j, k = 1, ..., ni where j 6= k
E(Zij |F ,Z) = mi
ni
, E(ZijZik|F ,Z) = mi(mi − 1)
ni(ni − 1) =
mi − 1
ni
where the second equality is true because in full matching, mi = 1 and ni = mi − 1 or
mi = ni − 1 and ni = 1. Then, the expectation of Vi(λ0) and the test statistic T (λ0) are
E{Vi(λ0)|F ,Z} =
ni∑
j=1
(r
(d1ij)
1ij − r(d0ij)0ij )− λ0(d1ij − d0ij)
E{T (λ0)|F ,Z} = 1
D
I∑
i=1
E{Vi(λ0)|F ,Z} = 1
D
(λ− λ0)
I∑
i=1
ni∑
j=1
(d1ij − d0ij)
For variance of Vi(λ0), Proposition 2 in Rosenbaum (2002, Sec. 2.4.4) gives us
V ar{Vi(λ0)|F ,Z}
=V ar

ni∑
j=1
Zij
(
ni
mi
y1ij,λ0 +
ni
ni −mi y0ij,λ0
)
|F ,Z

=
ni∑
j=1
(
mi
ni
− m
2
i
n2i
)
a2ij,λ0 +
(
mi − 1
ni
− m
2
i
n2i
)∑
j 6=k
aij,λ0aik,λ0
=
(
mi
ni
− m
2
i
n2i
− mi − 1
ni
+
m2i
n2i
) ni∑
j=1
a2ij,λ0 +
(
mi − 1
ni
− m
2
i
n2i
)∑
j,k
aij,λ0aik,λ0
=
1
ni
ni∑
j=1
a2ij,λ0 +
ni(mi − 1)−m2i
n2i
∑
j,k
aij,λ0aik,λ0
=
1
ni
ni∑
j=1
a2ij,λ0 −
1
n2i
∑
j,k
aij,λ0aik,λ0
=
1
ni
ni∑
i=1
(aij,λ0 − a¯i,λ)2
Finally, the variance of T (λ0) is given by
V ar{T (λ0)|F ,Z} = 1
D2
I∑
i=1
V ar{Vi(λ0)|F ,Z} = 1
D2
I∑
i=1
1
ni
ni∑
j=1
(aij,λ0 − a¯i,λ)2
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Lemma A.4. Let µi,λ0 = E{Vi(λ0)|F ,Z} and µλ0 = E{T (λ0)|F ,Z}. The bias of (4.6) in
estimating the variance of the test statistic in (4.5) is
E{S2(λ0)|F ,Z} − V ar{T (λ0)|F ,Z} = 1
I(I − 1)
I∑
i=1
(µi,λ0 − µλ0)2 (A.14)
Proof. Let v2i,λ0 = V ar{Vi(λ0)|F ,Z}. Under the generalized effect ratio, the bias of the
estimator (4.6) is
E{S2(λ0)|F ,Z}
=
1
I(I − 1)
I∑
i=1
E[{Vi(λ0)− T (λ0)}2|F ,Z]
=
1
I(I − 1)
I∑
i=1
E{V 2i (λ0)|F ,Z}+ E{T 2(λ0)|F ,Z} − 2E{Vi(λ0)T (λ0)|F ,Z}
=
1
I(I − 1)
I∑
i=1
(µ2i,λ0 + vi,λ0) +
µ2λ0 + 1I2
I∑
j=1
vj,λ0

− 2
I
µ2i,λ0 + vi,λ0 +∑
j 6=i
µi,λ0µj,λ0

=
1
I(I − 1)
I∑
i=1
vi,λ0 − 2I vi,λ0 + 1I2
I∑
j=1
vj,λ0

+
1
I(I − 1)
I∑
i=1
µ2i,λ0 + µ2λ0 − 2I
I∑
j=1
µi,λ0µj,λ0

=
(
I2 − 2I + I
I(I − 1)
)
1
D2
n∑
i=1
vi,λ0 +
1
I(I − 1)
I∑
i=1
(µi,λ0 − µλ0)2
=
1
I2
I∑
i=1
vi,λ0 +
1
I(I − 1)
I∑
i=1
(µi,λ0 − µλ0)2
Now, we can prove the Theorem as follows. We use the same notation adopted in the
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proof of Lemma A.4, mainly µi,λ¯, µλ¯, and v
2
i,λ¯
. In addition, let qi,λ¯ = E{V 2i (λ¯)|F ,Z}, and
vλ¯ = V ar{T (λ¯)|F ,Z}. First,
∑I
i=1 V
2
i (λ¯)/I is an unbiased estimator for
∑I
i=1 qi,λ¯/I. In
addition,
V ar
{
1
I
I∑
i=1
V 2i (λ¯)|F ,Z
}
≤ 1
I2
I∑
i=1
E{V 4i (λ¯)|F ,Z}
By the fourth moment condition in (4.7), we have
∑I
i=1 V
2
i (λ¯)/I −
∑I
i=1 qi,λ¯/I → 0 in
probability. Similarly, the same fourth moment condition in (4.7) and the same reasoning
gives T (λ¯)−µλ¯ → 0 in probability because of the growth of the variance of T (λ¯) is controlled
by the moment condition. Since µλ¯ = 0 for all I under the null hypothesis, we have, by the
continuous mapping theorem, T 2(λ¯) → 0 in probability. Combining all these convergence
results, we get that for  > 0 and δ > 0, there exists I∗ such that
for I ≥ I∗:P
{
1
I
I∑
i=1
V 2i (λ¯)−
1
I
I∑
i=1
qi,λ¯ < −

2
}
<
δ
2
, P
{
T 2(λ¯) < − 
2
}
<
δ
2
and
P
{
IS2(λ¯)− Ivλ¯ < −
}
=P
[
I
I − 1
{
1
I
I∑
i=1
V 2i (λ¯)− T 2(λ¯)
}
− Ivλ¯ < −
]
=P
[
I
I − 1
{
1
I
I∑
i=1
V 2i (λ¯)−
1
I
I∑
i=1
qi,λ¯ +
1
I
I∑
i=1
qi,λ¯ − T 2(λ¯)
}
− Ivλ¯ < −
]
=P
[
I
I − 1
{
1
I
I∑
i=1
V 2i (λ¯)−
1
I
I∑
i=1
qi,λ¯ − T 2(λ¯)
}
− Ivλ¯ +
1
I − 1
I∑
i=1
qi,λ¯ < −
]
≤P
[
I
I − 1
{
1
I
I∑
i=1
V 2i (λ¯)−
1
I
I∑
i=1
qi,λ¯ − T 2(λ¯)
}
< −
]
≤δ
2
+
δ
2
= δ
Stated in words, IS2(λ¯) will over-estimate Ivλ¯ with high probability.
Second, under the null hypothesis H0 : λ = λ¯ and from Lemma A.3,
∑I
i=1 µi,λ¯/I = 0.
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Hence, we can rewrite the test statistic as
T (λ¯) =
1
I
I∑
i=1
Vi(λ¯) =
1
I
I∑
i=1
[Vi(λ¯)− µi,λ¯]
where the test statistic becomes a sum of independent random variables Vi(λ¯) − µi,λ¯ with
mean zero and variance vi,λ¯.
Finally, combining the two facts, under the null H0 : λ = λ¯, we have
T (λ¯)
S(λ¯)
=
 1I ∑Ii=1{Vi(λ¯)− µi,λ¯}√
1
I2
∑I
i=1 vi,λ¯

√
1
I2
∑I
i=1 vi,λ¯√
S2(λ¯)

By conditions specified in Breiman (1992, pg 186) for the central limit theorem with non-
identical distributions, the first parenthesis term converges to the standard Normal distri-
bution. From our result about IS2(λ¯) overestimating Ivλ¯, the second parenthesis term will
be smaller than 1 with high probability. Hence, taking the sup of the entire expression, we
obtain
lim sup
I→∞
P
{
T (λ¯)
S(λ¯)
≤ −t|F ,Z
}
≤ Φ(−t), lim sup
I→∞
P
{
T (λ¯)
S(λ¯)
≥ t|F ,Z
}
≤ Φ(−t)
where Φ() is the standard normal distribution.
A.2.3. Proof of Corollary 4.1
First, we see that T (λ)/S(λ) = q implies T 2(λ) = q2S2(λ). This expression can be rewritten
as
T 2(λ) =
q2
I(I − 1)
I∑
i=1
(Vi(λ)− T (λ))2 = q
2
I(I − 1)
{
I∑
i=1
V 2i (λ)− IT 2(λ)
}
(A.15)
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Rearranging the terms in (A.15), we get
T 2(λ)
(
1 +
q2
I − 1
)
=
q2
I(I − 1)
I∑
i=1
V 2i (λ)
Second, we can re-express Vi(λ) as follows.
Vi(λ) =
ni∑
j=1
(
ni
mi
+
ni
ni −mi
)
ZijRij −
ni∑
j=1
ni
ni −miRij
−
ni∑
j=1
(
ni
mi
+
ni
ni −mi
)
λZijDij +
ni∑
j=1
ni
ni −miλDij
=
ni∑
j=1
n2i
mi(ni −mi)ZijRij −
 ni∑
j=1
ni
ni −miRij
 1
mi
ni∑
j=1
Zij

−
ni∑
j=1
n2i
mi(ni −mi)λZijDij +
 ni∑
j=1
ni
ni −miλDij
 1
mi
ni∑
j=1
Zij

=
n2i
mi(ni −mi)
 ni∑
j=1
ZijRij − 1
ni
ni∑
j=1
Rij
ni∑
j=1
Zij

− λ n
2
i
mi(ni −mi)
 ni∑
j=1
ZijDij − 1
ni
ni∑
j=1
Dij
ni∑
j=1
Zij

=
n2i
mi(ni −mi)
ni∑
j=1
(Zij − Z¯i.)(Rij − R¯i.)− λ n
2
i
mi(ni −mi)
ni∑
j=1
(Zij − Z¯i.)(Dij − D¯i.)
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Immediately, we also have Vi(λ) = Gi − λHi. Then, we can rewrite
∑I
i=1 V
2
i (λ) and T
2(λ)
as follows
I∑
i=1
V 2i (λ) =
I∑
i=1
(Gi − λHi)2
=
I∑
i=1
G2i − 2λ
I∑
i=1
GiHi + λ
2
I∑
i=1
H2i
T 2(λ) =
1
I2
{
I∑
i=1
Vi(λ)
}2
=
1
I2
{
I∑
i=1
(Gi − λHi)
}2
=
1
I2

(
I∑
i=1
Gi
)2
− 2λ
I∑
i=1
Gi
I∑
i=1
Hi + λ
2
(
I∑
i=1
Hi
)2
Overall, we can rewrite the equation (A.15) as
1
I2

(
I∑
i=1
Gi
)2
− 2λ
I∑
i=1
Gi
I∑
i=1
Hi + λ
2
(
I∑
i=1
Hi
)2
(
1 +
q2
I − 1
)
=
q2
I(I − 1)
(
I∑
i=1
G2i − 2λ
I∑
i=1
GiHi + λ
2
I∑
i=1
H2i
)
Finally, we pull out the coefficients associated with λ2 and λ, denoted as A2 and A1,
respectively. The remaining term are constants and we denote them as A0. All A2, A1, and
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A0 are explicitly written below.
A2 =
1
I2
(
I∑
i=1
Hi
)2
+
q2
I(I − 1)
1I
(
I∑
i=1
Hi
)2
−
I∑
i=1
H2i

= H¯2. −
q2
I(I − 1)
I∑
i=1
(Hi − H¯.)2
A1 = −2
[
1
I2
I∑
i=1
Gi
I∑
i=1
Hi +
q2
I(I − 1)
{
1
I
I∑
i=1
Gi
I∑
i=1
Hi −
I∑
i=1
GiHi
}]
= −2
[
G¯.H¯. − q
2
I(I − 1)
{
I∑
i=1
(Gi − G¯.)(Hi − H¯.)
}]
A0 =
1
I2
(
I∑
i=1
Gi
)2
+
q2
I(I − 1)
1I
(
I∑
i=1
Gi
)2
−
I∑
i=1
G2i

= G¯2. −
q2
I(I − 1)
I∑
i=1
(Gi − G¯.)2
If q = 0 in Corollary 4.1, there is only one solution to the quadratic equation since
A2λ
2 +A1λ+A0 = H¯
2
. λ
2 − 2H¯.G¯.λ+ G¯2. = (H¯.λ− G¯.)2 = 0
This gives us an explicit formula for the estimator of the effect ratio, denoted as λˆ.
λˆ =
G¯.
H¯.
=
∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Rij − R¯i.)(Zij − Z¯i.)∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Dij − D¯i.)(Zij − Z¯i.)
(A.16)
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A.2.4. Proof of Theorem 4.3
First, for all i = 1, . . . , I and j = 1, . . . , ni, we have
Zij − Z¯i. =

1− mini if Zij = 1
−mini if Zij = 0
Furthermore,
ni∑
j=1
(Zij − Z¯i.) = 0,
ni∑
j=1
(Zij − Z¯i.)2 = mi(ni −mi)
ni
Second, for fixed Zij , we have the following expected values for Ji
E(Ji) =0
E(J2i ) =V ar

ni∑
j=1
(Zij − Z¯i.)(ij − ¯i.)

=
ni∑
j=1
(Zij − Z¯i.)2V ar(ij − ¯i.) +
∑
j,k
(Zij − Z¯i.)(Zik − Z¯k.)Cov(ij − ¯i., ik − ¯i.)
=(1− 1
ni
)σ2i,R
ni∑
j=1
(Zij − Z¯i.)2 − 1
ni
σ2i,R
∑
j,k
(Zij − Z¯i.)(Zik − Z¯k.)
=σ2i,R
ni∑
j=1
(Zij − Z¯i.)2 − 1
ni
σ2i,R

ni∑
j=1
(Zij − Z¯i.)

2
=σ2i,R
mi(ni −mi)
ni
For the third moment, for each i, let k1, . . . , kni be non-negative integers and define the
multinomial coefficient as follows.
(
3
k1, . . . , kni
)
=
3!
k1! · · · kni !
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Then, we have
E(|J3i |) =E|

ni∑
j=1
(Zij − Z¯i.)(ij − ¯i.)

3
|
=E|
∑
k1+···+kni=3
(
3
k1, . . . , kni
) ni∏
j=1
{
(Zij − Z¯i.)(ij − ¯i.)
}kj |
≤
∑
k1+···+kni=3
(
3
k1, . . . , kni
) ni∏
j=1
|Zij − Z¯i.|kjE|ij − ¯i.|kj <∞
because third moments exist and are bounded for all ij and ni is bounded. Third, based
on these moment calculations, it immediately follows that
E
[
I∑
i=1
{
n2i
(mi)(ni −mi)Ji
}2]
=
I∑
i=1
{
n4i
(mi)2(ni −mi)2
}{
mi(ni −mi)
ni
σ2i,R
}
= s2I
Then, by Theorem 9.2 in Chapter 9, Section 3 of Breiman (1992) (pg 187), the sum of Ji
weighted by n2i /mi(ni −mi) is a standard Normal distribution
∑I
i=1
n2i
mi(ni−mi)Ji
sI
→ N(0, 1)
Fourth, for Hi, we have the following moments
E(Hi) =γmi(1− mi
ni
)
V ar(Hi) =V ar
 ni∑
j=1
(Zij − Z¯i.)(Dij − D¯i.)

=(1− 1
ni
)σ2i,D
ni∑
j=1
(Zij − Z¯i.)2 − 1
ni
σ2i,D
∑
j,k
(Zij − Z¯i.)(Zik − Z¯k.)
=σ2i,D
ni∑
j=1
(Zij − Z¯i.)2 − 1
ni
σ2i,D
 ni∑
j=1
(Zij − Z¯i.)
2
=σ2i,D
mi(ni −mi)
ni
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Fifth, by Theorem C in page 27 of Serfling (1980),
1
I
I∑
i=1
n2i
mi(ni −mi)Hi − γ
1
I
I∑
i=1
E
{
n2i
mi(ni −mi)Hi
}
=
1
I
I∑
i=1
n2i
mi(ni −mi)Hi − γ
1
I
I∑
i=1
ni → 0
Finally, combining all these facts together, we can rewrite the effect ratio estimator as
follows.
βˆ =
∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Rij − R¯i.)∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(Dij − D¯i.)
= β +
∑I
i=1
n2i
mi(ni−mi)
∑ni
j=1(Zij − Z¯i.)(ij − ¯i.)∑I
i=1
n2i
mi(ni−mi)Hi
= β +
∑I
i=1
n2i
mi(ni−mi)Ji∑I
i=1
n2i
mi(ni−mi)Hi
which leads to
√
I(βˆ − β) =

∑I
i=1
n2i
mi(ni−mi)Ji
sI


1√
I
sI
1
I
∑I
i=1
n2i
mi(ni−mi)Hi

Finally, using Slutsky’s Theorem,
√
I(βˆ−β) converges to a Normal distribution with mean
0 and stated asymptotic variance.
182
BIBLIOGRAPHY
A. Abadie. Semiparametric instrumental variable estimation of treatment response models.
Journal of Econometrics, 113(2):231 – 263, 2003.
M. Aidoo, D. J. Terlouw, M. S. Kolczak, P. D. McElroy, F. O. ter Kuile, S. Kariuki, B. L.
Nahlen, A. A. Lal, and V. Udhayakumar. Protective effects of the sickle cell gene against
malaria morbidity and mortality. The Lancet, 359(9314):1311–1312, 2002.
A. C. Allison. Polymorphism and natural selection in human populations. Cold Spring
Harbor Symposia on Quantitative Biology, 29:137–149, 1964.
E. Anderson. True fact: The lack of pirates is causing global warm-
ing. http://www.forbes.com/sites/erikaandersen/2012/03/23/
true-fact-the-lack-of-pirates-is-causing-global-warming/, 2012. Accessed:
2015-03-31.
T. W. Anderson and H. Rubin. Estimation of the parameters of a single equation in a
complete system of stochastic equations. Annals of Mathematical Statistics, 20:46–63,
1949.
D. W. K. Andrews. Consistent moment selection procedures for generalized method of
moments estimation. Econometrica, 67(3):543–563, 1999.
D. W. K. Andrews, M. J. Moreira, and J. H. Stock. Optimal two-sided invariant similar
tests for instrumental variables regression. Econometrica, 74(3):715–752, 2006.
J. D. Angrist and G. W. Imbens. Two-stage least squares estimation of average causal
effects in models with variable treatment intensity. Journal of the American Statistical
Association, 90(430):431–442, 1995.
J. D. Angrist and A. B. Krueger. Does compulsory school attendance affect schooling and
earnings? The Quarterly Journal of Economics, 106(4):979–1014, 1991.
J. D. Angrist and A. B. Krueger. Instrumental variables and the search for identification:
From supply and demand to natural experiments. The Journal of Economic Perspectives,
15(4):69–85, 2001.
J. D. Angrist, G. W. Imbens, and D. B. Rubin. Identification of causal effects using in-
strumental variables. Journal of the American Statistical Association, 91(434):444–455,
1996.
E. Arinaitwe, A. Gasasira, W. Verret, J. Homsy, H. Wanzira, A. Kakuru, and T. G. San-
dison. The association between malnutrition and the incidence of malaria among young
hiv-infected and-uninfected ugandan children: a prospective study. Malaria Journal, 11:
90, 2012.
183
M. T. Ashcroft, P. Desai, and S. A. Richardson. Growth, behaviour, and educational
achievement of jamaican children with sickle-cell trait. British Medical Journal, 1(6022):
1371–1373, 1976.
M. T. Ashcroft, P. Desai, G. A. Grell, B. E. Serjeant, and G. R. Serjeant. Heights and
weights of west indian children with the sickle cell trait. Archives of Disease in Childhood,
53(7):596–598, 1978.
M. Baiocchi, D. S. Small, S. Lorch, and P. R. Rosenbaum. Building a stronger instrument in
an observational study of perinatal care for premature infants. Journal of the American
Statistical Association, 105(492):1285–1296, 2010.
M. Baiocchi, J. Cheng, and D. S. Small. Instrumental variable methods for causal inference.
Statistics in Medicine, 33(13):2297–2340, 2014.
R. Baraniuk, M. Davenport, R. DeVore, and M. Wakin. A simple proof of the restricted
isometry property for random matrices. Constructive Approximation, 28(3):253–263,
2008.
S. Beckers, A. V. Peeters, F. De Freitas, I. L. Mertens, S. L. Verhulst, D. Haentjens, K. N.
Desager, L. F. Van Gaal, and W. Van Hul. Association study and mutation analysis
of adiponectin shows association of variants in apm1 with complex obesity in women.
Annals of Human Genetics, 73(5):492–501, 2009.
A. Belloni, D. Chen, V. Chernozhukov, and C. Hansen. Sparse models and methods for
optimal instruments with an application to eminent domain. Econometrica, 80(6):2369–
2429, 2012.
A. Bjo¨rklund and R. Moffitt. The estimation of wage gains and welfare gains in self-selection
models. The Review of Economics and Statistics, pages 42–49, 1987.
K. A. Bollen. Instrumental variables in sociology and the social sciences. Annual Review of
Sociology, 38:37–72, 2012.
N. Bouatia-Naji, D. Meyre, S. Lobbens, K. Se´ron, F. Fumeron, B. Balkau, B. Heude,
B. Jouret, P. E. Scherer, C. Dina, J. Weill, and P. Froguel. Acdc/adiponectin polymor-
phisms are associated with severe childhood and adult obesity. Diabetes, 55(2):545–550,
2006.
H. E. Bouis and L. J. Haddad. Agricultural Commercialization, Nutrition, and the Rural
Poor. Lynne Rienner Publishers, 1990.
H. E. Bouis and L. J. Haddad. Are estimates of calorie-income elasticities too high?: A
recalibration of the plausible range. Journal of Development Economics, 39(2):333–364,
1992.
J. Bound, D. A. Jaeger, and R. M. Baker. Problems with instrumental variables estimation
184
when the correlation between instruments and the endogenous variable is weak. Journal
of the American Statistical Association, 90:443–450, 1995.
A. M. Bradley-Moore, B. M. Greenwood, A. K. Bradley, B. R. Kirkwood, and H. M. Gilles.
Malaria chemoprophylaxis with chloroquine in young nigerian children. iii. its effect on
nutrition. Annals of Tropical Medicine and Parasitology, 79(6):575–584, 1985.
L. Breiman. Probability. SIAM: Society for Industrial and Applied Mathematics, 1992.
P. Brennan. Commentary: Mendelian randomization and gene–environment interaction.
International Journal of Epidemiology, 33(1):17–21, 2004.
M. A. Brookhart and S. Schneeweiss. Preference-based instrumental variable methods for
the estimation of treatment effects: assessing validity and interpreting results. The In-
ternational Journal of Biostatistics, 3(1):14, 2007.
P. Bu¨hlmann and S. van der Geer. Statistics for High-Dimensional Data: Methods, Theory
and Applications. Springer, 2011.
T. T. Cai and A. Zhang. Compressed sensing and affine rank minimization under restricted
isometry. IEEE Transactions on Signal Processing, 61(13):3279–3290, 2013a.
T. T. Cai and A. Zhang. Sharp rip bound for sparse signal and low-rank matrix recovery.
Applied and Computational Harmonic Analysis, 35(1):74–93, 2013b.
T. T. Cai, J. Fan, and T. Jiang. Distributions of angles in random packing on spheres. The
Journal of Machine Learning Research, 14(1):1837–1864, 2013.
E. J. Candes and T. Tao. Decoding by linear programming. IEEE Transactions on Infor-
mation Theory, 51(12):4203–4215, 2005.
D. Card. Using geographic variations in college proximity to estimate the return to school-
ing. In L. N. Christofides, E. K. Grant, and R. Swidinsky, editors, Aspects of Labor
Market Behaviour: Essays in Honour of John Vanderkamp. University of Toronto Press,
1995.
J. Cawley and C. Meyerhoefer. The medical care costs of obesity: an instrumental variables
approach. Journal of Health Economics, 31(1):219–230, 2012.
J. Cheng. Using the instrumental propensity score in observational studies for causal effects.
Joint Statistical Meeting Presentation, 2011.
J. Cheng, J. Qin, and B. Zhang. Semiparametric estimation and inference for distribu-
tional and general treatment effects. Journal of the Royal Statistical Society: Series B
(Statistical Methodology), 71(4):881–904, 2009.
R. Cholera, N. J. Brittain, M. R. Gillrie, T. M. Lopera-Mesa, S. A. S. Diakit, T. Arie,
M. A. Krause, A. Guindo, A. Tubman, H. Fujioka, D. A. Diallo, O. K. Doumbo, M. Ho,
185
T. E. Wellems, and R. M. Fairhurst. Impaired cytoadherence of plasmodium falciparum-
infected erythrocytes containing sickle hemoglobin. Proceedings of the National Academy
of Sciences, 105(3):991–996, 2008.
W. G. Cochran. The planning of observational studies of human populations. Journal of
the Royal Statistical Society: Series A (General), pages 234–266, 1965.
B. T. Crookston, S. C. Alder, I. Boakye, R. M. Merrill, J. H. Amuasi, C. A. Porucznik, J. B.
Stanford, T. T. Dickerson, K. A. Dearden, D. C. Hale, J. Sylverken, B. S. Snow, A. Osei-
Akoto, and D. Ansong. Exploring the relationship between chronic undernutrition and
asymptomatic malaria in ghanaian children. Malaria Journal, 9(39), 2010.
G. Davey Smith and S. Ebrahim. mendelian randomization: can genetic epidemiology con-
tribute to understanding environmental determinants of disease? International Journal
of Epidemiology, 32(1):1–22, 2003.
G. Davey Smith and S. Ebrahim. Mendelian randomization: prospects, potentials, and
limitations. International Journal of Epidemiology, 33(1):30–42, 2004.
R. Davidson and J. G. MacKinnon. Estimation and Inference in Econometrics. Oxford
University Press, New York, 1993.
J. L. Deen, G. E. L. Walraven, and L. von Seidlein. Increased risk for malaria in chronically
malnourished children under 5 years of age in rural gambia. Journal of Tropical Pediatrics,
48(2):78–83, 2002.
A. Deribew, F. Alemseged, F. Tessema, L. Sena, Z. Birhanu, A. Zeynudin, M. Sudhakar,
N. Abdo, K. Deribe, and S. Biadgilign. Malaria and under-nutrition: A community based
study among under-five children at risk of malaria, south-west ethiopia. PLoS One, 5(5):
e10775, 2010.
V. Didelez and N. Sheehan. Mendelian randomization as an instrumental variable approach
to causal inference. Statistical Methods in Medical Research, 16(4):309–330, 2007.
C. Dina, D. Meyre, S. Gallina, E. Durand, A. Krner, P. Jacobson, L. M. S. Carlsson,
W. Kiess, V. Vatin, C. Lecoeur, J. Delplanque, E. Vaillant, F. Pattou, J. Ruiz, J. Weill,
C. Levy-Marchal, F. Horber, N. Potoczna, S. Hercberg, C. Le Stunff, P. Bougne´res,
P. Kovacs, M. Marre, B. Balkau, S. Cauchi, J.-C. Che´vre, and P. Froguel. Variation in
FTO contributes to childhood obesity and severe adult obesity. Nature Genetics, 39(6):
724–726, 2007.
D. L. Donoho. For most large underdetermined systems of linear equations the minimal
1-norm solution is also the sparsest solution. Communications on Pure and Applied
Mathematics, 59(6):797–829, 2006.
J.-M. Dufour. Some impossibility theorems in econometrics with applications to structural
and dynamic models. Econometrica, pages 1365–1387, 1997.
186
J.-M. Dufour. Identification, weak instruments, and statistical inference in econometrics.
The Canadian Journal of Economics / Revue canadienne d’Economique, 36(4):767–808,
2003.
B. Efron, T. Hastie, I. Johnstone, and R. Tibshirani. Least angle regression. The Annals
of Statistics, 32(2):407–499, 2004.
S. Ehrhardt, G. D. Burchard, C. Mantel, J. P. Cramer, S. Kaiser, M. Kubo, R. N. Otch-
wemah, U. Bienzle, and F. P. Mockenhaupt. Malaria, anemia, and malnutrition in african
childrendefining intervention priorities. Journal of Infectious Diseases, 194(1):108–114,
2006.
F. Fillol, J. B. Sarr, D. Boulanger, B. Cisse, C. Sokhna, G. Riveau, K. B. Simondon, and
F. Remoue´. Impact of child malnutrition on the specific anti-plasmodium falciparum
antibody response. Malaria Journal, 8(1):116, 2009.
M. J. Friedman. Erythrocytic mechanism of sickle cell resistance to malaria. Proceedings
of the National Academy of Sciences, 75(4):1994–1997, 1978.
M. Fro¨lich. Nonparametric iv estimation of local average treatment effects with covariates.
Journal of Econometrics, 139(1):35–75, 2007.
M. Fro¨lich and B. Melly. Estimation of quantile treatment effects with stata. Stata Journal,
10(3):423–457, 2010.
J. L. Gastwirth, A. M. Krieger, and P. R. Rosenbaum. Asymptotic separability in sensitivity
analysis. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 62
(3):545–555, 2000.
E. Gautier and A. B. Tsybakov. High-dimensional instrumental variables regression and
confidence sets. arXiv preprint arXiv:1105.2454, 2011.
L. A. Gennetian, K. Magnuson, and P. A. Morris. From statistical associations to causation:
What developmentalists can learn from instrumental variables techniques coupled with
experimental data. Developmental Psychology, 44(2):381, 2008.
B. Genton, F. Al-Yaman, M. Ginny, J. Taraika, and M. P. Alpers. Relation of anthropom-
etry to malaria morbidity and immunity in papua new guinean children. The American
Journal of Clinical Nutrition, 68(3):734–41, 1998.
A. Ghansah, K. A. Rockett, T. G. Clark, M. D. Wilson, K. A. Koram, A. R. Oduro,
L. Amenga-Etego, T. Anyorigiya, A. Hodgson, P. Milligan, W. O. Rogers, and D. P.
Kwiatkowski. Haplotype analyses of haemoglobin c and haemoglobin s and the dynamics
of the evolutionary response to malaria in kassena-nankana district of ghana. PLoS ONE,
7(4):e34565, 04 2012.
M. M. Glymour, E. J. Tchetgen Tchetgen, and J. M. Robins. Credible mendelian ran-
187
domization studies: approaches for evaluating the instrumental variable assumptions.
American Journal of Epidemiology, 175(4):332–339, 2012.
B. B. Hansen. Full matching in an observational study of coaching for the sat. Journal of
the American Statistical Association, 99(467):609–618, 2004.
B. B. Hansen and S. O. Klopfer. Optimal full matching and related designs via network
flows. Journal of Computational and Graphical Statistics, 15(3):609–627, 2006.
L. P. Hansen. Large sample properties of generalized method of moments estimators. Econo-
metrica, pages 1029–1054, 1982.
T. Hastie, R. Tibshirani, and J. Friedman. The Elements of Statistical Learning: Data
Mining, Inference, and Prediction, volume 2. Springer, 2009.
R. M. Hauser. Survey response in the long run: The wisconsin longitudinal study. Field
Methods, 17(1):3–29, 2005.
A. Haviland, D. S. Nagin, and P. R. Rosenbaum. Combining propensity score matching
and group-based trajectory analysis in an observational study. Psychological Methods, 12
(3):247, 2007.
J. J. Heckman and R. Robb Jr. Alternative methods for evaluating the impact of interven-
tions: An overview. Journal of Econometrics, 30(1):239–267, 1985.
M. A. Herna´n and J. M. Robins. Instruments for causal inference: An epidemiologist’s
dream? Epidemiology, 17(4):360–372, 2006.
A. V. S. Hill, C. E. M. Allsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe,
S. Bennett, D. Brewster, A. J. McMichael, and B. M. Greenwood. Common west african
hla antigens are associated with protection from severe malaria. Nature, 352(6336):595–
600, 1991.
J. L. Hodges and E. L. Lehmann. Estimation of location based on ranks. Annals of
Mathematical Statistics, 34(2):598–611, 1963.
P. W. Holland. Causal inference, path analysis, and recursive structural equations models.
Sociological Methodology, 18(1):449–484, 1988.
J.-P. Hwang, S.-J. Tsai, C.-J. Hong, C.-H. Yang, J.-F. Lirng, and Y.-M. Yang. The val66met
polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric
depression. Neurobiology of Aging, 27(12):1834–1837, 2006.
G. W. Imbens and D. B. Rubin. Bayesian inference for causal effects in randomized exper-
iments with noncompliance. The Annals of Statistics, 25(1):305–327, 1997.
Institute of Medicine of the National Academies: Immunization Safety Review Committee.
Immunization Safety Review: Vaccines and Autism. National Academies Press, 2004.
188
J. B. Kadane and T. W. Anderson. A comment on the test of overidentifying restrictions.
Econometrica, 45(4):1027–1031, 1977.
H. Kang, B. Kreuels, O. Adjei, R. Krumkamp, J. May, and D. S. Small. The causal effect of
malaria on stunting: a mendelian randomization and matching approach. International
Journal of Epidemiology, 42(5):1390–1398, 2013.
H. Kang, A. Zhang, T. T. Cai, and D. S. Small. Instrumental variables estimation with
some invalid instruments and its application to mendelian randomization. Journal of the
American Statistical Association, 2015.
M. B. Katan. Apoupoprotein e isoforms, serum cholesterol, and cancer. The Lancet, 327
(8479):507–508, 1986.
L. J. Keele and J. Morgan. Stronger instruments by design. Working Paper, 2013.
F. Kleibergen. Pivotal statistics for testing structural parameters in instrumental variables
regression. Econometrica, 70(5):1781–1803, 2002.
F. Kleibergen. Generalizing weak instrument robust iv statistics towards multiple parame-
ters, unrestricted covariance matrices and identification statistics. Journal of Economet-
rics, 139(1):181–216, 2007.
R. Kobbe, C. Kreuzberg, S. Adjei, B. Thompson, I. Langefeld, P. A. Thompson, H. H.
Abruquah, B. Kreuels, M. Ayim, W. Busch, F. Marks, K. Amoah, E. Opoku, C. G.
Meyer, O. Adjei, and J. May. A randomized controlled trial of extended intermittent
preventive antimalarial treatment in infants. Clinical Infectious Diseases, 45(1):16–25,
2007.
M. Kolesa´r, R. Chetty, J. N. Friedman, E. L. Glaeser, and G. W. Imbens. Identification
and inference with many invalid instruments. National Bureau of Economic Research,
page No. w17519, 2013.
T. C. Koopmans, H. Rubin, and R. B. Leipnik. Measuring the equation systems of dynamic
economics. In Statistical Inference in Dynamic Economic Models. John Wiley & Sons,
Inc., 1950.
E. L. Korenromp, J. R. M. Armstrong-Schellenberg, B. G. Williams, B. L. Nahlen, and
R. W. Snow. Impact of malaria control on childhood anaemia in africa–a quantitative
review. Tropical Medicine & International Health, 9(10):1050–1065, 2004.
M. S. Kramer, Y. Rooks, and H. A. Pearson. Growth and development in children with
sickle-cell trait: a prospective study of matched pairs. New England Journal of Medicine,
299(13):686–689, 1978.
B. Kreuels, S. Ehrhardt, C. Kreuzberg, S. Adjei, R. Kobbe, G. Burchard, C. Ehmen,
M. Ayim, O. Adjei, and J. May. Sickle cell trait (hbas) and stunting in children below
two years of age in an area of high malaria transmission. Malaria Journal, 8(1):16, 2009.
189
B. Kreuels, C. Kreuzberg, R. Kobbe, M. Ayim-Akonor, P. Apiah-Thompson, B. Thompson,
C. Ehmen, S. Adjei, I. Langefeld, O. Adjei, and J. May. Differing effects of hbs and hbc
traits on uncomplicated falciparum malaria, anemia, and child growth. Blood, 115(22):
4551–4558, 2010.
D. A. Lawlor, R. M. Harbord, J. A. C. Sterne, N. Timpson, and G. Davey Smith. Mendelian
randomization: Using genes as instruments for making causal inferences in epidemiology.
Statistics in Medicine, 27(8):1133–1163, 2008.
J. Little and M. J. Khoury. Mendelian randomisation: a new spin or real progress? The
Lancet, 362(9388):930–931, 2003.
A. Mart´ınez-Calleja, I. Quiro´z-Vargas, I. Parra-Rojas, J. F. Mun˜oz-Valle, M. A. Leyva-
Va´zquez, G. Ferna´ndez-Tilapa, A. Vences-Vela´zquez, M. Cruz, E. Salazar-Mart´ınez, and
E. Flores-Alfaro. Haplotypes in the crp gene associated with increased bmi and levels of
crp in subjects with type 2 diabetes or obesity from southwestern mexico. Experimental
Diabetes Research, 2012:1–7, 2012.
J. May, J. A. Evans, C. Timmann, C. Ehmen, W. Busch, T. Thye, T. Agbenyega, and
R. D. Horstmann. Hemoglobin variants and disease manifestations in severe falciparum
malaria. Journal of the American Medical Association, 297(20):2220–2226, 2007.
I. A. McGregor, H. M. Gilles, J. H. Walters, A. H. Davies, and F. A. Pearson. Effects
of heavy and repeated malarial infections on gambian infants and children: Effects of
erythrocytic parasitization. The British Medical Journal, 2(4994):686–692, 1956.
F. Mealli and B. Pacini. Using secondary outcomes to sharpen inference in randomized
experiments with noncompliance. Journal of the American Statistical Association, 108
(503):1120–1131, 2013.
A. Mikusheva. Robust confidence sets in the presence of weak instruments. Journal of
Econometrics, 157(2):236–247, 2010.
M. J. Moreira. A conditional likelihood ratio test for structural models. Econometrica, 71
(4):1027–1048, 2003.
M. P. Murray. Avoiding invalid instruments and coping with weak instruments. The Journal
of Economic Perspectives, 20(4):111–132, 2006.
B. K. Natarajan. Sparse approximate solutions to linear systems. SIAM Journal on Com-
puting, 24(2):227–234, 1995.
National Institute of Health. Clinical guidelines on the identification, evaluation, and treat-
ment of overweight and obesity in adults: The evidence report. Obesity Research, 2:
51S–209S, 1998.
J. Neyman. On the application of probability theory to agricultural experiments. Statistical
Science, 5:463–480, 1923.
190
S.-L. T. Normand, M. B. Landrum, E. Guadagnoli, J. Z. Ayanian, T. J. Ryan, P. D. Cleary,
and B. J. McNeil. Validating recommendations for coronary angiography following acute
myocardial infarction in the elderly: a matched analysis using propensity scores. Journal
of Clinical Epidemiology, 54(4):387–398, 2001.
A. M. Nyakeriga, M. Troye-Blomberg, A. K. Chemtai, K. Marsh, and T. N. Williams.
Malaria and nutritional status in children living on the coast of kenya. Scandinavian
Journal of Immunology, 59(6):615–616, 2004.
E. L. Ogburn, A. Rotnitzky, and J. M. Robins. Doubly robust estimation of the local average
treatment effect curve. Journal of the Royal Statistical Society: Series B (Statistical
Methodology), 77(2):373–396, 2015.
S. B. Omer, D. A. Salmon, W. A. Orenstein, M. P. deHart, and N. Halsey. Vaccine refusal,
mandatory immunization, and the risks of vaccine-preventable diseases. New England
Journal of Medicine, 360(19):1981–1988, 2009.
R. A. Price, W.-D. Li, and H. Zhao. Fto gene snps associated with extreme obesity in cases,
controls and extremely discordant sister pairs. BMC Medical Genetics, 9(1):4, 2008.
N. Rehan. Growth status of children with and without sickle cell trait. Clinical Pediatrics,
20(11):705–709, 1981.
A. L. Rice, L. Sacco, A. Hyder, and R. E. Black. Malnutrition as an underlying cause of
childhood deaths associated with infectious diseases in developing countries. Bulletin of
the World Health Organization, 78(10):1207–1221, 2000. ISSN 0042-9686.
D. H. Richardson and D.-M. Wu. A note on the comparison of ordinary and two-stage least
squares estimators. Econometrica, pages 973–981, 1971.
N. S. Roetker, J. A. Yonker, C. Lee, V. Chang, J. J. Basson, C. L. Roan, T. S. Hauser,
R. M. Hauser, and C. S. Atwood. Multigene interactions and the prediction of depression
in the wisconsin longitudinal study. British Medical Journal Open, 2(4):e000944, 2012.
P. R. Rosenbaum. A characterization of optimal designs for observational studies. Journal
of the Royal Statistical Society. Series B. Methodological, 53(3):597–610, 1991.
P. R. Rosenbaum. Observational Studies. Springer Series in Statistics. Springer-Verlag,
New York, second edition, 2002.
P. R. Rosenbaum. Design of Observational Studies. Springer Series in Statistics. Springer,
New York, 2010.
P. R. Rosenbaum and J. H. Silber. Amplification of sensitivity analysis in matched obser-
vational studies. Journal of the American Statistical Association, 104(488):1398–1405,
2009.
T. J. Rothenberg. Identification in parametric models. Econometrica, pages 577–591, 1971.
191
D. B. Rubin. Estimating causal effects of treatments in randomized and nonrandomized
studies. Journal of Educational Psychology, 66(5):688, 1974.
D. B. Rubin. Comment on “randomized analysis of experimental data: The fisher random-
ization test”. Journal of the American Statistical Association, 75(371):591–593, 1980.
D. B. Rubin. Causal inference using potential outcomes. Journal of the American Statistical
Association, 100(469):322–331, 2005.
D. B. Rubin. The design versus the analysis of observational studies for causal effects:
parallels with the design of randomized trials. Statistics in Medicine, 26(1):20–36, 2007.
D. B. Rubin and R. P. Waterman. Estimating the causal effects of marketing interventions
using propensity score methodology. Statistical Science, pages 206–222, 2006.
J. K. Rybakowski, A. Borkowska, M. Skibinska, A. Szczepankiewicz, P. Kapelski,
A. Leszczynska-rodziewicz, P. M. Czerski, and J. Hauser. Prefrontal cognition in
schizophrenia and bipolar illness in relation to val66met polymorphism of the brain-
derived neurotrophic factor gene. Psychiatry and Clinical Neurosciences, 60(1):70–76,
2006.
T. H. Sach, G. R. Barton, M. Doherty, K. R. Muir, C. Jenkinson, and A. J. Avery. The
relationship between body mass index and health-related quality of life: comparing the
eq-5d, euroqol vas and sf-6d. International Journal of Obesity, 31(1):189–196, 2006.
J. D. Sargan. The estimation of economic relationships using instrumental variables. Econo-
metrica, pages 393–415, 1958.
J. A. G. Scott, J. A. Berkley, I. Mwangi, L. Ochola, S. Uyoga, A. Macharia, C. Ndila,
B. S. Lowe, S. Mwarumba, E. Bauni, K. Marsh, and T. N. Williams. Relation between
falciparum malaria and bacteraemia in kenyan children: a population-based, case-control
study and a longitudinal study. The Lancet, 378(9799):1316–1323, 2011.
R. J. Serfling. Approximation Theorems of Mathematical Statistics. Wiley, 1980.
N. A. Sheehan, V. Didelez, P. R. Burton, and M. D. Tobin. Mendelian randomisation and
causal inference in observational epidemiology. PLoS Medicine, 5(8):e177, 2008.
Y. Y. Shugart, L. Chen, I. N. M. Day, S. J. Lewis, N. J. Timpson, W. Yuan, M. R.
Abdollahi, S. M. Ring, S. Ebrahim, J. Golding, D. A. Lawlor, and G. Davey Smith. Two
british women studies replicated the association between the val66met polymorphism
in the brain-derived neurotrophic factor (bdnf) and bmi. European Journal of Human
Genetics, 17(8):1050–1055, 2009.
D. S. Small. Sensitivity analysis for instrumental variables regression with overidentifying
restrictions. Journal of the American Statistical Association, 102(479):1049–1058, 2007.
192
D. S. Small, J. L. Gastwirth, A. M. Krieger, and P. R. Rosenbaum. Simultaneous sensitivity
analysis for observational studies using full matching or matching with multiple controls.
Statistics and Its Interface, 2:203–211, 2009.
R. W. Snow, P. Byass, F. C. Shenton, and B. M. Greenwood. The relationship between an-
thropometric measurements and measurements of iron status and susceptibility to malaria
in gambian children. Transactions of The Royal Society of Tropical Medicine and Hygiene,
85(5):584–589, 1991.
N. Solovieff, C. Cotsapas, P. H. Lee, S. M. Purcell, and J. W. Smoller. Pleiotropy in complex
traits: challenges and strategies. Nature Reviews Genetics, 14(7):483–495, 2013.
A. J. Sovey and D. P. Green. Instrumental variables estimation in political science: A
readers guide. American Journal of Political Science, 55(1):188–200, 2011.
D. Staiger and J. H. Stock. Instrumental variables regression with weak instruments. Econo-
metrica, 65(3):557–586, 1997.
J. H. Stock, J. H. Wright, and M. Yogo. A survey of weak instruments and weak identifica-
tion in generalized method of moments. Journal of Business & Economic Statistics, 20
(4), 2002.
E. A. Stuart. Matching methods for causal inference: A review and a look forward. Statis-
tical Science, 25(1):1, 2010.
S. A. Swanson and M. A. Herna´n. Commentary: How to report instrumental variable
analyses (suggestions welcome). Epidemiology, 24(3):370–374, 2013.
Z. Tan. Regression and weighting methods for causal inference using instrumental variables.
Journal of the American Statistical Association, 101(476):1607–1618, 2006.
F. O. ter Kuile, D. J. Terlouw, S. K. Kariuki, P. A. Phillips-Howard, L. B. Mirel, W. A.
Hawley, J. F. Friedman, Y. P. Shi, M. S. Kolczak, A. A. Lal, J. M. Vulule, and B. L.
Nahlen. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants
in an area of intense perennial malaria transmission in western kenya. The American
Journal of Tropical Medicine and Hygiene, 68(4 suppl):68–77, 2003.
D. C. Thomas and D. V. Conti. Commentary: the concept of mendelian randomization.
International Journal of Epidemiology, 33(1):21–25, 2004.
G. Thorleifsson, G. B. Walters, D. F. Gudbjartsson, V. Steinthorsdottir, P. Sulem, A. Hel-
gadottir, U. Styrkarsdottir, S. Gretarsdottir, S. Thorlacius, I. Jonsdottir, T. Jonsdottir,
E. J. Olafsdottir, G. H. Olafsdottir, T. Jonsson, F. Jonsson, K. Borch-Johnsen, T. Hansen,
G. Andersen, T. Jorgensen, T. Lauritzen, K. K. Aben, A. L. Verbeek, N. Roeleveld,
E. Kampman, L. R. Yanek, L. C. Becker, L. Tryggvadottir, T. Rafnar, D. M. Becker,
J. Gulcher, L. A. Kiemeney, O. Pedersen, A. Kong, U. Thorsteinsdottir, and K. Stefans-
193
son. Genome-wide association yields new sequence variants at seven loci that associate
with measures of obesity. Nature Genetics, 41(1):18–24, 2008.
R. Tibshirani. Regression shrinkage and selection via the lasso. Journal of the Royal
Statistical Society. Series B (Methodological), pages 267–288, 1996.
R. J. Tibshirani. The lasso problem and uniqueness. Electronic Journal of Statistics, 7:
1456–1490, 2013.
N. J. Timpson, D. A. Lawlor, R. M. Harbord, T. R. Gaunt, I. N. M. Day, L. J. Palmer,
A. T. Hattersley, S. Ebrahim, G. Lowe, A. Rumley, and G. Davey Smith. C-reactive
protein and its role in metabolic syndrome: Mendelian randomisation study. The Lancet,
366(9501):1954–1959, 2005.
G. W. Torrance. Utility approach to measuring health-related quality of life. Journal of
Chronic Diseases, 40(6):593–600, 1987.
K. Trakas, P. I. Oh, S. Singh, N. Risebrough, and N. H. Shear. The health status of obese
individuals in canada. International Journal of Obesity, 25(5):662–668, 2001.
J. A. Tropp. Just relax: Convex programming methods for identifying sparse signals in
noise. IEEE Transactions on Information Theory, 52(3):1030–1051, 2006.
O. Ukkola, E. Ravussin, P. Jacobson, L. Sjo¨stro¨m, and C. Bouchard. Mutations in the
adiponectin gene in lean and obese subjects from the swedish obese subjects cohort.
Metabolism, 52(7):881–884, 2003.
United States Surgeon General. The Health Consequences of Smoking. US Department of
Health and Human Services, 1988.
J. Wang and E. Zivot. Inference on structural parameters in instrumental variables regres-
sion with weak instruments. Econometrica, pages 1389–1404, 1998.
G. L. Wehby, R. L. Ohsfeldt, and J. C. Murray. mendelian randomization equals instrumen-
tal variable analysis with genetic instruments. Statistics in Medicine, 27(15):2745–2749,
2008.
WHO Multicentre Growth Reference Study Group. WHO child growth standards based on
length/height, weight and age. Acta Paediatrica. Supplement, 450:76–85, 2006.
M. Willcox, A. Bjo¨rkman, J. Brohult, P. Pehrson, L. Rombo, and E. Bengtsson. A case-
control study in northern liberia of plasmodium falciparum malaria in haemoglobin s and
beta-thalassaemia traits. Annals of Tropical Medicine and Parasitology, 77(3):239–246,
1983.
T. N. Williams, T. W. Mwangi, D. J. Roberts, N. D. Alexander, D. J. Weatherall,
S. Wambua, M. Kortok, R. W. Snow, and K. Marsh. An immune basis for malaria
protection by the sickle cell trait. PLoS medicine, 2(5):e128, 2005.
194
J. M. Wooldridge. Econometric Analysis of Cross Section and Panel Data. MIT press, 2nd
ed. edition, 2010.
World Health Organization. World malaria report 2014. World Health Organization, 2014.
F. Yang, J. R. Zubizarreta, D. S. Small, S. Lorch, and P. R. Rosenbaum. Dissonant conclu-
sions when testing the validity of an instrumental variable. The American Statistician,
68(4):253–263, 2014.
W.-S. Yang, P.-L. Tsou, W.-J. Lee, D.-L. Tseng, C.-L. Chen, C.-C. Peng, K.-C. Lee, M.-J.
Chen, C.-J. Huang, T.-Y. Tai, and L.-M. Chuang. Allele-specific differential expression
of a common adiponectin gene polymorphism related to obesity. Journal of Molecular
Medicine, 81(7):428–434, 2003.
W.-S. Yang, Y.-C. Yang, C.-L. Chen, I.-L. Wu, J.-Y. Lu, F.-H. Lu, T.-Y. Tai, and C.-J.
Chang. Adiponectin snp276 is associated with obesity, the metabolic syndrome, and
diabetes in the elderly. The American Journal of Clinical Nutrition, 86(2):509–513, 2007.
J. R. Zubizarreta, D. S. Small, N. K. Goyal, S. Lorch, and P. R. Rosenbaum. Stronger
instruments via integer programming in an observational study of late preterm birth
outcomes. The Annals of Applied Statistics, 7(1):25–50, 2013.
195
